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ABSTRACT 
SOCIAL DETERMINANTS OF CARDIOMETABOLIC DISEASE CONTROL:       
AN ECOSOCIAL APPROACH 
SEPTEMBER 2018 
CRISTINA HUEBNER TORRES, B.A. MOUNT HOLYOKE COLLEGE 
M.A., NEW YORK UNIVERSITY 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Elizabeth Bertone-Johnson 
 
Cardiovascular disease (CVD) is the leading cause of death in the United States. Diabetes 
mellitus, hypertension, and dyslipidemia are three primary risk factors for CVD. Each is 
disproportionately distributed in the population by race/ethnicity. Social determinants of health 
(SDoH) research indicate that social and environmental factors upstream of individual behaviors 
can impede an individual’s chronic disease control. Guided by Michael Marmot’s SDoH 
theoretical framework and by an ecosocial approach, this study used data from a cross-sectional 
mixed methods study conducted in Western Massachusetts at a federally qualified health center 
from 2014 to 2018 (RxHL) to examine the association between SDoH—food insecurity and 
social stressors—and cardiometabolic disease control. Based on the theoretical framework, self-
reported and pill count medication adherence were assessed as a possible mediator of the 
exposure/outcome relationship.  
In Chapter 1, we situated social determinants of health and cardiometabolic disease 
control within a social epidemiologic approach using Michael Marmot’s social determinants of 
health and an ecosocial theoretical framework to address the concept of embodiment.  
In Chapter 2, we examined food insecurity, medication adherence, and cardiometabolic 
disease control and examined mediation by self-reported medication adherence. We had 
unexpected null findings for food insecurity and diabetes control and hypertension control. Food 
viii	
	
insecurity was independently associated with higher lipid levels. Self-reported medication 
adherence partially mediated the association between food insecurity and dyslipidemia as 
measured by Non-HDL-C.  
In Chapter 3, we examined social stressors, medication adherence, and cardiometabolic 
chronic disease control. Unexpectedly, there was no association observed between social stressors 
and glycemic control among those with diabetes or SBP control among those with hypertension. 
Adjusted multivariable analyses indicated social stressors were independently associated with 
higher lipid levels as measured by LDL-C. Self-reported medication adherence partially mediated 
the association between social stressors and LDL-C. 
In Chapter 4, we examined racial/ethnic differences in social determinants, medication 
adherence and cardiometabolic disease control. Using linear and proportional odds models, 
predicted continuous outcomes and predicted prevalence, and pairwise comparisons, we found 
race/ethnicity was independently associated with each outcome variable compared to non-
Hispanic whites controlling for covariates. Pairwise comparisons highlighted additional 
significant differences between groups.  
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CHAPTER 1 
INTRODUCTION AND BACKGROUND: 
A SOCIAL EPIDEMIOLOGY APPROACH 
 
1.1. Introduction 
Cardiovascular disease is the leading cause of death in the United States (CDC, 2016). 
Four commonly co-occurring conditions are risk factors for CVD and include type 2 diabetes, 
hypertension (high blood pressure), dyslipidemia (abnormal cholesterol), and obesity (AHA, 
2016).  Based on National Health and Nutritional Examination Survey data (2010), forty-five 
percent of U.S. adults were found to have either diabetes, hypertension, or hyperlipidemia, 13% 
had two of the chronic conditions, and 3% had all three (Fryar et al., 2010). Each of these 
diseases is disproportionately distributed in the population by race and ethnicity such that 
racial/ethnic minorities have higher rates of having one or more of these diseases compared to 
whites (CDC, 2016; Fryar et al., 2010). 
 
1.1.2. Diabetes Mellitus 
Diabetes mellitus is categorized into four distinct types: Type 1 diabetes, Type 2 diabetes, 
Gestational diabetes mellitus, diabetes due to other causes (ADA, 2016; CDC, 2014). The vast 
majority (90-95%) of all cases of diabetes is categorized as Type 2 diabetes (ADA, 2016). Type 2 
diabetes (T2D) occurs in “individuals who have insulin resistance and usually relative (rather 
than absolute) insulin deficiency” (ADA, 2016, p. S16). Unlike Type 1 diabetes, autoimmune 
destruction of !-cells is not the cause of Type 2 diabetes (ADA, 2016). Among those with Type 2 
diabetes being overweight or obese or having fat concentrated in the abdominal region is common 
and overweight/obesity can lead to insulin (ADA, 2016). Weight loss and medication can 
improve insulin resistance (ADA, 2016). Type 2 diabetes is more common in “those with 
	 	
	
	 	
	 	
	
2	
hypertension or dyslipidemia and in certain racial/ethnic subgroups (African American, American 
Indian, Hispanic/Latino, and Asian American)” (ADA, 2016, p.S17). There are several blood 
tests used independently to diagnose diabetes. Among them is the Hemoglobin A1c test which 
measures average blood glucose (blood sugar) levels over the prior 8 to 12 weeks. An A1c >6.5% 
(48 mmol/mol) is diagnosed as diabetes and, without medically confirmed hyperglycemia, repeat 
testing is recommended (ADA, 2016). In addition, those with increased risk for developing 
diabetes—defined by an A1c> 5.7% and <6.5%--are categorized as having prediabetes (ADA, 
2016).   
As of 2014, 29.1 million (9.3%) of the U.S. population had either diagnosed diabetes 
(21.9 million) or undiagnosed pre-diabetes (8.1 million) (CDC, 2014; ADA, 2016, ). 2,3 Of those, 
only 4.3% (1.25 million) are adults and children with Type 1 diabetes.  According to a study 
using National Health and Nutrition Examination Survey data from 1999-2008, 16% of adults 
with diabetes had uncontrolled blood glucose levels (HbA1c>9%) (Berkowitz et al., 2013). 
Adults living with diabetes have a 70% increased risk of hypertension and a 2- to 4-fold increased 
likelihood of having heart disease, stroke or other heart conditions compared to those without 
diabetes (CDC, 2016; DHHS, 2007). Type 2 diabetes (T2D) is the seventh leading cause of death 
in the U.S. and is disproportionately distributed in the population by race and ethnicity.  6,7 Nearly 
twice as many Blacks (13.2%) and Hispanics (12.8%) compared to whites (7.6%) aged 20 or 
older were diagnosed with diabetes as of 2014 in the U.S. (CDC, 2015; ADA, 2014). Among 
Hispanics (12.8%), Puerto Ricans (14.8%) account for the largest group with diabetes (ADA, 
2016). Each year, 1.4 million individuals in the U.S. are diagnosed with diabetes (ADA, 2014). 
Age-adjusted all-cause mortality data from 2003 to 2006 indicate that those with diabetes have a 
1.5 times higher chance of death compared to those without the disease (CDC, 2014). 2 Because 
diabetes is the leading cause of microvascular complications including blindness and non-
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traumatic lower-limb amputations 2, prevention and management of diabetes is a major public 
health concern.  
The cost of diagnosed diabetes in the U.S. in 2012 was $245 billion--$176 billion of 
which was related to actual medical costs and $69 billion related to decreased productivity among 
those with diagnosed diabetes (ADA, 2016). Age- and sex-adjusted medical costs indicate that 
expenditures are 2.3 times higher among those with diabetes compared to those without (ADA, 
2016).  In addition to the serious and costly complications associated with diabetes, diabetes is a 
serious risk factor for cardiovascular disease (CVD) and, among those with diabetes, CVD is the 
leading cause of early death (CDC, 2016). In 2011, 7.6 million adults aged 35 or older diagnosed 
with diabetes self-reported having had a heart attack or stroke (CDC, 2013). 
Recommendations to reduce and/or manage diabetes include regular blood glucose self-
monitoring, following a recommended diet for optimal blood glucose control, increasing physical 
activity, adhering to regular medical appointments and medications, and annual foot and eye 
exams.  
 
1.1.3 Hypertension 
Hypertension (high blood pressure) is defined as having systolic blood pressure—the pressure in 
the blood vessels when the heart beats—of 140 mmHg or higher and/or diastolic blood 
pressure—the pressure in the blood vessels between beats—of 90 mmHg or higher. 
Approximately 70 million (29%)—or 1 in 3—adults in the U.S. have hypertension. Among those 
with hypertension, just over half (52%) have their high blood pressure in control. This is more 
than twice that of diabetes. Reported prevalence rates, however, are likely underestimates since 
approximately 20% of adults with hypertension are unaware of their diagnosis (CDC, 2016). 
Among those with hypertension, there is four-fold increased risk of death from stroke and a three-
	 	
	
	 	
	 	
	
4	
fold increased risk of death from heart attack (CDC, 2016). Hypertension is associated with $46 
billion in health care costs each year. Recommendations to reduce and/or manage hypertension 
include eating a reduced sodium diet, adhering to prescribed medications and medical 
appointments, getting adequate physical activity and stopping smoking.  
 
1.1.4. Dyslipidemia 
Dyslipidemia, defined as “elevated total or low-density lipoprotein (LDL) cholesterol levels, or 
low levels of high-density lipoprotein (HDL) cholesterol” and has been identified as a primary 
risk factor for CHD (Fodor, 2011, p.1207). One manifestation of dyslipidemia is 
hyperlipidemia—high cholesterol—and is defined by having low density lipoprotein level (LDL) 
>130 mg/dL. However, among them less a third (29.5%) have their hyperlipidemia in control. 
Among those with hyperlipidemia, there is a 2-fold increased risk of CVD compared to those 
without hyperlipidemia (CDC, 2015). The highest rates of hyperlipidemia are among Blacks and 
Hispanics. For each of these chronic conditions, disease management aims to control disease 
progression through prescribed medication, heart-healthy diets, increased physical activity, 
tobacco treatment, and minimizing alcohol consumption.  
 
1.1.5. Obesity 
Over a third of U.S. adults are obese (CDC, 2016; Ogden et al., 2014) and obesity is a risk factor 
for diabetes, heart disease, stroke and other chronic diseases (CDC, 2016). Obesity, like the other 
chronic diseases it is associated with, is disproportionately distributed among non-Hispanic 
blacks (47.8%) and Hispanics (42.5%), followed by non-Hispanic whites (32.6%) and non-
Hispanic Asians (10.8%) (CDC, 2016; Ogden et al., 2014). Many federal and state policies and 
initiatives have been instituted to address obesity rates in the U.S., though, rates appear to have 
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held steady since 2003-2004 and 2009-2010 as measured by the National Health and Nutrition 
Examination Survey (NHANES) (Ogden et al., 2014).  
 
1.1.6. Comorbidity/Multimorbidity 
Comorbidity is defined as “a specific combination of diseases or additional diseases beyond the 
index disease under study” (van den Akker et al., 1998, p.367). In contrast, multimorbidity is 
defined as “the co-occurrence of multiple chronic or acute diseases and medical conditions within 
one person” and often described as two or more chronic conditions at the same time (Koroukian 
et al., 2015, p.1; Goodman et al., 2013; Valderas et al, 2009; van den Akker, 1998).  
 
1.1.7. Cardiometabolic Risk 
 Cardiometabolic risk is defined by the American Diabetes Association and the American 
College of Cardiology Foundation as “the lifetime risk for cardiovascular disease” and is 
measured by the presence of at least 3 out of five factors: 1) central obesity; 2) insulin resistance; 
3) high blood glucose levels; 4) low HDL (good cholesterol); and 5) hypertension. Individuals 
living with diabetes are more likely to have many of these factors (Brunzell et al., 2008; CDC, 
2016). The National Diabetes Education Program’s campaign to manage risk factors for CVD and 
diabetes focuses on modifiable risk factors referred to as the “ABCs”: A: Hemoglobin A1c (blood 
glucose) less than 7%; B: blood pressure less than 130/80 mmHg; C: Cholesterol (LDL less than 
100 mg/dl); and s: Stop Smoking (NDEP, 2016).  
Cardiometabolic risk as defined above is multi-level and can be categorized into micro- 
(biologic/cellular), individual- (behavioral), macro-level (social/environmental) factors. 
According to the American Diabetes Association (ADA) and the American Heart Association 
(AHA), managing diabetes, hypertension, and dyslipidemia requires a lifestyle of a heart-healthy 
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diet, regular moderate physical activity, reduced alcohol consumption, adherence to medications 
and medical appointments, and on-going self-management education. Each cardiometabolic 
disease has specific recommendations within these broad categories. For diabetes management, 
daily blood glucose monitoring, daily self-exam of feet, and attending diabetes self-management 
classes are recommended (ADA, 2016; CDC, 2013). In addition to daily self-management, 
recommended preventive care practices to avoid disease progression include: annual dilated eye 
exam, annual foot exam, annual doctor’s visit, two or more hemoglobin A1c tests per year, and 
annual influenza vaccine (CDC, 2013). For hypertension, maintaining a diet low in sodium, 
regular blood pressure monitoring, and quitting smoking are recommended (AHA, 2016). And, 
for cholesterol, maintain a diet low in saturated and trans fats is recommended. (AHA, 2016).  
It has been well established in the literature that behavior modification of individual-level 
factors (e.g., exercise, diet, alcohol use, tobacco use) can greatly reduce cardiometabolic risk and 
onset of cardiometabolic diseases such as T2D, hypertension and hyperlipidemia. As such, nearly 
five decades of public health and clinical research from the 1950s to early 2000s to address the 
prevention and management of chronic disease has been largely focused on individual-level 
behaviors and risk factors often referred to as modifiable risk factors or behaviors (AHA, 2016).  
A modifiable behavior implies that the individual is in control and has the capacity to 
make the change and places the onus of achieving improved health outcomes on the individual. 
However, from a social epidemiologic perspective, it is imperative to examine whether the 
modifiable risk factors are in fact modifiable and, if so, for whom and in what regions are they 
truly modifiable at the individual level? Social, environmental and economic factors frequently 
constrain individuals and groups from making behavior changes and/or predispose them to 
increased exposure to associated risk factors. For instance, urban dwelling, low income 
individuals have decreased access to safe, walkable spaces, increased rates of food insecurity, and 
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are exposed to increased sources of stress related to disease management and obtaining basic 
needs. Therefore, eating healthier and moving more may not be a matter of choice but rather may 
be unattainable and smoking, for example, may not be reduced as a result of the increased stress 
associated with living with insufficient resources.  Observational studies have found that, as a 
result, interventions and policy changes that promote behavior change have been less effective in 
the long-term than expected (Berkman, 2009). Additionally, cultural health beliefs—the meaning 
that individuals from different cultural backgrounds make about their health and illness and what 
is believed to cause or remedy disease—vary and therefore subsequent behaviors may not align 
with medical treatment plans (Shaw et al., 2012; Orzech et al., 2013; Shaw et al., 2009). This can 
further complicate the notion of modifiable behaviors.  
According to the American Diabetes Association and the American Heart Association, 
the non-modifiable cardiometabolic risk factors include age, race/ethnicity, gender, and 
family/genetic history (AHA, 2016). Chronic exposure to poverty over the lifetime (and, often 
times, transgenerationally), the built and social environments, and the effects of racial 
discrimination can all impede the degree to which an individual is able to modify behavior in 
order to prevent or manage cardiometabolic disease. Interventions and policies aimed at 
eliminating systems-level barriers and inequities can make individual-level behavior changes a 
more achievable goal—particularly for those who are disproportionately burdened by 
cardiometabolic disease. 
 
1.2. Social Epidemiology of Cardiometabolic Disease Control  
1.2.1. Social Epidemiology 
Social epidemiology—the social determinants and distribution of disease in human populations— 
emerged in response to the shift from infectious disease to noncommunicable chronic diseases as 
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the lead cause of morbidity and mortality in most regions of the world post WWII era (Berkman 
et al., 2014). It evolved to better understand the etiology, distribution and determinants of 
diseases not adequately explained by the more traditional epidemiologic triangle of host, agent, 
and environment used in infectious disease research (Cassel, 1964). Social epidemiologists drew 
from the social and behavioral sciences including medical sociology to develop theoretical 
frameworks that can address the interface between the biological, psychosocial and ecological 
factors. These frameworks are used to guide epidemiologic investigations that can address social 
factors as part of the etiology of disease and can link social/environmental exposures with health 
outcomes (Susser & Stein, 2009; Berkman & Kawachi, 2014). When examining the relationship 
between social determinants of health and health outcomes, theoretical frameworks and research 
methods that address the multiple-level factors involved (e.g., social/environment, individual, 
biological) are needed.  
Much of the public health and clinical research in adult chronic disease prevention and 
management over the past five decades has focused on individual-level risk factors and 
behavioral modifications. As described above, the cardiometabolic disease burden in the U.S. is 
disproportionately distributed among communities of color. Among low income, ethnically 
diverse, urban-dwelling individuals living with chronic disease—namely diabetes and/or 
cardiovascular disease—making recommended behavioral modifications are often constrained by 
issues associated with poverty such as lack of access to healthy, affordable foods for improved 
dietary intake or safe and walkable spaces for increased physical activity. Low health literacy 
(Shaw et al., 2012), cultural and linguistic barriers (Shaw et al., 2009), and other social 
determinants of health pose significant challenges to self-care. These factors complicate patients’ 
ability to make behavioral changes. Yet, to date, much of the research addressing prevention and 
management of chronic disease is focused on behavior change at the individual level. Therefore, a 
	 	
	
	 	
	 	
	
9	
social epidemiologic approach is necessary as it prioritizes “an understanding of the complex 
social and economic dynamics driving what seems to be, but is not, individual choice” (Berkman, 
Kawachi & Glymour, 2014, p. 9).   
Geoffrey Rose, a foremost epidemiologist, identified that “a large number of people at a 
small risk may give rise to more cases of disease than the small number who are at high risk” 
(Rose, 2001, p. 431). Rose introduced the idea that, while the medical and public health fields 
often aim to identify and protect those at high risk, the focus should instead be a population 
approach which aims “to discover and control the causes of incidence” (Rose, 2001, p.427). 
Rose’s work gets at why certain individuals and populations are affected by disease while others 
are not or are to a lesser degree—a key concept in health disparities and social determinants of 
health research that aim to address the “causes of the causes” (Marmot, 2006, p.2) or those factors 
that are upstream of individual-level risk factors like lifestyle and behavior (Berkman et al., 
2014).  
 
1.2.2. Social Determinants of Health 
The World Health Organization defines the social determinants of health as “the 
conditions in which people are born, grow, work, live, and age, and the wider set of forces and 
systems shaping the conditions of daily life. These forces and systems include economic policies 
and systems, development agendas, social norms, social policies and political systems” (WHO, 
2016). Several federal institutions and initiatives have defined the social determinants of health 
and identified primary domains of focus to eliminate health disparities, improve health outcomes, 
and reduce health care costs. Specifically, Healthy People 2020 (ODPHP, 2016), the American 
Heart Association’s Scientific Report on the social determinants of risk and outcomes for CVD 
(AHA, 2015), the National Academy of Medicine’s (formerly the IOM) report “Capturing Social 
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and Behavioral Domains in the Electronic Medical Record—Phase 2 (IOM, 2014), and the 
National Association of Community Health Center’s Protocol for responding to and assessing 
patients’ assets, risks and experiences (PRAPARE) (NACHC, 2016) tool each identifies and 
defines the primary social determinants of health domains/variables to be addressed through 
various health policy, initiatives, research, and clinical and public health programs (Appendix 1). 
As demonstrated in Appendix 1, the domains and corresponding subcategories are largely 
comparable across the various institutions and initiatives helping to focus the scope of SDoH 
research, policy, and intervention.  
Drawing from these definitions, the domains of the SDoH, and from the work of Michael 
Marmot, epidemiologist and a leader of research on health inequities, the term “social 
determinants of health” is used in this paper to represent four primary constructs (Figure 1). First, 
it refers to the well-established fact that “health follows a social gradient: the higher the social 
position, the better the health” (Marmot & Wilkinson, 2006, p.2) and that this phenomenon exists 
even among those not living in poverty but rather at every point on the social spectrum (Marmot 
et al., 2006). Second, it refers to the social conditions in which people live and work and 
identifies these factors as the cause of the social gradient of health. It is these social conditions 
that are thought to influence behaviors that are then more proximally associated with biologic 
markers of disease. Therefore, the focus of SDoH is to identify “the causes of the causes” 
(Marmot et al., 2006, p.2). Very specifically, medicine and public health have tended to approach 
disease prevention and management from an individual-level perspective addressing the 
behaviors associated with markers of health or illness (e.g., high density, low nutrient diets and 
obesity; smoking). SDoH looks upstream of individual behaviors to identify the social, economic 
and environmental circumstances in which people are at increased risk to consume high density, 
low nutrient foods, to be physically inactive, and to experiences increased stress associated with 
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having insufficient access to material resources throughout life (Barnard et al., 2015). These 
circumstances have been associated with increased engagement in behaviors, such as overeating 
and smoking—coping methods known to increase risk and poor health outcomes. Third, it refers 
the impact of chronic stress on biologic processes that can result in disease and early death 
(Marmot et al., 2006). National and global policies are upstream of social and environmental 
factors and thus critical sources where change can have broad and lasting impacts—both positive 
and negative depending on the policy (Marmot et al., 2006). Therefore, to address SDoH at the 
policy level is one way to effect change in the rates and distribution of disease where decades of 
emphasis on individual and behavioral factors in public health and medicine have not. 
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Figure 1. Social determinants of health (Marmot et al., 2006, p. 9)  
 
 
 
 
1.3. Physiology of Social Determinants and Cardiometabolic Disease Control  
 
Three broad areas have been hypothesized as links between social conditions and health 
outcomes: 1) social/built environments; 2) health behaviors; and 3) stress and cognitive/affective 
processes (Kubzansky et al., 2014, p.512). The possible physiologic mechanisms include: 1) 
Autonomic function; 2) HPA axis; 3) Immune function; 4) Inflammatory processes; and 5) 
Apoptotic regulation (Kubzansky et al., 2014, p. 513). As illustrated in Marmot’s model of social 
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determinants of health (Figure 1), the more proximal/downstream factors like behavior, 
psychological and biologic processes that are associated with disease are modeled as possible 
mediators in the relationship between the social environment and health or illness (Marmot et al., 
2006).  “These downstream factors are the proximal causes of disease which tend to be the main 
focus of medical attention” (p. 9). From a social epidemiologic approach, the term “ecosocial” is 
used to encompass the possible mechanisms that explain the effect of upstream systems-level or 
neighborhood-level exposures, such as factors associated with systems- or neighborhood-level 
poverty, on health outcomes.18,19 There are several mechanisms that may explain the association 
between social determinants and cardiometabolic disease control and multimorbidity.3,10-12 For 
each of the subsequent papers, a detailed description of the specific mechanisms for each 
exposure (food insecurity, health literacy and social stress) and outcome (cardiometabolic disease 
control and multimorbidity) will be described. The following is a brief and overarching summary.  
While there is extensive and compelling evidence of the psychological, behavioral, and 
biological pathways associated with the risk and management of cardiometabolic chronic 
diseases, there is a paucity of research that examines these psychological, behavioral, and 
biological factors as potential mediators in the relationship between social determinants of health 
and cardiometabolic chronic disease management (Havranek et al., 2015). To date, much of this 
research addresses the effect of social/environmental factors at the neighborhood-level on health 
behaviors (Kawachi & Berkman, 2003). Neighborhoods that have characteristics associated with 
deprivation have been associated with higher prevalence of cardiometabolic risk factors, higher 
rates of diabetes and other cardiometabolic diseases, and lower rates of chronic disease control 
(Laraia et al., 2012; Diez Roux & Mair, 2010; Seligman, Laraia & Kushel, 2010). For instance, 
“the impact of walkability [of a neighborhood] on walking behavior” and the impact of access to 
healthy foods on eating behaviors and levels of obesity (Diez Roux, 2016, p. 430) are two 
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examples of how neighborhood factors can impact individuals’ health behaviors and may impede 
adoption or maintenance of recommended behavior changes to prevent or manage chronic 
disease. Educational level, “the most used indicator of socioeconomic position in the United 
States” has been associated with health literacy levels (Havranek et al., 2015, p. 875). 
Neighborhoods with higher rates of low educational attainment (< high school) have been found 
to also have higher rates of low health literacy (Havranek et al., 2015). Low health literacy has 
been associated with higher rates of CVD and poorer cardiometabolic chronic disease 
management (Havranek et al., 2015). Neighborhoods characterized by higher rates of social and 
environmental stressors associated with violence and crime and lower SEP have been found to 
have increased rates of depression and depression symptoms (Havranek et al., 2015), which are in 
turn associated with increased rates and risk of cardiometabolic chronic diseases and poor 
management. Conversely, the higher social support or social cohesion associated with ethnic 
density in a neighborhood may lead to decreased rates of depression or depression symptomology 
and improved behaviors, even in the presence of neighborhood barriers (Becares et al., 2014).  
Based on a recent and summative review conducted by the American Heart Association, 
there are three primary biologic pathways that link SDoH to cardiovascular health. The pathways 
include: 1) socioeconomic disadvantage leads to increased burden of risk factors; 2) on-going 
social and environmental stressors lead to cumulative stress on the biologic systems or allostatic 
load; and 3) lifecourse exposure to low SEP (e.g., in utero and during critical windows of 
development) can have long term effects on risk for CVD in adulthood (Havranek et al., 2015).  
The possible biologic mechanisms by which social/environmental neighborhood-level factors 
including low SEP are related to health include “increased stimulation of stress hormones, 
inflammation, endothelial dysfunction, thrombosis, vascular hyperactivity, and metabolic 
disturbances” (Havranek et al., 2015, p. 884).   
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1.4. Theoretical Frameworks 
Nancy Krieger poses the critical question whether all epidemiology is in fact social epidemiology. 
(Krieger 2001). There is substantial debate about this given the social context in which we exist 
(Kaplan, 2004; Oakes, 2013). To this aim, Krieger (2001) questions whether there is any 
biological process or physiologic experience that occurs in the absence of a social environment 
and vice versa. To be clear, this argument by no means minimizes the importance of identifying 
and understanding the behavioral and biologic mechanisms underlying disease. Rather, it 
encourages an expanded vantage point so that the biologic processes, often identified as the 
“cause” of disease, are within context upstream of individual biology and related to the social 
position of individuals in their environments. While the controversy as to whether in fact all 
epidemiology is “social” remains, three primary theoretical frameworks have emerged from 
social epidemiology to contextualize the psychological, social and environmental factors 
associated with risk and distribution of chronic disease. These theoretical frameworks can be used 
to inform the development of interventions and policy that address systems-level factors in 
concert with individual-level ones. A more extensive review of all three (1. psychosocial, 2. 
ecosocial, and 3. political ecology of health) can be found in the Minor Exam paper. For the 
purposes of this study, we will be using the ecosocial framework guided by the subconstruct, 
embodiment (Krieger, 2001; 2005), in combination with Marmot’s model of the social 
determinants of health to guide the research questions and methods. 4  
The theoretical frameworks that have emerged in social epidemiology have both 
developed in response to evidence from landmark studies such as the Whitehall study of British 
civil servants (Marmot, Shipley & Rose, 1984) and based on the need to examine factors not well 
understood by the traditional epidemiologic triangle. These theoretical frameworks address the 
social gradient of health (Marmot & Wilkinson, 2006; Marmot et al., 1984), 
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upstream/downstream or distal/proximal factors (Link & Phelan, 1995; 2004; 2010), and social 
determinants of health (Marmot et al., 2006). They provide a framework with which to examine 
disproportionate burden of disease among vulnerable populations and the associated health 
disparities and inequities (Marmot & Wilkinson, 2006; Marmot et al., 1984). The effect of these 
factors at different points in life or across generations (Kuh & Ben-Shlomo, 2004) has become a 
primary focus of social epidemiologic theoretical frameworks (Berkman et al., 2014) particularly 
as they relate to chronic disease epidemiology.  
 
1.4.1. Ecosocial Theoretical Framework  
Identification of the upstream determinants of health is not, on its own, sufficient to determine 
how the individual/biological-level factors and the exogenous social factors are linked to cause 
disease or to improve health. Krieger suggests a blended, multilevel theoretical framework which 
considers both or multiple levels simultaneously.  
The ecosocial theoretical framework has evolved in response to the realization that that 
social epidemiology must consider causal relationships from a “multidimensional and dynamic” 
perspective (Krieger, 2001). According to Krieger, the ecosocial framework is multilevel in its 
approach, taking time, history, the political ecology and economy into account but also 
considering the level, pathway and power of each contributing factor over the lifecourse (Krieger, 
2008). Ecosocial theory is dynamic in that it is constantly evolving and building on prior efforts 
to address the multidimensional reality of the social distribution and determinants of disease in a 
population as they shift over time (Krieger, 1994; Susser, 1994; Susser, 1973; Krieger 2001; 
Krieger, 2008; Gary-Webb, 2013). In comparison to other “eco-focused” models that have 
evolved over time, Krieger’s ecosocial model “fully embraces a social production of disease 
perspective while aiming to bring in a comparably rich biological and ecological analysis” 
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(Krieger, 2001, p.672). She identifies ecosocial constructs within the ecosocial model that, when 
taken together, can be used to develop multilevel pathways to examine the effects of “racial 
discrimination and their biological embodiment across the life course” (p. 673).  
 
1.4.2. Ecosocial Construct: Embodiment 
Embodiment—one of the constructs of ecosocial theory (Krieger, 2001; 2008)——is defined as 
“how we literally incorporate, biologically, the material and social world in which we live, from 
conception to death” and thus it is understood that an individual’s biological process cannot be 
accurately examined without including the social, historical and environmental factors in which 
she lived (Krieger, 2001, p.668). The construct of embodiment is not unique to social 
epidemiology. Theoretical constructs of embodiment exist across a range of disciplines including 
anthropology, psychology, feminist, gender and queer studies and somatic studies (Fuchs, 2012; 
Koch, Caldwell & Fuchs, 2013). Each addresses, in some capacity, the biological incorporation of 
the social, cultural, psychological, and/or political environment. Given the corporeal capacity to 
incorporate interactions with the world and with people at the cellular level, it only makes sense 
that, in order to change individual-level experiences of health or disease, the social and 
environmental conditions in which the individual exists must be addressed as well. A primary 
focus of embodiment is the effect of systems-level sources of oppression (e.g., institutional 
racism and discrimination) on bodies (Krieger, 2004). For example, inequitable distribution of 
and access to necessary material resources such as fresh, healthy food, safe and affordable 
housing, quality education, and safe, walkable neighborhoods over a lifetime or over the course 
of multiple generations may lead to actual biological changes (Krieger, 2000; 2004). It is 
important to consider how best to capture or measure the “stories” that bodies tell (Krieger, 
2005).  
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1.4.3. Mixed-Method Approach 
Mixed-method studies that rely on both epidemiologic quantitative methods and qualitative 
methods from the social sciences, in particular medical anthropology, can provide context and 
meaning to quantitative findings (Trostle & Sommerfield, 1996). The dataset being used for the 
current study comes from the NIH-funded cross-sectional Medication Adherence Health Literacy 
and Cultural Health Beliefs Study (RxHL) and includes a rich qualitative databank. While those 
data will not be included in this study, they are used in publications from the overall study 
elsewhere.  
 
1.5. Conclusion 
Moving forward, additional research is needed to continue to understand the relationship between 
social and environmental factors and their effect on individual behaivor and biology so that we 
can develop more effective policy and interventions to eliminate health disparities. Engaging the 
theoretical frameworks and methods of social epidemiology can facilitate research on the social 
determinants of health and can contribute critical information to the field regarding how biologic 
processes are situated within a larger context of social, political, historical and environmental 
circumstances. Toward achieving these aims, chapters two through four will be guided by the 
ecosocial theoretical framework outlined in Figure 2. Each will address the social determinants of 
cardiometabolic disease control. They are:  
1) Food insecurity and cardiometabolic disease control and possible mediation by 
medication adherence; 
2) Social stressors and cardiometabolic disease control and possible mediation by 
medication adherence; 
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3) Racial/ethnic differences in social determinants of health, medication adherence, and 
cardiometabolic disease control. 
 
Figure 2. Study Model: Social Determinants of Cardiometabolic Disease Control 
 
Food insecurity was explored as a social determinants of health, as identified by Healthy People 
2020 SDoH domains. Social stressors were examined as a measure of stress associated with 
social determinants from all five Healthy People 2020 SDoH domains. Each of these SDoH 
exposures were measured at the individual level in the RxHL study but represent systems-level, 
social/environmental conditions.  
 The goal for conducting social epidemiologic reseasrch is, in large part, to inform policy 
development since policy is at the outermost ring of an ecologic map—even more upstream than 
the social determinants. It is crucial in defining resource distribution to environments and thus the 
social conditions of the environments in which people live and work and ultimately how health 
and illness are distributed throughout the population.  
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CHAPTER 2 
 
FOOD INSECURITY, MEDICATION ADHERENCE AND 
CARDIOMETABOLIC DISEASE CONTROL: AN ECOSOCIAL APPROACH 
 
 
2.1. Introduction: Cardiometabolic Disease Control 
 
As discussed in the Introduction Chapter, cardiovascular disease (CVD) is the leading cause of 
death in the United States (CDC, 2016). Three cardiometabolic diseases—diabetes mellitus, high 
blood pressure (hypertension) and high blood cholesterol (hyperlipidemia) –have been identified 
as modifiable risk factors for CVD (AHA, 2016).  Effective management of each of these 
cardiometabolic diseases is fundamental to preventing morbidity and mortality associated with 
disease progression and to reduce the risk of CVD events (e.g., heart attack and stoke). For 
instance, glycemic control is one of the primary methods of diabetes management and poor 
glycemic control is associated with higher risk of microvascular (e.g., retinopathy, neuropathy) 
and macrovascular complications (e.g., cardiovascular events) (Giugliano et al., 2018; CDC, 
2016). As of 2014, 20.5% of adults with diabetes in the U.S. have poor glycemic control 
(glycosylated hemoglobin (HbA1c) >9%) and prevalence is higher among low income ethnic 
minorities (HP2020, 2016). Hispanics with diagnosed diabetes had the highest prevalence of poor 
glycemic control (30.2%)—twice the prevalence of non-Hispanic whites (14.6%)—followed by 
non-Hispanic Blacks (25.5%) and non-Hispanic Asians (17.3%) (HP2020, 2016). As of 2014, just 
over half (54%) of adults with hypertension in the U.S. had their blood pressure under control 
(systolic blood pressure (SBP)<140 mmHg and diastolic blood pressure (DBP) <90 mmHg) 
(Merai et al., 2016; CDC, 2018). Similar to diabetes management, prevalence of blood pressure 
control is also lower among racial/ethnic minorities (HP2020, 2016). Compared to non-Hispanic 
Whites (54.8%), African American (43.1%), Asian (40.1%), and Hispanic/Latino (45%) all had 
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lower prevalence of blood pressure control (HP2020, 2016). Little is known about racial/ethnic 
differences in dyslipidemia control (Tayie et al., 2009).  
Medication adherence is one of the primary recommendations to achieve cardiometabolic 
disease control, along with adherence to diet and physical activity guidelines, reduction or 
cessation of tobacco and alcohol use, and adherence to medical appointments (ADA, 2018; CDC, 
2018). Medication adherence is low (Osterberg et al., 2005)—approximately 50%--among those 
with chronic diseases in developed countries (Sabaté, 2003; Oung et al., 2017). As described in 
the introduction chapter, according to Marmot’s social determinants of health model (Marmot, 
2006), medication adherence is a behavior and is hypothesized to act as a mediator between more 
upstream social determinants—such as food insecurity—and disease outcomes.  
 
2.1.2. Food Insecurity 
Food insecurity is identified as one of the Healthy People 2020 social determinants of health 
(SDoH) under the domain of economic stability (HP2020, 2016), and has been examined as a risk 
factor for chronic disease and poor disease management, especially among low-income ethnic 
minority populations (Seligman et al., 2012). Food insecurity is defined as having “limited or 
uncertain availability of nutritionally adequate and safe foods or limited or uncertain ability to 
acquire acceptable foods in socially acceptable ways” (Anderson, 1990, p. 1576; USDA, 2015). 
Food insecurity, particularly in the U.S. among low income individuals, is an episodic and cyclic 
phenomenon such that individuals and households experience adequate access to food (though 
often food that is calorie dense, nutrient poor) for most of the month followed by food scarcity 
toward the end of the month (Seligman et al., 2010; Seligman et al., 2011). 
 Food insecurity is broken into categories: low food security and very low food security 
(Castillo et al., 2012). Low food security is “characterized by irregular access to food, binge 
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eating when food is available, overconsumption of energy-dense foods, obesity, and even type 2 
diabetes” (p.245). Low food security characterized in this manner is common in low income 
urban environments in industrialized, high income countries like the U.S. (Castillo et al., 2012). 
Very low food security is characterized by lack of access to food and starvation—a very different 
outcome from low food security—and is more commonly found in developing nations (Castillo et 
al., 2012). Food insecurity in the U.S. is often measured by the United States Department of 
Agriculture’s U.S. Household Food Security Survey Module (Appendix 2). Research using this 
scale sometimes combines the low food security and very low food security groups to represent 
food insecurity (Coleman-Jensen et al 2015; Nord et al., 2004; USDA 2012; Appendix 2 and 3).  
First reported in 1995 by the USDA, food insecurity was prevalent at that time in 
approximately 11.9% of households (Carlson et al, 1999). As of 2016, 12.3% (15.6 million 
households) of households in the United States were food insecure (USDA, 2017). 7.4% had low 
food security and 4.9% had very low food security (USDA, 2017). In 2014, Black non-Hispanic 
households had nearly twice the national prevalence of food insecurity (26.1%) followed by 
Hispanics (22.4%). Households with incomes less than 185% of the federal poverty level 
($24,008 for a family of 4 in 2014) had the greatest food insecurity (33.7%). The prevalence of 
food insecurity in 2004 in Massachusetts was 7.1% (USDA, 2004). As of 2014, it was estimated 
that 9.6% of households (375,695 households) in Massachusetts were food insecure, a 35% 
increase over the past decade (USDA, 2014). 
With food insecurity so common in the U.S.—particularly among ethnically diverse and 
low-income groups—there is a need to better understand its effect on the management of one or 
more cardiometabolic diseases such as diabetes mellitus, hypertension, and hyperlipidemia. Food 
insecurity has been examined as a risk factor for cardiometabolic diseases and for poor chronic 
disease management especially among low income populations (Laraia, 2013; Seligman et al., 
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2010; Seligman et al., 2007; Castillo et al., 2012; Seligman et al., 2009). Living in a food desert—
defined by the USDA and Healthy Food Financing Initiative (HFFI) as “a low-income census 
tract where a substantial number or share of residents has low access to a supermarket or large 
grocery store” (USDA, 2011)—is associated with high rates of food insecurity (Tolzman et al., 
2014; Seligman et al., 2010). Energy dense, low nutrient foods are those high in saturated fats and 
sugars, often highly processed, and with long shelf life that are cheaper and easily accessible but 
offer little nutrients. They include sodas or other sugar sweetened beverages, fast/fried foods, 
cakes, cookies, chips, and other “empty calories”. Diets high in energy dense foods are common 
in food deserts because they are cheaper, last longer, and more readily accessible than nutrient 
dense foods, and have been associated with weight gain and the development or progression of 
chronic diseases (Laraia, 2013).   
   
2.1.2. Ecosocial/Physiologic Mechanisms  
There are several ecosocial and physiologic mechanisms that may link food insecurity and risk of 
poor cardiometabolic disease control as defined in Outcome Assessment section (Seligman et al., 
2010b; Seligman et al., 2012). The term “ecosocial” is used to describe mechanisms that explain 
the link between social conditions and health outcomes (Krieger, 2001a; Krieger, 2001b; Krieger, 
2011; Krieger, 2012). The mechanisms described are considered from the perspective of 
embodiment (discussed in Chapter 1) and how social and environmental “exposures ‘outside the 
body’ get under the skin to influence physical health and disease” (Kubzansky, Seeman & 
Glymour, 2014, p.513; Krieger, 2001b).  
Three broad areas have been proposed as links between social conditions and health 
outcomes: 1) social/built environments; 2) health behaviors; and 3) stress and cognitive/affective 
processes (Kubzansky et al., 2014, p.512; Introduction Figure 1). Each of these broad categories 
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is upstream of relevant physiologic processes though research to examine the actual causal 
pathways is limited due to the complexity of the possible mechanisms involved (Krieger, 2008; 
Braveman et al 2011). The physiologic processes then impact cardiometabolic regulation and 
tissue which then impacts health outcomes.  
 This proposed eco/physiologic mechanism is consistent with Marmot’s model of social 
determinants of health (Introduction, Figure 2)which also posits SDoH as upstream of health 
behaviors and psychological processes which are upstream of the biologic processes (Marmot & 
Wilkinson, 2006). It is also in sync with the American Heart Association’s proposed biologic 
pathways that link SDoH to cardiovascular health discussed in the Introduction Chapter 
(Havranek et al., 2015).  In each case, the proposed mechanisms situate the individual and their 
behavior within the social and environmental context. Much of the clinical and medical literature 
focuses specifically on the relationship between individual-level, modifiable health behaviors and 
health outcomes. With regard to cardiometabolic disease prevention and management, the five 
focal behaviors most frequently addressed are diet, exercise, tobacco use, alcohol use, and 
medication adherence. As described in Paper 1 based on the social determinants of health 
theoretical framework (Marmot & Wilkinson, 2006) and based on the scope of the current study 
and available data, we focus on medication adherence as the primary individual-level behavior of 
interest and examine its role as a possible mediator of the association between food insecurity and 
cardiometabolic disease control while addressing the other behaviors as possible covariates.  
 Based on several studies of food insecurity and diabetes risk and management, it has been 
suggested that food insecurity is associated with both hyper- and hypoglycemia (Seligman et al., 
2010, 2012):  
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Hypoglycemia may occur when meals are skipped or caloric intake is reduced1 in  
response to inadequate food supplies. Hyperglycemia may result from the inability to 
afford diabetes-appropriate foods, overconsumption during food adequacy (a behavior 
often observed among adults exposed to episodic food scarcity), reduced medication 
adherence, or lack of medication intensification by clinicians because of frequent 
hypoglycemic episodes or unpredictable dietary intake (Seligman et al., 2010 b, p.1231). 
Several possible pathways have been proposed in the diabetes literature that may explain the 
proposed associations. The mechanisms include: 1) barriers to diets prescribed for chronic disease 
management, 2) frequent fluctuations in daily caloric intake; 3) competing costs (e.g., medicine, 
transportation); 4) increased disease-related emotional stress; and 5) as proposed in the literature 
with regard to diabetes, provider-initiated relaxed glycemic targets (Seligman et al., 2010b; 
Seligman et al., 2012). We posit that at least two of these possible mechanisms—barriers to 
prescribed diets for disease management and competing costs—may extend to the other two 
cardiometabolic diseases, hypertension and dyslipidemia, given that they are both diet-sensitive 
diseases and both rely on self-management treatment plans that often include a medication 
regimen, dietary and other recommendations. 
In terms of the first possible mechanism, (i.e., barriers to diets prescribed for diabetes 
management) diets prescribed for diabetes are generally characterized by food practices 
associated with health promotion such as high intake of fresh produce and low intake of high-fat 
meats and processed foods (Salas-Salvado et al., 2011). Food insecure individuals, however, are 
characterized by their limited access to quality food items and lack of well-balanced meals. Food 
insecure individuals tend to have high consumption of energy-dense, nutrient-poor foods because 
																																																						
1	It is clinically noted that this would be the case if the individual was taking insulin or 
sulfonylurea medications.  
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they are cheaper and more accessible, (Seligman et al., 2010b; Seligman et al., 2012) however 
such foods have been found to impede glycemic control (Seligman et al., 2010b). By extension, 
energy dense, nutrient poor foods are also high in sodium and saturated fats and could therefore 
also impede blood pressure control among those with hypertension and lipid control among those 
with dyslipidemia. Therefore, it is plausible that food insecurity may increase risk for poor 
disease control because food insecure individuals may be unable to follow a disease-specific 
recommended diet.   
Second, frequent fluctuation in daily caloric intake (Seligman et al., 2010b) is common 
among food insecure individuals given their intermittent access to adequate foods and, at times, 
the need to skip meals (Seligman et al., 2010b; Seligman et al., 2012). Fluctuating caloric intake 
can lead to widely varied blood glucose levels and can complicate adherence to a regularly 
scheduled medication regimen (Seligman et al., 2010b). Under these circumstances, food 
insecurity may increase risk for poor glycemic control through frequent fluctuations in daily 
caloric intake and related medication nonadherence.  
The cost of food may be in direct competition with the cost of other chronic disease-
related necessities including medication and transportation to medical appointments or the 
pharmacy (Seligman et al., 2010b). This third possible mechanism proposes that competing costs 
can compromise self-management and therefore increase risk for poor disease control.  
Increased disease-related emotional distress (Seligman et al., 2012) associated with not 
having regular access to adequate foods and the increased effort associated with trying to adhere 
to a diabetes-specific diet in the presence of being food insecure can complicate disease 
management (Seligman et al., 2010b; Seligman et al., 2012). Therefore, increased emotional 
distress may increase the risk for poor control.  
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Lastly, food insecure individuals with diabetes are at increased risk for experiencing 
clinically significant episodes of hypoglycemia (due to frequent fluctuations in daily caloric 
intake) (Seligman et al., 2010b; Seligman et al., 2012) and, as a result, providers may relax the 
overall glycemic target in order to decrease the likelihood of hypoglycemic events. Increasing the 
target HbA1C (e.g., from <7.0% to 8.0%) may ultimately result in poorer glycemic control.  
In summary, there are multiple interrelated eco/physiologic mechanisms that support the 
hypothesis of a positive association between food insecurity and poor cardiometabolic disease 
control.  
 
2.1.3. Epidemiologic Evidence 
The majority of studies that have examined the association of food insecurity and chronic disease 
have been cross-sectional and focused specifically on diabetes risk and/or diabetes management 
(Ippolito et al., 2016; Seligman et al., 2015, 2014, 2012, 2011, 2010b, 2007; Mayer et al., 2015; 
Heerman et al., 2016; Silverman et al.; 2015; Berkowitz et al., 2015, 2013; Sattler et al., 2014; 
Vivian et al., 2014; Kollannoor-Samuel et al., 2012, 2011; Knight et al., 2016, Smalls et al, 2015; 
Dipnall et al., 2015; Seligman et al., 2014; Billimek et al., 2012; Vijayaraghavan et al., 2011). 
Few have examined this association among patients with multiple chronic diseases  (Seligman et 
al., 2010a; Wang et al., 2015). In this section, we provide a review of existing literature 
examining food insecurity and each of the cardiometabolic diseases. We consider covariates and 
possible mediators and moderators. At the end of each sub-section, we synthesize findings, 
summarize past results, and identify gaps to orient the current study. 
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2.1.3.1. Diabetes Control 
Food insecurity has been found to be significantly associated with higher risk of diabetes 
(Seligman 2007; Seligman 2010) and independently associated with poor diabetes control as 
measured by hemoglobin A1c (Mayer et al., 2015; Heerman et al., 2016; Wang et al., 2015; 
Berkowitz et al., 2015, 2013; Seligman, 2012; Seligman, 2010).  
Significant associations between food insecurity and diabetes risk have been 
demonstrated (Seligman et al., 2007). Multiple cross-sectional studies conducted by Seligman and 
colleagues have also identified significant associations between food insecurity and diabetes self-
management factors including hypoglycemia or glycemic control,  medication and glucose 
monitoring adherence, and self-efficacy (Seligman et al., 2010; 2011). Seligman et al. (2011) 
conducted a cross-sectional survey and chart review with 711 patients with T2D from community 
health centers in San Francisco and Chicago to examine food insecurity and severe 
hypoglycemia. Food insecurity was assessed using the 6-item USDA Household Food Security 
Survey Module and hypoglycemic episodes were assessed by asking “In the past year, how many 
times have you had a severe low blood sugar reaction, such as passing out or needing to help to 
treat the reaction?” (Seligman et al., 2011, p.1204). Overall, 46% of the participants reported 
being food insecure and 28% reported at least one severe hypoglycemic episode. Compared to 
food secure participants, food insecure participants had nearly a 3-fold higher odds of having 4 or 
more severe episodes of hypoglycemia (AOR 2.95, 95% CI 1.48, 5.91). Inability to purchase food 
due to cost (43.2%) among the food insecure was significantly associated with the higher 
frequency of hypoglycemic episodes compared to among the food secure participants (6.8%) 
(p<0.001).  
In a later study, Seligman et al. (2012) conducted a cross-sectional study among the 711 
patients (of 782 eligible, 91% response rate) diagnosed with diabetes who were participants in the 
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Immigration, Culture and Healthcare Study from 2008 to 2009. The adjusted mean HbA1c was 
8.6% among food insecure patients compared to 8.1% in food secure patients (p=.06).  Rates of 
poor glycemic control were higher among food insecure participants as compared to food secure 
patients (adjusted OR 1.46 95% CI 1.07-2.04). The association between food insecurity and poor 
glycemic control was attenuated when three possible mechanisms (following a diabetic diet, self-
efficacy, and emotional distress) were included in the adjusted model. A randomized control trial 
by the same investigators has begun to explore the effect of providing diabetes-appropriate foods 
at food banks to improve glycemic control (Seligman et al., 2015). 
Another series of studies conducted by Berkowitz and colleagues has investigated the 
association of food insecurity and chronic disease control. A cross-sectional analysis of NHANES 
data from 1999-2008 with 2,557 adults with type 1 or type 2 diabetes was conducted to examine 
food insecurity and metabolic control (Berkowitz, 2013). Poor metabolic control was assessed as 
HbA1c>9.0%, or LDL>100 mg/DL, or SBP>140 mmHg.  Overall, 12% of the sample was food 
insecure, however, among those with poor glycemic control, 22% were food insecure. A total of 
16% had poor glycemic control. There was a 53% higher odds of poor glycemic control (AOR 
1.53, 95% CI 1.07, 2.19) and an 86% higher odds of poor cholesterol control (AOR 1.86, 95% CI 
1.01, 3.44) among the food insecure compared to the food secure (Berkowitz et al., 2013). No 
statistically significant association was found between food insecurity and blood pressure control.  
One of the few prospective cohort studies—the Boston Puerto Rican Health Study—
included Puerto Rican adults with diabetes to assess food-insecurity, dietary patterns and 
longitudinal glycemic control (Berkowitz et al., 2014a). Food insecurity was assessed using the 
10-adult item USDA Household Food Security Survey Module and dietary patterns were 
measured using the Healthy Eating Index-2005 (HEI). Higher HEI scores indicate higher intake 
of healthy foods like fruits and vegetables and a lower intake of solid fats, alcoholic beverages 
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and added sugars (SoFAAS) (Berkowitz et al., 2014a). Glycemic control was measured using 
HbA1c at baseline and follow-up visits 2 years later. There was a statistically nonsignificant 
positive association between food insecurity and poor diet quality (p=0.07). Overall, 26% of the 
sample reported being food insecure while, among those with lower diet quality, food insecurity 
was 29.6%. For every one-point increase in total HEI score  (! = −0.014, 95%	-. −.022, −0.005), vegetables (! = −0.101, 95%	-. − .184, −0.019), and calories from SoFAAS 
(calories from solid fats (! = −0.035, 95%	-. − .056, −0.014), alcoholic beverages and added 
sugars) there was a statistically significant decrease in HbA1c. Therefore, food insecurity was 
associated with lower diet quality which was found to be statistically and clinically significantly 
associated with poorer HbA1c control (Berkowitz et al., 2014a). Suggestions for future research 
were to consider diet quality and access to vegetables among food insecure populations 
(Berkowitz et al., 2014a).  
Three very recent cross-sectional studies have mixed findings regarding food insecurity 
and glycemic control. The first was a cross-sectional telephone survey with 407 low income 
adults with T2D (Mayer et al., 2015). Overall, 40.5% of the sample reported being food insecure 
and food insecurity was significantly associated with poor glycemic control such that compared 
to the food secure, those who were food insecure had more than a 2-fold higher odds of poor 
glycemic control (OR 2.23, 95% CI 1.22, 4.10). The second study, also cross-sectional, analyzed 
data from a health literacy randomized control trail among 401 adults with T2D (Heerman et al., 
2016). Nearly three quarters of the sample (73%) reported food insecurity. Again, this study 
found food insecurity to be significantly associated with poor glycemic control (adjusted ! =0.12, 95%	-.	.01, .23) such that for every one-unit increase in food insecurity, there was a 
statistically significant 0.12 increase in HbA1c (Heerman et al., 2016). The third study found no 
association between food insecurity and diabetes control as measured by hemoglobin A1c 
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(Ippolito et al., 2016). However, compared to the food secure group, among the very low food 
secure group diabetes self-management outcomes were worse as measured by self-efficacy, 
diabetes distress, medication non-adherence, number of hypoglycemic episodes, depression 
symptoms, and other management “trade-offs” (Ippolito et al., 2016, p. 2).  
In summary, the majority of epidemiologic studies of food insecurity and disease control 
have been cross-sectional and have focused on diabetes. The prevalence of food insecurity ranged 
from 12% (Berkowitz et al., 2014a) to 73% (Heerman et al., 2016) and one study found twice the 
food insecurity prevalence among those with poor glycemic control compared to those with 
adequate glycemic control (Berkowitz et al., 2014a). All but one study (Ippolito et al., 2016) 
found a statistically significant association between food insecurity and glycemic control. Among 
those who were food insecure, higher odds of poor glycemic control ranged from 53% 
(Berkowitz, 2013) to 2-fold (Mayer, 2015) compared to those who were food secure. And, severe 
episodes of hypoglycemia were found to be 3-fold higher among the food insecure (Seligman, 
2011) compared to the food secure. Several studies have had nationally representative samples 
from the NHANES (Seligman et al., 2007; Berkowitz et al., 2013) while others have examined 
the association among community health center patients (Seligman, 2011), food pantry clients 
(Ippolito et al, 2016; Seligman et al., 2015) and ethnic/immigrant-specific cohorts (Seligman et 
al., 2012; Berkowitz, 2014a).  Among these studies, possible mechanisms by which food 
insecurity may decrease glycemic control were explored (Seligman et al., 2012). These studies 
provide important evidence of an association between food insecurity and disease control among 
those with diabetes and therefore serve as foundation from which to further examine this 
association and possible mechanisms among individuals with diabetes and other diet-sensitive, 
cardiometabolic diseases like hypertension and dyslipidemia.  
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2.1.3.2. Hypertension Control 
Self-reported hypertension has been identified as higher among the food insecure (Irving et al., 
2014). Few studies have examined the association between food insecurity and hypertension 
control (Grillo et al. 2015; Wang et al., 2015; Seligman, 2010;). A randomized controlled trial to 
compare a home blood pressure telemonitoring (HBPTM) program with the same plus nurse case 
management (HBPTM+NCM) was conducted with 28 English and Spanish speaking individuals 
with type 2 diabetes and uncontrolled hypertension in New York City (Grillo et al., 2015). They 
measured food insecurity using the 6-item USDA Household Food Insecurity Survey Module and 
tracked systolic blood pressure (SBP) at baseline and 6 months. They identified 57.1% food 
insecurity in the overall sample and greater food insecurity among Hispanic participants 
compared to Black participants (P=.04). Overall, there was a statistically non-significant 2.7 
mmHg reduction in SBP in both groups. Among the food secure group, the decrease in SBP over 
six months was statistically and clinically significant (b=-0.77, t=-4.35, P<.001). However, 
among the food insecure group, the interventions had no significant effect (b=0.25, t=1.52, 
P=.14).  The overall drop in SBP among the food secure group was 9.2 mmHg while for the food 
insecure group SBP increased by 3.1 mmHg over the same time period. The investigators suggest 
that standard behavioral interventions for chronic disease management are insufficient when 
working with populations experiencing food insecurity (Grillo et al., 2015). 
In summary, data to examine the association between food insecurity and hypertension 
control are limited. To date, they have included a cross-sectional study using national sample 
(Irving et al., 2014) and an intervention to test home-based blood pressure telemonitoring (Grillo 
et al., 2015). The prevalence of food insecurity ranged from 17.3% (Irving et al., 2014) to 57.1% 
(Grilo et al., 2015) and the rate was nearly double among Hispanics and African Americans 
compared to non-Hispanic whites (Irving et al., 2014). The cross-sectional study found a 
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statistically significant association between food insecurity and hypertension control (Irving et al., 
2014) while the intervention found that, among individuals who are food insecure, behavioral 
interventions alone are inadequate to address blood pressure control (Grillo et al., 2015). 
 
2.1.3.3. Dyslipidemia Control 
A cross-sectional study to examine food insecurity and dyslipidemia (Tayie et al, 2009) used 
NHANES data from 1999-2002 with 5,549 adults. They measured food insecurity using the 10-
item USDA Household Food Security Survey Module and dyslipidemia based on serum lipids 
data including serum triglycerides, total cholesterol, high-density lipoprotein cholesterol and low-
density lipoprotein cholesterol. The prevalence of food insecurity (defined here as with and 
without hunger) was 11% overall. While there was no association detected between food 
insecurity and dyslipidemia in men, among women, marginal food security was significantly 
associated with dyslipidemia indicators, specifically LDL-C and triglyceride/HDL-C ratio (Tayie 
et al., 2009). This study identified an association between food insecurity and dyslipidemia 
control as well as possible differences in the association by gender. Additional studies to examine 
the association between food insecurity and dyslipidemia as well as possible effect modifiers are 
needed.  
 
2.1.4. Common Covariates  
Most studies examining food insecurity and at least one of the cardiometabolic diseases of 
interest have adjusted for factors known to be associated with food insecurity or chronic disease 
control. These include age, gender, race/ethnicity, language, educational level, income or %FPL, 
employment status, marital status, and insurance coverage. Some studies included other possible 
confounders such as smoking status, body mass index, duration of disease(s), comorbidity or 
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number of other medical condition, insulin use (in studies of diabetes), medication adherence, 
social support, and depression.  Based on these, the following section provides a more detailed 
review of potential mediators and effect modifiers to be examined in the proposed study.  
 
2.1.4.1. Chronic Disease Self-Management Behaviors: Medication Adherence 
Medication adherence is one of several primary chronic disease self-management behaviors 
(ADA, 2016; AHA, 2016). Medication non-adherence and cost-related medication underuse are 
addressed in several studies of food insecurity and cardiometabolic disease risk or 
management/control (Ippolito et al., 2016; Seligman et al., 2015; Heerman et al., 2016; Silverman 
et al., 2015; Grillo et al., 2015; Sattler et al., 2014; Seligman et al., 2010; Knight et al., 2016; 
Smalls et al., 2015; Berkowitz et al., 2014b; Billimek et al., 2012; Vijayaraghavan et al., 2011; 
Herman et al., 2015; Alfulani et al., 2015). Several studies were specifically focused on 
medication adherence and its association with food insecurity among individuals with chronic 
disease outcomes. All were cross-sectional studies and several used data from the National Health 
Interview Survey (Knight et al., 2016; Herman et al., 2015; Berkowitz et al., 2014b;).  
These studies have identified among individuals with chronic disease, those who are food 
insecure are 30% to 6 times as likely to have cost-related nonadherence (CRN) or “medication 
scrimping” compared to the food secure (Patel et al., 2016; Knight et al., 2016; Berkowitz et al., 
2014b; Billimek et al., 2012). One study that examined food insecurity as a SDoH determined 
that providing cost-reducing strategies can help to reduce CRN. Increased screening for both 
medical and social/environmental stressors as well as self-management education for patients to 
promote patient-provider communication about cost-reducing treatments are recommended (Patel 
et al., 2016). However, none to our knowledge, specifically examined medication adherence as a 
potential mediator of food insecurity and chronic disease control.   
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2.1.4.2. Psychosocial Factors: Depression 
Depression has been associated with increased risk of chronic disease and has been found to be a 
common comorbidity of chronic disease (Walker et al., 2016; Chapman et al., 2005). A literature 
review of the link between chronic disease and depressive disorders found depression to both 
“precipitate” and be “exacerbated” by chronic disease (Chapman et al., 2005). The U.S. 
Preventive Services Task Force recommends depression screening to the general adult population 
in settings where diagnosis and resulting treatment can be adequately provided (U.S. PSTF, 
2016). Because cardiometabolic disease management is complex, those with limited resources 
and who face increased barriers to self-management are at increased risk for comorbid depression 
and chronic disease (Chapman et al., 2005; Osborn et al., 2014).  
Several studies have specifically examined the association between food insecurity, 
depression and chronic disease outcomes. A cross-sectional analysis of baseline data from a 
randomized control trial—Peer support for achieving Independence in Diabetes (Peer-AID)—
examined food insecurity, depression, diabetes distress and medication adherence among 287 low 
income patients with uncontrolled type 2 diabetes (T2D) (Silverman et al., 2015). Compared to 
the food secure participants, those who were food insecure had 50% higher odds of elevated 
HbA1c after adjusting for possible confounders. Depression and diabetes distress were both 
tested as possible mediators between food insecurity and glycemic control using Sobel-Goodman 
mediation tests. The association was mediated by depression (8.3% of total effect) and by 
diabetes distress (18.7% of total effect) (Silverman et al., 2015). Because there was no 
statistically significant association found between medication adherence and glycemic control, 
medication adherence was not tested as a possible mediator (Silverman et al., 2015).  
In another study, investigators examined the association of food insecurity and depression 
among Latinos with type 2 diabetes and assessed social support as a possible mediator. Using the 
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DIALBEST randomized controlled trial—an intervention to assess use of community health 
workers to facilitate diabetes self-care—investigators conducted a cross-sectional analysis of 
baseline data. Participants were 211 Latinos with uncontrolled Type 2 Diabetes (HbA1c >7%) in 
Hartford, Connecticut. Social support was tested as a mediator to determine if it buffered the 
effects of food insecurity on depression symptoms. They found a lower risk of depression among 
those with higher levels of social support across the range of food insecurity levels (Kollannoor-
Samuel et al., 2011) and therefore social support acted as a buffer (p.986). These studies 
demonstrate the need to consider the role of social support and depression when examining food 
insecurity and cardiometabolic disease management or control. Depression has been found to 
mediate the association between food insecurity and glycemic control (Silverman et al., 2015) 
and social support to modify these effects acting as a buffer against the negative effects of food 
insecurity on depression symptoms (Kollannoor-Samuel et al., 2011). Future research should 
evaluate depression and social support as possible mediators and/or effect modifiers to better 
inform the development of meaningful and targeted interventions. 
 
2.1.5. Summary 
Despite the high prevalence of both food insecurity and multimorbidity of chronic disease among 
low income, ethnic minority individuals, particularly those residing in urban environments, 
epidemiologic research to investigate the association between food insecurity and 
cardiometabolic diseases had been predominantly focused diabetes, generally-speaking. Fewer 
studies have addressed cardiometabolic disease control particularly among those with 
hypertension and/or dyslipidemia. Both hypertension and dyslipidemia are diet-sensitive diseases 
and treatments include self-management recommendations, including dietary and medication. 
Few studies include both U.S.-born and foreign-born racially/ethnically diverse populations. And, 
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to our knowledge, none so far have examined medication adherence as a possible mediator of the 
relationship between food insecurity and cardiometabolic disease control.  
To address this gap in the literature, we used an ecosocial approach from a cross-
sectional study to examine the relationship between food insecurity, medication adherence and 
cardiometabolic disease control. This study included low-income, adult patients from five 
racial/ethnic groups (African American, Latino, Vietnamese, Russian-speaking, and white) with a 
clinical diagnosis of diabetes, hypertension, and/or hyperlipidemia and co-morbid depression who 
were enrolled in a larger study of health literacy, cultural beliefs, and medication adherence 
(RxHL). Given the paucity of research examining food insecurity and cardiometabolic disease 
control, this study will contribute to existing literature and expand our understanding of the role 
of SDoH in chronic disease control among diverse groups.  
 
2.1.6. Hypotheses and Specific Aims 
Preliminary findings from the current study have identified statistically significant 
associations between measures of food insecurity and inadequate medication adherence—both by 
self-report and assessed by pill count. This study expanded those analyses to assess food 
insecurity, medication adherence (as a possible mediator) and cardiometabolic disease control. To 
achieve this, an ecosocial approach was used.  
 
Specific Aims 
1: To examine the relationship between food insecurity and cardiometabolic disease control. We 
hypothesized that patients with higher levels of food insecurity would have:  
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1a) poorer cardiometabolic disease control as measured by their respective clinical 
marker of disease control (Diabetes: HbA1c; Hypertension: SBP; Dyslipidemia: non-
HDL-C and LDL-C);  
2. To examine whether medication adherence mediates the association between food insecurity, 
cardiometabolic disease control. Based on Marmot’s model of SDoH, we hypothesized food 
insecurity would be: 
2a) negatively associated with medication adherence (higher food insecurity would be 
associated with lower medication adherence); 
And, that lower medication adherence would be: 
2b) positively associated with poorer cardiometabolic disease control.   
3. To evaluate whether the association between food insecurity and cardiometabolic disease 
control varies by: a) depression status (not depressed vs. depressed); b) BMI status (not obese vs. 
obese). Based on Marmot’s model of SDoH, we hypothesized that the association between food 
insecurity and cardiometabolic disease control would: 
  3a) be higher among those with depression or higher levels of depressive symptoms; and  
3b) be higher among those with BMI>30 (obese)  
 
2.2. Methods 
2.2.1. Study Design and Population 
This study assessed the association between food insecurity, medication adherence and 
cardiometabolic disease control using cross-sectional data from the Medication Adherence, 
Health Literacy and Cultural Health Beliefs mixed-methods study (RxHL) study.  They study was 
conducted at Caring Health Center in Springfield, Massachusetts from January 2014 to December 
2018 (Figure 3).  
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Caring Health Center (CHC), a section 330 federally qualified health center, serves 
approximately 20,000 patients per year. CHC serves primarily low-income, ethnically diverse 
populations. As the only refugee health assessment site in Western Massachusetts, CHC provides 
translation services in over 30 languages. Over 52% of patients at CHC require translation 
services and over 90% are Medicaid insured.  
The RxHL study used a convenience sample generated by provider referral and by review 
of CHC’s EPIC/OCHIN electronic medical record to identify potential participants. Patients were 
invited to participate in the study if they had a medical diagnosis of at least one of four chronic 
diseases (diabetes, hypertension, dyslipidemia and/or depression) and were 1) taking at least one 
daily oral medication to manage their chronic disease; 2) 18 years or older; and 3) self-identified 
as non-Hispanic U.S.-born white, non-Hispanic U.S.-born African American, Latino, Russian-
speaking or Vietnamese2. Trained, bilingual/bicultural interviewers administered surveys 
containing demographic, exposure and outcome measures at baseline, conducted a pill count of 
all daily oral medications at baseline and 3-months follow-up, and collected the most recent 
clinical data from the patients’ medical record at baseline. For the purposes of the current study, 
participants diagnosed with at least one of the three qualifying cardiometabolic disease—diabetes, 
hypertension, and/or hyperlipidemia—were included as well as those with or without comorbid 
depression. Those diagnosed with depression only were excluded from the analyses. In addition, 
																																																						
2	Because the larger RxHL study is in large part examining the effect of cultural health beliefs 
and practices on medication adherence and disease management, an effort was made to decrease 
the heterogeneity of culture represented by each racial/ethnic group. Therefore, the RxHL study 
defines white as U.S. born. In this way, white is distinguished from Russian-speaking based on 
the difference in culture and language. Similarly, African American was also defined as U.S. 
born. Therefore, this group does not individuals who self-identify as Black African or Black 
Caribbean. Again, this was done in an effort to limit the heterogeneity of culture and language 
among the self-identified African American group. Based on the location of the study, Latinos are 
primarily Puerto Rican. The research team is aware that these study groups do not reflect the 
usual Census-derived racial/ethnic categories.  
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participants with missing food insecurity and/or disease control outcome data (A1c, SBP, LDL-C, 
Non-HDL-C) were also excluded. 
 
2.2.2. Exposure Assessment 
Food insecurity was measured at baseline using the 6-item U.S. Department of Agriculture’s 
Household Food Security Module (Appendix 1). The 6-item survey is a short version of the 18-
item survey and only pertains to households with adults. The scoring of the survey categorizes 
individuals/households into three groups: food secure, low food security, and very low food 
security. As is common in the literature, we then group low food security and very low food 
security into one to represent food insecurity (USDA, 2012). 
 For Spanish, we used the USDA’s Spanish translation of the 6-item scale (USDA, 2013) 
and modified it from its primarily Latin American Spanish to meet the language needs of Puerto 
Rican speakers using a professional Spanish translator. For Russian and Vietnamese, we had the 
scale professionally translated. Final revisions of the professional translation in each language 
were provided by the team’s bilingual/bicultural interviewer, respectively.  
Trained, bilingual interviewers administer surveys in the participant’s preferred language 
(English, Spanish, Russian or Vietnamese). The module includes six questions about the food 
eaten in the individual’s household in the last 12 months and specifically addresses whether the 
individual was able to afford the quantity of food needed (Appendix 3). The first three items on 
the scale are used as a screen of food insecurity. Participants are asked to rate the first two 
statements regarding running out of food and eating balanced meals on a three-point Likert scale 
ranging from “often true” to “never true”. The third item is a yes/no question and assesses 
whether meals are cut or skipped due to a lack of money for food. Those who responded “never 
true” to the first two items and “no” to the third will be assigned a zero score and will be 
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designated as food secure. The remaining questions (4-6) determine the degree of food insecurity. 
The fourth item determines the frequency of skipped meals due to lack of funds for food and 
respondents are asked to use a 3-point Likert scale ranging from “almost every month” to “only 1 
or 2 months”. In the fifth and sixth questions, the participant is asked to respond yes/no about 
their eating practices based on a lack of money. Food secure individuals obtained a score of 0 or 1 
(includes those identified with marginal food security raw score 1 when using the 18-item scale 
(USDA, 2012)). Food insecure individuals obtained a score of 2 to 6 (Appendix 3).  
 
2.2.2.1. Validity of exposure assessment 
The 6-item U.S. Household Food Security Survey Module has been demonstrated to be a 
valid and reliable measure of food insecurity in diverse populations (Bickel, Nord, Price, 
Hamilton and Cook, 2000; Gulliford et al., 2004). In one study that tested the reliability and 
validity of the 6-item survey in a Caribbean community, internal consistency measured by 
Cronbach’s alpha was 0.84 and Pearson correlation by ethnic group ranged from 0.52 to 0.79 
(Gulliford et al., 2004). Intraclass correlation coefficients by household size were high for all 
items and for the classification of food insecurity (ICC ranged from .68 [95% CI 0.61, 0.75] 
to .78 [95% CI 0.73, 0.83) (Gulliford et al., 2004). Food insecurity as measured by the 6-item 
U.S. Household Food Security Survey Module has been associated with poor chronic disease 
outcomes in previous studies (Seligman et al., 2010b; Seligman et al., 2012).  
 
2.2.3. Outcome Assessment 
The outcomes of interest are cardiometabolic disease control in patients with diabetes, 
hypertension and/or dyslipidemia. Cardiometabolic disease control was assessed as a clinical 
measure of disease control using HbA1c, SBP, and non-HDL/LDL. At the baseline survey, the 
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most recent value was collected from the patient’s electronic medical record by a trained medical 
record abstractor.  
 For those with a medical diagnosis of diabetes HbA1c value was used. The HbA1c test 
measures average blood glucose (blood sugar) levels over the prior 8 to 12 weeks. An HbA1c 
>6.5% (48 mmol/mol) is diagnosed as diabetes and, without medically confirmed hyperglycemia, 
repeat testing is recommended (ADA, 2016). Based on the American Diabetes Association 
(ADA) recommended guidelines for diabetes management, HbA1c levels <7% will be 
categorized as controlled and >7% will be categorized as uncontrolled.   
For those with a medical diagnosis of hypertension, SBP was used. Based on the 
American Heart Association (AHA) guidelines for hypertension management, SBP<140 mmHg 
was categorized as controlled and SBP>140 mmHg was categorized as uncontrolled (NHBEP, 
2004; Pickering et al., 2005).   
For those with a medical diagnosis of dyslipidemia, we used two measures of control: 
non-high-density lipoprotein cholesterol (non-HDL-C)<130 mg/dL and low-density lipoprotein 
cholesterol (LDL-C)<100 mg/dL. We selected these two measures of dyslipidemia control in 
alignment with the 2014 National Lipid Association Guidelines which retained the cholesterol 
goals. . Additionally, though the 2013 ACC/ACH guidelines focus on statin intensity per 
atherosclerotic cardiovascular disease risk, the treatment goal identifies levels for both Non-HDL-
C and LDL-C. Non-HDL-C is a useful measure because, unlike LDL-C, it accounts for all 
lipoproteins that are atherogenic (Virani, 2011).   
 
2.2.3.1. Validity of outcome assessment 
 HbA1c is a measure of the average level of blood glucose attached to hemoglobin in the 
red blood cell over the past three months (NIDDK, 2018; NGSP 2018; Penttilä et al., 2016).  
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Since its introduction into diabetes management in 1976, the HbA1c test has been recognized as 
the gold standard approach to assess glycemic control (Higgins, 2012). Quality reports indicate 
substantial improvements in HbA1c quality over the past three decades regarding reliability and 
validity whether using the % or mmol/mol units (Penttilä et al., 2016). HbA1c is frequently used 
as the primary measure of diabetes control in epidemiologic research (Ippolito et al., 2016; Mayer 
et al, 2015; Heerman et al., 2016; Silverman et al., 2015; Seligman et al 2012, 2015; Berkowitz et 
al., 2013; 2014, 2015; Smalls et al, 2015). 
 According to the AHA’s 2005 Scientific Statement of recommendations for hypertension 
measurement in human populations, systolic and diastolic blood pressure measurement is the gold 
standard to detect and monitor hypertension (AHA, 2005). Hypertension is defined by a systolic 
blood pressure (SBP) >140 mm Hg, diastolic blood pressure (DBP) > 90 mm Hg, and/or current 
use of antihypertensive medication (AHA, 2005). SBP is frequently used as the primary measure 
of hypertension control in epidemiologic studies (Grillo et al., 2015; Berkowitz et al., 2013). It is 
known that blood pressure measurement can vary depending on the method and setting (AHA, 
2005). 
In 2014, the National Lipid Association (NLA) established an expert panel to review both 
the similarities and differences between the two existing guidelines3 to establish a set of patient-
																																																						
3	According to the NCEP ATP III guidelines released in May 2001, LDL was identified as a 
primary cause of CHD and, as a result, LDL-lowering therapies were identified as a primary 
target for treatment of dyslipidemia (NCEP, 2001). The ATP III was based on a robust review of 
clinical trial data as well as other epidemiologic studies and showed that lowering LDL was 
associated with overall decreased risk of morbidity and mortality from CHD (NCEP, 2001). In 
2013, the American College of Cardiology (ACC) and the AHA released a new guideline on the 
treatment of blood cholesterol (Stone et al, 2013). These guidelines differed from the ATP III in 
that the guidelines drew upon findings only from randomized control trials and focused primarily 
on lifestyle promotion and statin use (Stone et al, 2013). Efforts to compare the two guidelines—
ATP III and ACC/AHA—have raised concerns that the ACC/AHA guidelines were based on 
older RCT studies and perhaps not generalizable to the current U.S. population and that the 
lifestyle recommendations were not supported by RCT evidence (Grundy, 2013).  
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centered recommendations (Jacobson et al., 2014). Based on their expert assessment of the 
existing guidelines by ATP III and ACC/AHA (2013), the NLA has identified non-HDL-C<130 
mg/dL and LDL-C<100 mg/dL and as the primary and secondary cutoffs, respectively, for 
cholesterol control. In addition, this is in alignment with the research site’s general practice. Total 
cholesterol concentration >240 mg/dL is less often considered because total cholesterol can be 
elevated if HDL is high (per the calculation formula) (Jacobson et al., 2014). 
 
2.2.4. Covariate Assessment 
 Sociodemographic and clinical variables known to be associated with food insecurity and 
cardiometabolic disease control were included. Variables obtained through self-report during the 
survey interviews included age (continuous), gender (male/female), race/ethnicity (white, African 
American, Vietnamese, Russian-speaking, Latino), educational level (< than high school, high 
school/GED, some college/college), monthly household income (continuous) and monthly 
household income equivalence (continuous)4, language spoken at home (English, Spanish, 
Vietnamese, Russian), employment status (not employed, part/full time employed), health literacy 
																																																						
Both the ATP III (2001) and the ACC/AHA (Stone et al., 2013) guidelines continue to be 
used to guide clinical detection, evaluation and treatment of dyslipidemia (Grundy, 2013). 
Therefore, per provider or per practice, decision making about the detection and treatment of 
dyslipidemia or hyperlipidemia can vary. This is true at the research site where some providers 
follow ACC/AHA guidelines and, for example, prescribe a statin to anyone between the ages of 
40-70 with an hbA1c >7.5%, while others adhere to a more ATP III informed approach and base 
their diagnosis and treatment on the complete cholesterol panel including close review of LDL 
levels.  
	
4 In the absence of a household size variable in the RxHL dataset, for this study we used monthly 
household income and living situation/partnership status to create an equivalence income 
measure. We followed the square root equivalence scale (OECD, 2018; Atkinson et al., 1995; 
Kawachi et al., 1997) approach. Household income equivalence was calculated as the monthly 
income from all sources divided by the square root of 2 for those participants who reported living 
with a partner. 
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level (low health literacy, high health literacy) and depressive symptoms level (continuous; 
dichotomous: no depression symptoms, depression symptoms). Sociocultural factors included 
primary language spoken at home, partner status (living single/not partnered, living with 
partnered/family), and social support (continuous). Clinical data including diagnosis of diabetes 
(0/1), hypertension (0/1), dyslipidemia (0/1) and depression (0/1), oral medications (0/1)), insulin 
use (0/1), tobacco (no, yes/current) and alcohol use (no, yes/current), body mass index (BMI) 
(continuous; dichotomous: not obese <30 kg/m2, obese >30 kg/m2, and health insurance status 
(yes, no, don’t know) were collected from the electronic medical record (EMR). Prior studies 
demonstrating a positive association between food insecurity and poor cardiometabolic disease 
control have included these covariates in their analyses (Seligman et al., 2010a; 2012).  
 Several variables were assessed as possible mediators or moderators of the association 
between food insecurity and cardiometabolic disease control. Based on Marmot’s SDoH model, 
the factors examined as possible mediators or effect modifiers in this study are conceptualized as 
downstream of the social determinant (food insecurity) but upstream of the biologic mechanisms 
and disease control. They include the medication adherence (8-item Morisky Medication 
Adherence Scale-self-reported: adequate vs. low; pill count >80% vs. <80) as a possible mediator 
and depression (not depressed vs. depressed) and BMI (<30 not obese vs. >30 obese) as possible 
effect modifiers.  
 
2.2.4.1. Medication Adherence 
 Medication adherence was examined as a possible mediator of food insecurity and 
chronic disease outcomes (Specific Aim 2). Of the four approaches typically used to measure 
medication adherence (self-report, electronic monitoring, pill count, and pharmacy fill rates 
(Morisky, et al. 2008, 11)), the RxHL study used self-report and manual pill count.  Self-reported 
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medication adherence is assessed using the Morisky 8-Item Medication Adherence Scale at 
baseline and at 3-months follow-up. Responses from the 8-items create a score ranging from 0-8. 
Response categories are yes/no for each item and a 5-point Likert response for the last item. The 
original scale score is categorized into three groups: high adherence (0), medium adherence (1-2), 
and low adherence (3-8). The RxHL study reversed the order such that a higher score (7.01-8.00) 
reflects high adherence, a medium score (5.01-7.00) reflects adequate adherence and lower score 
(0-5) reflects low adherence. We then dichotomized the groups into adequate/high adherence (1) 
(scores ranging 5.01-8.0) and low adherence (0 ) (scores ranging 0-5) (Morisky et al, 2008; Kelly 
et al., 2016). 
Pill counts are one of the objective measures used to calculate medication adherence 
(Lam et al., 2015; Farmer et al., 1999). Medication adherence using pill count is based on the 
number of prescribed pills taken between two points (e.g., two clinical visits) and is calculating 
using the formula (Lam et al., 2015; Farmer et al., 1999): % Adherence by Pill Count= 
        (number of dosage units dispensed - number of dosage units remained)      X  100 
(prescribed number of dosage unit per day x number of days between two visits) 
 
For the larger RxHL study, pill counts are conducted at baseline and at 3-months follow-up. 
Percentage adherence rates collected at baseline and at 3-month follow-up of at least 80% are 
used to define an acceptable level of medication adherence for the conditions targeted in this 
study (Osterberg et al., 2005; Lee et al., 2006; Gerin et al., 2007; Ho et al., 2009; James et al. 
2014; Martin et al., 2011; Noble et al., 2016; Ritchey et al., 2016). We calculated both overall and 
disease-specific mean adherence rates based only on viable pill counts. Viable pill counts 
included: 1) a baseline and 3-month follow-up pill count for the specified medication; 2) no 
changes in dose, instructions or type of medication between the two time points for the specified 
medication; and 3) a medication prescribed for daily oral use (medications prescribed “as needed” 
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were not viable). Of the total 361 participants in the sample for this study, there were 45 missing 
viable pill counts and therefore pill count analyses are based on n=316. We also created 
dichotomized overall and disease-specific pill count medication adherence: <80% under-
adherent; >80% adherent. All participants in the study were taking at least one daily oral 
medication to manage their disease(s). There was not, however, an equivalent objective measure 
of adherence for participants taking insulin (n=44).  
 
2.2.4.2. Depression   
To assess depression in patients, the Patient Health Questionnaire (PHQ)-2 and 9 are used. The 
PHQ-2 is administered first as an initial screen for depression (Kroenke et al., 2003). The 
questions ask whether “Over the past 2 weeks, how often have you been bothered by any of the 
following problems: 1) Little interest or pleasure in doing things; 2) Feeling down, depressed or 
hopeless” (Kroenke et al., 2003). The 4-point response option ranges from “Not at all” to “Nearly 
Every Day”.  If the patient responds positively to both questions on the PHQ-2, the PHQ-9 
administered (Kroenke, K., Spitzer, R. L., Williams, J. B., 2001, 2003). The PHQ-9 contains nine 
questions and the same 4-item response option. The first two questions are the same as the PHQ-2 
and are followed by seven additional questions that get at issues of sleep, energy level, appetite, 
feeling badly about oneself, centration, movement and speech patterns, and suidcide ideation 
(Kroenke et al., 2001, 2003). PHQ-9 scores of 5, 10, 15, and 20 represents mild, moderate, 
moderately severe and severe depression (Kroenke et al., 2001, 2003). We dichotomized the 
depression score: <5 no depression, >5 depression. In addition, a medical diagnosis of depression 
using ICD-9 and/or ICD-10 codes was collected from the electronic medical record. If either 
PHQ-9>=5 OR ICD code indicated depression, the subject was coded as depressed. 
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2.2.4.3. Obesity (BMI>30)  
To assess BMI, height and weight as documented in the electronic medical record were abstracted 
by the trained interviewer following the baseline survey administration. Height and weight are 
measured using standard clinical procedure and entered into the EMR. BMI is automatically 
generated by the EMR once height and weight values are entered and updates based on the latest 
values entered. The continuous BMI value from the medical record was then dichotomized into 
not obese (<30 kg/m2) and obese (>30 kg/m2).  
 Obesity is defined for adults ages 20 and older as having a body mass index (BMI, 
measured as weight in kilograms divided by height in meters squared) of > 30. The CDC 
identifies healthy eating and active living as the key recommendations to reduce the rates of 
overweight/obesity. There are initiatives aimed at achieving these guidelines that range from 
national to local-level (CDC, 2016).  The first clinical guidelines for the identification, evaluation 
and treatment of overweight and obesity were first established in 1998 (NHLBI, 2000). In 2013, a 
new guideline for managing overweight and obesity in adults was released (NHLBI, 2013). 
Recommendations continue to focus on lifestyle and behavioral changes to increase physical 
activity and changes in dietary intake (NHLBI, 2013).  
 
2.2.5. Statistical Analysis  
 
We conducted statistical analyses using Stata 12.1 (STATA Corporation, College Station, Texas). 
Two-sided P values of less than 0.05 were considered to be statistically significant. 
We calculated percent distribution disease control (HbA1c, SBP, non-HDL, and LDL). 
We calculated the number and percent or mean and standard deviation of categorical and 
continuous variables, respectively, to include food insecurity and the proposed covariates.  
 Based on the literature, covariates known to be associated with food insecurity and 
cardiometabolic disease control were identified a priori. Categorical covariates were cross-
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tabulated with both the exposure and the outcome variables using chi-square tests or Fisher’s 
exact tests, as appropriate. Corresponding p-values were reported. For continuous covariates, 
mean and standard deviations were presented for both the exposure and outcome variables.   
Separate unadjusted logistic regression models were built to examine the cross-sectional 
relationship between food insecurity and cardiometabolic disease control (diabetes control: 
HbA1c <7.0%; hypertension control: SBP<140 mmHg; dyslipidemia control: non-HDL-C <130 
gm/dL; LDL-C <100 mg/dL). Separate unadjusted linear regression models were also built to 
examine the cross-sectional relationship between food insecurity and the cardiometabolic disease 
outcomes as continuous measures (diabetes: HbA1c; hypertension: SBP; dyslipidemia: non-HDL-
C and LDL-C). 
 We built linear regression models to examine the association between food insecurity and 
each continuous cardiometabolic control outcome and adjusted for possible confounders. We 
built two adjusted models for each exposure-outcome relationship. First, we built a saturated 
model (Model A) and adjusted for variables identified a priori in the literature as associated with 
the exposure and outcome (age, gender, race/ethnicity, education, income, employment, health 
insurance, comorbidities/number of diseases, and depression, BMI, social support, tobacco use). 
We also included variables with a crude association with the exposure or outcome based on a  p-
value of <.25 (alcohol use, homelessness, cost barriers to care and medications, transportation 
barriers to care and pharmacy, and social stress). Second, we then built a parsimonious or trim 
model (Model B). We began with the saturated model and removed one covariate at a time. In the 
final parsimonious model, we adjusted for those covariates that, when included in the model 1) 
resulted in more than 10% change in estimate or resulted in a F-Partial Test p-value of <.05. 
Covariates that were established as important for inclusion in the literature but did not meet these 
two criteria were retained in the model.  
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 We followed the same model procedure using individual logistic regression models to 
examine the association between food insecurity and uncontrolled cardiometabolic disease. In 
these models, the parsimonious model adjusted only for those covariates whose inclusion in the 
model resulted in more than 10% change to the log odds or where the Likelihood Ratio Test had a 
p-value of <.05.  
 
2.2.5.1. Mediation 
Based on the social determinants of health theoretical framework (Marmot et al., 2006) discussed 
in Chapter 1, we conducted mediation analyses to assess whether medication adherence, a key 
component of chronic disease management, mediated the association between the upstream social 
determinant of food insecurity and the downstream physiology of cardiometabolic disease 
control. We followed the 4-step procedure as described by Baron and Kenny (1986) to assess 
self-reported medication adherence and pill count medication adherence and then compared the 
results of the two methods. The 4-step procedure includes examining whether there is an 
independent association between: 1) the exposure and the outcome; 2) the exposure and the 
mediator; 3) the mediator and the outcome (Baron et al., 1986). In step 4, the multivariable model 
includes all three variables.  Complete mediation is identified if in step 4 there is no longer an 
independent association between the exposure and the outcome (Baron et al., 1986). Partial 
mediation is identified if in step 4 the association is attenuated (Baron et al., 1986). We assessed 
the potential for mediation by medication adherence ( self-report and pill count) for each of the 
exposure-outcome associations. 
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2.2.5.2. Effect Modification 
Possible effect modification by BMI was assessed by stratifying the linear and logistic regression 
models of food insecurity and cardiometabolic disease control by BMI (not obese < 30 kg/m2 vs. 
obese >30 kg/m2). If the odds ratios or beta coefficients of each stratum differ from one another 
and from the overall odds ratio, we conducted a Mantel-Haenszel test of homogeneity to assess 
whether the stratum-specific odds ratios and beta coefficients were significantly different from 
one another. If they were found to be significant, we included a multiplicative interaction term 
(food insecurity X BMI status) in our final models. We used likelihood ratio tests or F-partial 
tests to determine if the interaction term was statistically significant in the logistic or linear 
regression model, respectively. We presented stratum-specific odds ratios to describe the 
association between food insecurity and cardiometabolic disease control per BMI group. We 
followed the same procedure to assess depression (not depressed vs. depressed) as a possible 
effect modifier in the association of food insecurity and cardiometabolic disease control.  
 
 
2.2.5.3. Human Subject Protection 
 
The Institutional Review Board of the University of Arizona and the University of Massachusetts, 
Amherst, approved the RxHL Study. Signed informed consent forms were obtained from all 
study participants indicating that they were 18 years or older and understood their participation 
was voluntary, that they could refuse to answer any question or withdraw their participation from 
the study at any time, and that their medical care at Caring Health Center would not be impacted 
by their decision of whether or not to participate. 
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2.2.5.4. Permission to Access Data 
We were given permission by the principal investigator of the RxHL Study (Susan J. Shaw) to 
access the data for the purpose of conducting the current study. We will have access to all of the 
study data including the baseline survey data, pill count data, and medical record data. 
 
2.3. Results 
Participant characteristics for the study sample of 361 community health center patients are 
shown in Table 1a.  This is a sub-sample from the larger RxHL study sample as of November 22, 
2016 (n= 422) and includes all participants with a diagnosis of at least diabetes, hypertension 
and/or dyslipidemia. RxHL participants with only a diagnosis of depression (n=44) were 
excluded from this study.  
 The study sample mean age was 58.8 (standard deviation [SD] 11.6) and participant age 
ranged from 21-86.  The majority were female (57.9%). Participants were from five self-reported 
mutually exclusive cultural/ethnic groups including Vietnamese (26.9%), African American 
(23.6%), Latino (21.1%), Russian-speaking (17.5%), and white (11.1%). The majority (57.9%) 
speak a language other than English at home including Spanish (14.4%), Vietnamese (26.6%) and 
Russian (16.9%). More than two thirds (69.9%) of the participants had a high school degree/GED 
or less education (38. 8% < HS education; 31.3% HS/GED) and over a third had low health 
literacy (37.1%). The mean (SD) monthly household income was $1,165 ($745). The equivalence 
scale household monthly income was $1,001 (SD=$565) and accounts for those living with a 
partner or family member by dividing the total reported income by square root of two (OECD, 
2018). Nearly two thirds of the sample reported living single (61.8%) and 8% report being 
homeless. Over half of the study sample was obese (52.9%) and an additional 25.8% were 
overweight. Over two thirds (69.3%) of the sample received Supplemental Nutrition Assistance 
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Program (SNAP) and report a mean (SD) monthly SNAP assistance of $126.76 (122.33). Nearly 
half of the sample reported using tobacco (43.2%) and 20.2% report using alcohol. While nearly 
all participants report having health insurance coverage (96.4%), health care access barriers were 
also common: gaps in coverage (10.6%), cost of care (8.3%), cost of medications (25.2%), 
transportation to care (19.9%), and transportation to pharmacy (13.6%) were reported health care 
access barriers.  
Since eligibility of the larger RxHL study required all participants have one of four 
chronic diseases (diabetes, hypertension, dyslipidemia, and/or depression), everyone in the study 
had one or more chronic diseases. In this sample, prevalence of hypertension (85.6%) was highest 
followed by dyslipidemia (66.2%) and diabetes (47.4%) (Table 1a.). Thirty percent had only one 
of the cardiometabolic diseases, 41% had two and 29% had all three. Over a quarter (26.6%) had 
a comorbid medical diagnosis of depression. Across the three cardiometabolic diseases, 
dyslipidemia was the least controlled followed by diabetes and hypertension.  
Among those with diabetes, mean (SD) A1c was 8.3% (9.9) and 46.2% had uncontrolled 
A1c (>7.0%).  
 Participants with dyslipidemia (n=239) had a mean (SD) non-HDL-C of 136.7 (41.3) and 
a mean (SD) LDL-C of 105.1 (41.1). Nearly half of participants had uncontrolled dyslipidemia 
with 47.7% having uncontrolled LDL-C (>100 mg/dL) and 49.4% having uncontrolled non-HDL-
C (>130 mg/dL) (Table 1a).  
Those with hypertension (n=309) had a mean (SD) SBP of 130.9 (16.4) and 29.1% had 
uncontrolled hypertension (SBP>140 mmHg) (Table 1a). 
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2.3.1. Food Insecurity 
Just over one third of participants reported food insecurity (36.3%) with 22.7% reporting 
low food security and 13.6% very low food security. Among those with only one disease (n=108; 
29.9%), food insecurity was highest in those with dyslipidemia (52%) compared to those with 
either hypertension (36%) or diabetes (36%). Food insecurity differed significantly by 
race/ethnicity (p<.001) (Table 2). Among the food insecure, the majority were Latino (66%) and 
African American (42%) followed by white (35%), Vietnamese (23%), and Russian-speaking 
(14.3%) (row %). Similarly, among the food insecure, more were English- (51.2%) and Spanish-
speakers (26%) compared to the food secure among whom most were English (37%), Vietnamese 
(32.2%) and Russian-speakers (23%) (p<001). Compared to food secure patients, food insecure 
participants were younger (mean age 54.5 versus 61.3, p<.001), had lower social support 
(p<0.001), and were more likely to use tobacco (p<.001). They had higher rates of transportation 
barriers to care and medication (<.001) and cost barriers to medication (<.001). The food insecure 
participants had higher social stress (p<.001) and higher prevalence of depression as measured by 
both medical diagnosis (p=.003) and by the PHQ-9 depression symptom screener (p<.001).  
 
2.3.2. Diabetes Control 
Participants with uncontrolled diabetes (A1c>7.0%) were more likely to be insulin users (p<.001) 
and obese (p=.02) (Table 3). Mean A1c was significantly higher among insulin users (8.9%) 
compared to those not using insulin (7.1%) (p<.001) (not shown).  
There was no association between food insecurity and uncontrolled diabetes in 
unadjusted (OR = 1.02; 95%CI = 0.53, 1.96) or in adjusted analyses (Model A OR = 1.29; 95% 
CI = 0.56, 2.97; Model B OR = 1.27; 95% CI = 0.58, 2.77) (Table 4a).  
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In simple and multiple linear regression models of continuous HbA1c level, there were 
no differences observed between those reporting food insecurity with those reporting being food 
secure (unadjusted MD = 0.56%; 95% CI = -0.03, 1.16;  Model A adjusted MD = 0.44%; 95% CI 
-0.25, 1.13; Model B: Beta = 0.27%; 95% CI = -0.41, 0.95) (Table 5a).  
 
2.3.3. Hypertension Control 
In logistic regression models of uncontrolled hypertension, there was no association between food 
insecurity and uncontrolled hypertension in unadjusted (OR = 1.04; 95% CI = 0.62, 1.73) or 
adjusted analyses (Model A OR = 1.09; 95% CI = 0.57, 2.12; Model B: (OR = 0.89; 95% CI = 
0.51, 1.53) (Table 4b).  
In simple and multiple linear regression models of SBP, food insecurity was not 
associated with SBP in unadjusted (MD = -2.42 mmHg; 95% CI = -6.27, 1.43) or adjusted 
(Model A MD = 0.24 mmHg, 95% CI = -4.17, 4.65; Model B MD = -1.22 mmHg, 95% CI -5.19, 
2.76) analyses (Table 5b).  
 
2.3.4. Dyslipidemia Control 
Uncontrolled dyslipidemia differed significantly by cultural/ethnic group (p=.03) and was highest 
among Vietnamese participants (28.8%) and lowest among white participants (11.9%) and was 
similar among African Americans (20.3%), Russian-speakers (20.3%), and Latinos (18.6%). 
Participants with uncontrolled dyslipidemia reported more gaps in health insurance (p=.001), cost 
barriers to care (p<.001) and medication (p=.04) compared to those with controlled dyslipidemia 
(Table 3).  
Participants with uncontrolled dyslipidemia (non-HDL>130) reported higher rates of 
food insecurity (p=.02). Among those reporting food insecurity, mean non-HDL-C (149.1) was 
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significantly higher than among those reporting food security (130.3) (p=.001). Similarly, mean 
LDL-C was significantly higher (115.2) among the food insecure compared to the food secure 
(102.3) (p=.02). (Table 3).  
In unadjusted logistic regression, we observed a significant association between food 
insecurity and dyslipidemia control as measured by non-HDL-C, , with significantly higher odds 
of uncontrolled dyslipidemia among the food insecure compared to those reporting food security 
(OR = 2.26; 95% CI = 1.27, 4.02); as well as with dyslipidemia control as measured by LDL-C 
(OR = 1.78; 95% CI = 1.10, 3.13) (Table 4c-d). After adjustment for the a priori potential 
confounders, we observed a significant positive association between food insecurity and 
dyslipidemia control as measured by non-HDL-C (OR = 2.56; 95% CI = 1.18, 5.55). After similar 
adjustment, the association between food insecurity and LDL-C control became null and we 
observed wider confidence intervals (OR = 1.91; 95% CI = 0.88, 4.10).  
In the final parsimonious model using non-HDL-C, we observed a slightly attenuated 
significant association. Participants reporting food insecurity had a 2.3-fold higher odds of 
uncontrolled dyslipidemia than food secure (95% CI = 1.29, 4.29). Confounding did not explain 
much, if any, of the observed bivariate relationship. In the final parsimonious model using LDL-
C, the wider confidence intervals for LDL-C indicate the possibility of no association (OR = 1.96; 
95% CI = 0.98, 3.97).  
There was an independent positive association between food insecurity and non-HDL-C 
evaluated continuously; those reporting food insecurity had 18.73 mg/dL higher non-HDL-C 
(95% CI = 7.49, 29.97) than those reporting being food secure, and this association remained 
after adjusting for all priori potential confounders (MD = 15.45 mg/dL; 95% CI = 3.25, 27.66) 
(Table 5c). In final parsimonious model, participants reporting food insecurity had non-HDL-C 
levels 13.3 mg/dL higher than those reporting food security (95% CI = 1.72, 24.92). While food 
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insecurity was associated with continuous LDL-C levels in unadjusted analyses (MD = 12.89 
mg/dL; 95% CI = 2.08, 23.69), after adjustment the confidence intervals were wider and suggest 
the association may be null (MD = 10.18 mg/dL; 95% CI = -1.43, 21.78). The same was true for 
the final parsimonious model (MD = 9.02 mg/dL; 95% CI = -2.22, 20.26) (Table 5d).  
 
2.3.5. Medication Adherence  
 
Participant characteristics of medication adherence are shown in Table 1b. Among the entire 
study sample (N=361), self-reported adequate medication adherence using the 8-item Morisky 
Medication Adherence Scale was 70.4%  compared to 55.4% adequate adherence (>80%) as 
measured by pill count among participants with viable pill count data (n=316; viable medications 
include medications prescribed for conditions other than diabetes, hypertension and dyslipidemia) 
(Table 1b).	Disease-specific self-reported adequate medication adherence ranged from 69.6% 
among those with diabetes to 73.6% among those with dyslipidemia and was lowest among those 
with co-morbid depression (51%). Disease-specific pill count adherence ranged from 68.1% 
among those with hypertension to 71.9% among those with dyslipidemia. The highest pill count 
adherence was among those with co-morbid depression (92.9%).  
The majority of participants took one (23.7%), two (24.7%), or three (20.9%) 
medications. Fewer (17.7%) were identified with polypharmacy (4+ medications).	Food insecure 
participants had lower self-reported medication adherence compared to the food secure (p<.001).  
A similar association was not found for food insecurity and pill count adherence.  
Distribution of medication adherence by disease outcomes are shown in Table 3. 
Participants with uncontrolled dyslipidemia (non-HDL-C>130, LDL-C>100) self-reported higher 
prevalence of low medication adherence (p=.002) compared to those with controlled 
dyslipidemia. Participants with uncontrolled hypertension (SBP>140) were more likely to have 
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<80% adherence to hypertension medications (p=.003) with a mean (SD) medication adherence 
to hypertension medications of 70% (63.3) compared to 80% (22.4) among those with controlled 
hypertension. There were no significant associations between self-reported or pill count 
adherence and diabetes control. Mean pill count adherence by self-reported medication adherence 
is presented in Table 6. Those who self-reported adequate adherence had a mean pill count 
adherence of 75%(21.4) (p=0.004), under the 80% benchmark to indicate adequate adherence by 
pill count.  
 
2.3.6. Mediation Analyses: Evaluation of Mediation of Food Insecurity Association with 
Dyslipidemia Control by Medication Adherence  
	
Primary analyses for diabetes control and hypertension control were null. Therefore, mediation 
analysis was performed to further investigate the observed association between food insecurity 
and dyslipidemia control (non-HDL-C: MD = 18.73 mg/dL; 95% CI = 7.5, 30.0; LDL-C: MD = 
12.9 mg/dL; 95% CI = 2.1, 23.7). The unmediated model—Step 1 (Baron & Kenny, 1986)—is 
illustrated in Figure 7.  
 We found that food insecurity was independently associated with self-reported 
medication adherence (Step 2; Figure 8-9) such that food insecure individuals had a 1.12 unit 
(95% CI-1.48, -0.77) lower self-reported medication adherence score compared to food secure 
individuals. Lastly, we determined there was an independent association between self-reported 
medication adherence and dyslipidemia control as measured by non-HDL-C (unadjusted MD = -
4.15; 95% CI = -7.5, -0.81)  (Figure 8) and by LDL-C (unadjusted MD -17.6, 95% CI=-29.27, -
5.95) (Step 3; Figure 9). There was not, however, a similar independent association between pill 
count adherence and dyslipidemia control.  
Therefore, the final mediation analysis examined the association between food insecurity, 
self-reported medication adherence, and dyslipidemia control using both non-HDL-C and LDL-C. 
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The independent association between food insecurity and dyslipidemia control as measured by 
non-HDL-C was attenuated when self-reported medication adherence was included in the model 
(MD15.55 mg/dL, 95% CI4.30, 26.80) and only slightly further attenuated after adjusting for the 
a priori covariates (MD 15.18 mg/dL, 95% CI = 2.86, 27.5) indicating that self-reported 
medication adherence partially mediated the association and that there was minimal additional 
confounding (Figure 8).  The independent association between food insecurity and dyslipidemia 
control using LDL-C became null after adding self-reported medication adherence to the model 
indicating that self-reported medication adherence completely mediated the association 
(MD=10.23 mg/dL, 95% CI -0.63, 21.09). The association was only slightly further attenuated 
after adjusting for a priori covariates (MD 10.16 mg/dL, 95% CI=-1.58, 21.91) similarly 
indicating minimal confounding (Figure 9).  
 
2.3.7. Evaluation of Potential Effect Modification 
We assessed whether the association between food insecurity and each of the cardiometabolic 
outcomes was modified by BMI (not obese, obese) or depression (not depressed vs. depressed) 
(Tables 7-10). After identifying differing stratum-specific estimates from linear regression and 
logistic regression models for food insecurity and dyslipidemia control among obese compared to 
non-obese, we tested a food insecurity X BMI interaction term and found no evidence of effect 
modification of the food insecurity-dyslipidemia control relationships by BMI (LDL-C: p=0.31; 
non-HDL-C: p=0.52). The same was true for depression and, after testing a food insecurity X 
depression interaction term, we found no evidence of effect modification of the food insecurity-
dyslipidemia control relationship (LDL-C: p=0.71; non-HDL-C: p=0.84).  
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2.4. Discussion 
 
While several literature reviews have considered the social context of food insecurity and chronic 
disease (Castillo et al., 2012; Popovic-Lipovac et al., 2015; Barnard et al., 2015), social 
epidemiologic studies of this association are lacking. Given the multilevel nature of food 
insecurity—at the neighborhood level it is often associated with residing in a food desert; and at 
the household and individual-levels it can be associated with SES and self-management 
behaviors—consideration of food insecurity as an upstream SDoH from a social epidemiologic 
lens is an opportunity to better understand chronic disease control among community health 
center patients. In this analysis, we aimed to examine the association between food insecurity and 
uncontrolled cardiometabolic disease using Marmot’s social determinants of health theoretical 
framework. We found a significant positive association of food insecurity with risk of 
uncontrolled dyslipidemia, particularly as measured by non-HDL-C. Those patients reporting 
food insecurity had approximately a 2-fold higher odds of uncontrolled dyslipidemia compared to 
the food secure. We did not find significant associations between food insecurity and diabetes 
control or hypertension control. These analyses contribute to the literature on food insecurity and 
dyslipidemia control and contrast with the one prior study that reported null findings (Seligman et 
al., 2010). 
We also identified self-reported dyslipidemia medication adherence as a partial mediator 
of the association between food insecurity and uncontrolled dyslipidemia. This finding has 
important potential applied implications and can help to target dyslipidemia control interventions 
among food insecure populations in clinical settings—a strategy, to the best of our knowledge, 
not otherwise reported in the literature.  
As with prior research, we found similarly elevated mean HbA1c among the food 
insecure compared to the food secure (Seligman et al., 2012). However, our findings differed 
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unexpectedly from the majority of previous cross-sectional studies in which a significant positive 
association between food insecurity and poor glycemic control was detected (Seligman et al., 
2010; Seligman et al., 2012; Berkowitz et al., 2013; Mayer et al., 2015; Wang et al., 2015; 
Heerman et al., 2016).  Our findings were similar to one prior study that found no association 
between food insecurity and diabetes control but found a significant association between very low 
food security and diabetes self-management factors—specifically medication adherence and 
depression (Ippolito et al., 2016). Most research has reported food insecurity as a categorical or 
dichotomous variable as did we in this study. Given this analysis had the smallest sample size 
(n=162), using food insecurity as a continuous variable in the multivariable regression modeling 
is warranted. Additionally, next steps aim to conduct similar analyses with a similar but larger 
sample size.  
Our null findings of the association between food insecurity and uncontrolled 
hypertension adds to the few existing studies with mixed findings including null (Seligman et al., 
2010) and a positive significant association (Wang et al., 2015). Given that the sample size for 
this analysis was the largest of the disease-specific models (n=309) and that an independent 
association was detected among those with dyslipidemia which has fewer participants (n=224), 
the null finding warrants additional consideration beyond sample size and lack of power to detect 
effects.   
Our study found similarly high prevalence of food insecurity ranging as prior studies 
which ranged from 40-75% (Seligman et al., 2007; Mayer et al., 2015; Heerman et al., 2016). In 
this study, prevalence of food insecurity among Latino participants was 66% and African 
American participants was 42%, 1.5 to three times the national rate of 22% among minority 
populations as of 2015 (Coleman-Jensen et al., 2016). 
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Unexpectedly, individuals reporting food insecurity had higher levels of education 
compared to the food secure. We found that food insecurity differed significantly by cultural 
group with the greatest rates among Latinos and African Americans and the lowest rates among 
Vietnamese and Russian-speaking. To contextualize these differences, preliminary qualitative 
data analyses (not reported here) indicate that Vietnamese participants are older and have 
larger/stronger social/cultural networks that help to secure access to important resources 
including food, food stamps, travel to local food pantries, and home health aids. The Vietnamese 
also have the lowest educational levels. Latinos, in contrast, are younger, report higher levels of 
stress associated with running out of food each month and sacrificing meals when food is scarce 
to ensure their children eat. They do not report similar social networks for resource sharing as 
reported by the Vietnamese which corresponds with their lower rates of receiving SNAP benefits.   
We observed an overall self-reported medication adherence rate of 70.4% and pill count 
medication adherence rate of 55.4%. There is currently no gold stand approach to medication 
adherence, however, multimeasure approaches such as ours are recommended (Lam et al., 2015). 
Both the rates and their difference (15%) observed are in accordance with prior research on self-
reported and pill count adherence (Lee et al., 2007; Osterberg et al., 2005; Garber et al, 2004; 
Grymonpre et al., 1998;  ) in which self-reported adherence is found to be an overestimate 
compared to pill count adherence. To our knowledge, however, no prior study has examined 
disease-specific medication adherence by self-report or by pill count and the role of medication 
adherence in the association between food insecurity and dyslipidemia control.  
 
2.4.1. Strengths and Limitations 
There are several important strengths to this study. This study includes a diverse sample of 
community health center patients from five racial/ethnic groups including both U.S. and foreign-
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born immigrant and refugee groups less frequently including in SDoH and health disparities 
research. It allowed for consideration of cardiometabolic disease control among a federally 
qualified health center patient population where multimorbidity cardiometabolic diseases and 
SDoH-related barriers are prevalent. This study was able to assess disease-specific medication 
adherence by both self-report and pill count. Finally, it offered an opportunity to examine an 
important theoretical framework of social determinants of health focused on food insecurity 
among a patient population for whom addressing social and environmental barriers to care is 
necessary.  
There were also several limitations. As with the majority of the existing literature on the 
association of food insecurity and cardiometabolic disease control, this was a cross-sectional 
study and therefore precluded any determination of temporality in the relationships observed. We 
were unable to assess whether higher food insecurity led to poor cardiometabolic disease control, 
or whether poor cardiometabolic disease control led to higher food insecurity. In addition, food 
insecurity is a cyclic and time varying phenomenon; therefore, given the cross-sectional design 
we have a single measure of food insecurity.  
Small sample size was another limitation. We observed wide confidence intervals and 
were underpowered to detect smaller effects. 
Measurement error related to self-reported variables and EMR data was another possible 
limitation. While the USDA Household Food Security Survey Module is the primary measure of 
food insecurity in the U.S., as a self-reported measure, there is some potential for nondifferential 
misclassification of exposure.  
Culturally-rooted differences identified in the larger RxHL mixed-methods study, may 
have impacted either actual difference in self-reported food insecurity or perceptions of self-
reported food insecurity.  For instance, Vietnamese participants reported multiple means of access 
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to alternative food resources primarily through well-established social networks linking 
individuals and families with community-based resources and navigational supports. In contrast, 
Latinos did not report similar support networks and instead frequently reported running out of 
food before the end of the month and sacrificing food to ensure children had sufficient food. In 
contrast to both Vietnamese and Latino participants, Russian-speaking participants described the 
U.S. food environment as abundant compared to the conditions they previously lived through in 
former, native countries where lack of access to any food sources was common. Each of these 
differing cultural perceptions could impact participant responses to each of the screening and 
frequency questions included in the food security survey and could lead to an over- or under-
estimate among groups. The data were collected by bilingual, bicultural interviewers who were 
trained to administer the survey in a standardized, non-judgmental and culturally appropriate 
manner to all study participants. For this reason, we expect to have minimized the likelihood of 
nondifferential misclassification of exposure.  
 Cardiometabolic disease control was measured based on having a medical diagnosis of 
one of three diseases as documented in the electronic medical record and on the most recent 
laboratory values recorded in the electronic medical record. Trained medical chart abstracters 
obtained diagnosis, HbA1c, SBP, non-HDL-C and LDL-C data from participants’ medical 
records at baseline after administering the survey where food insecurity is assessed. 
Nondifferential misclassification of disease control for diabetes, dyslipidemia, and hypertension 
is possible. HbA1c and lipid levels are based on point of care blood draws and SBP is determined 
by doing a blood pressure reading. Each of these clinical measures are all time varying measures 
and thus would depend on reproducibility of blood levels/blood pressure reading.  It is also 
possible that lab variability could result in nondifferential misclassification of HbA1c, non-HDL-
C or LDL-C. Measurement error associated either with human error or error associated with the 
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actual blood pressure cuff and instrument could result in nondifferential misclassification of SBP. 
In addition, regarding diabetes control, while HbA1c is generally accepted as the gold standard, 
some literature suggests that HbA1c is not a perfect measurement of glycemic control, in part 
because of possible hemoglobin variants and the fact that it measures control over a broader time 
period (2-3 months). However, clinical measurement of HbA1c, SBP, non-HDL-C and LDL are a 
part of routine diabetes, hypertension, and dyslipidemia management within the primary care 
environment and clinical staff are trained to collect/measure each. These measures are similar to 
ones used in other studies and, given our results and unexpected findings regarding diabetes and 
hypertension, it is possible that this nondifferential misclassification of outcome may help to 
explain the differences from what others have found.  
  It is also possible those with uncontrolled disease, may have different self-reporting of 
food insecurity, either due to differential over or under reporting or generally poorer recall 
(imprecision).   
 
2.4.2. Confounding 
Confounding can be an issue, where factors related to food insecurity and disease control could 
lead to biased estimates of the association of interest. We measured and controlled for a fairly 
large number of variables  including age, gender, race/ethnicity, educational level, health literacy, 
income or income equivalence, employment status, partner status, language spoken at home, body 
mass index, comorbid conditions/number of diseases (e.g., diabetes, hypertension, dyslipidemia 
and depression), smoking use, alcohol use, insulin (among those with diabetes), health insurance 
status, cost and transportation barriers to care and medications, BMI, social support, and social 
stress. However, their inclusion in the models with small sample size resulted in wide confidence 
intervals. Residual confounding due to both unmeasured confounders and measurement error in 
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those confounders included in models is always a potential limitation. Though limited by sample 
size, based on the crude and adjusted analyses, we observed minimal change in estimate. It is 
possible that several important unmeasured confounders including exercise, duration of disease, 
length of time in U.S., and household size could have resulted in residual confounding.  
One confounder that did result in a change in estimate was insulin. Insulin is an effective 
medication used in diabetes management particularly among those with uncontrolled HbA1c 
and/or for whom diet, exercise, and oral medications are insufficient to adequately control HbA1c 
levels.  Though all of the diabetes disease control models were null (unadjusted and adjusted), 
inclusion of insulin in the model resulted in an overall change in the size and direction of the odds 
ratio indicating it may be an important potential confounder of the association between food 
insecurity and diabetes control. To assess this more closely, we conducted two sensitivity 
analyses. First, we examined the association between food insecurity and diabetes control and 
excluded all insulin users (n=41). Second, because the majority of insulin users were also Latino 
(29%), we also examined the association between food insecurity and diabetes control by 
excluding Latinos. Both sensitivity analyses were non-significant but similar to each other. 
Adjusting for insulin when assessing A1c control among individuals with diabetes is critical. 
However, given the non-significant results and the relatively limited power and small sample 
size, these results cannot be adequately interpreted. They do indicate a potentially important role 
and overlap between insulin users and Latino identity that may be important to explore in future 
research and may have contributed to the lack of association observed in this study. Only a few of 
the prior studies examining the association between food insecurity and diabetes control 
specifically report adjustment for insulin and, among those that did, results were mixed.  
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2.5. Significance 
 
The findings of this study contribute to understanding the role of food insecurity in dyslipidemia 
control and the role of self-reported medication adherence in that association. Food insecurity is 
prevalent in the U.S. and highest among minority populations. This study indicates food 
insecurity rates two- to four-times national averages among this study population thereby further 
complicating effective management of diet-sensitive chronic diseases.  This analysis indicates 
that being food insecure increases odds of uncontrolled dyslipidemia 2-fold and that adherence to 
dyslipidemia medications partially mediates that association. Therefore, food insecurity screening 
is needed to better target dyslipidemia management interventions, including medication 
adherence. Additionally, public health programming—like existing national campaigns to address 
diabetes and hypertension prevention and management—are needed to increase awareness of 
dyslipidemia control and to increase access to healthy, affordable foods among those with 
dyslipidemia. Our null findings with diabetes and hypertension are unexpected and warrant 
further consideration. Next steps aim to conduct similar research with a larger, similar patient 
population to explore this further.  
The findings in this study may be generalizable to other patient populations seeking care 
from similar urban settings where food insecurity is associated with increased access to low 
nutrient, high density foods.  
 Additional research is needed to assess the association between food insecurity and 
cardiometabolic disease control and the possible role of medication adherence among diverse 
patient populations. Prospective studies with sufficient sample sizes to adequately examine 
differences by racial/ethnic/cultural group and that specifically examine whether food insecurity 
increases risk of poor dyslipidemia control would be useful to inform future targeted public health 
and community health initiatives. Current public health programs aimed to prevent and manage 
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hypertension (e.g., AHA’s Check, Change, Control) and diabetes (CDC’s Diabetes Prevention 
Program) are common in community health center settings. Campaigns, educational 
programming, and practice/policy interventions have been developed to increase awareness and 
adoption of self-management behaviors for diabetes and hypertension while reducing 
social/environmental barriers to care, for instance, by introducing community health workers into 
primary care teams. It is possible that these public health interventions have been successful in 
increasing diabetes and hypertension control and should be expanded to target dyslipidemia. 
Development of similar clinical and public health initiatives to address dyslipidemia prevention 
and management, particularly in regions serving diverse patient populations with higher rates of 
food insecurity, may be warranted.  
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Table 1a. Participant Characteristics, n=361 
 
 
Characteristics
Continuous Variables Mean SD
Diabetes 
     A1c (n=162) 7.5 1.8
Hypertension
     SBP (n=309) 130.9 16.4
Dyslipidemia 
      Non-HDL-C  (224) 136.7 41.3
      LDL-C  (n=223) 106.7 39.2
BMI 32.1 7.9
Food insecurity score 1.5 2.0
Health Literacy Score 13.8 4.9
Social Stress 4.6 4.1
Age 58.8 11.6
Monthly household income (all sources) 1,165.06 745.4
Monthly household income-Equialence         
Scale (Income/sqrt2 if living with 
partner/family) 1,001.08 565.4
Monthly mean SNAP 126.76 122.33
Social support overall 4.1 1.1
Categorical Variables N %
     Diabetes Only 11 3.1
     Hypertension Only 69 19.1
     Dyslipidemia Only 25 6.9
     Depression Only 0 0.0
     Diabetes All 171 47.4
     Hypertesion All 309 85.6
     Dyslipidemia All 239 66.2
     Depression All 96 26.6
     Pre-diabetes 24 6.7
Numbner of diseases
     1 cardiometabolic disease 108 29.9
     2 cardiometabolic disease 148 41.0
     3 cardiometabolic disease 105 29.1
Disease Control  
Diabetes (n=171)
     A1c Controlled (<7) 83 48.5
     A1c Uncontrolled (>=7) 79 46.2
     missing 9 5.3
Hypertension (n=309)
     SBP Controlled (<140) 219 70.9
     SBP Uncontrolled (>=140) 90 29.1
Dyslipidemia  (n=239)
     Non-HDL Controlled (<130) 106 44.4
     Non-HDL Uncontrolled (>=130) 118 49.4
     missing 15 6.2
     LDL Controlled (<100) 109 45.6
     LDL Uncontrolled (>=100) 114 47.7
     missing 16 6.7
Depression Screen_All (PHQ-9)
     No Depression 269 74.5
     Depression 91 25.2
BMI 
     <30 (not obese) 145 40.2
     >30 (obese) 191 52.9
     missing 25 6.9
Insulin (among those with DM n=171)
     No  127 74.3
     Yes 44 25.7
Tobacco Use
     No 202 56.0
     Yes 156 43.2
     missing 3 0.8
Alcohol Use
     No 280 77.6
     Yes 73 20.2
     missing 8 2.2
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Table 1a. Participant Characteristics (continued) n=361 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1a. Participant Characteristics (continued) n=361
Categorical Variables n %
Food Insecurity 
     Food Secure 230 63.7
     Low Food Security (Categ) 82 22.7
     Very low food security (Categ) 49 13.6
     Food Insecure (Dichot) 131 36.3
Social Stress_overall 
    No Stress 56 15.5
   Stress 305 84.5
Health Literacy
     Adequate Health Literacy (15+) 227 62.9
     Low Health Literacy (0-14) 134 37.1
Gender
     Male 152 42.1
     Female 209 57.9
Ethnicity
     White 40 11.1
     African American 85 23.6
     Vietnamese 97 26.9
     Russian-speaking 63 17.5
     Latino 76 21.1
Employment
     Not emplyed 303 83.9
      Part/Full-time employed 57 15.8
      missing 139 (44) 0.3
SNAP
     No 111 30.8
     Yes 250 69.3
Educational Level
    <High School 140 38.8
     High School Degree (or GED) 113 31.3
     Some college+ 107 29.6
     missing 139 (44) 0.3
Partner/Household Status
     Living single/not partnernered 223 61.8
     Living with partner/family 138 38.2
Homeless
     No 331 91.7
     Yes/Shelter 30 8.3
Language Spoken at Home
      English 152 42.1
     Spanish 52 14.4
     Vietnamese 96 26.6
     Russian 61 16.9
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Table 1a. Participant Characteristics (continued) n=361 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Participant Characteristics (continued) n=361
Categorical Measures n %
Health Insurance Coverage
     No 7 1.9
     Yes 348 96.4
     Don't know 6 1.7
Medicare
     No 177 49.0
     Yes 171 47.4
     Don't know 13 3.6
Gap in Health Insurance
     No 322 89.2
     Yes 37 10.3
     missing 2 0.5
Barriers to Care-Cost
     No 330 91.4
     Yes 30 8.3
     missing 139 (44) 0.3
Barriers to Care-Transportation
     No 287 79.5
     Yes 72 19.9
     missing 2 0.6
Barriers to Medication-Cost
     No 269 74.5
    Yes 91 25.2
     missing 139 (44) 0.3
Barriers to Medication-Transportation 
    No 311 86.2
    Yes 49 13.6
     missing 1 0.3
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Table 1b. Participant characteristics for medication adherence (Morisky self-report and pill count) 
and medication use 
 
 
 
 
 
 
 
Characteristics
Mean SD
Morisky Medication Adherence Score (self-report) 6 1.7
Mean % Medication Adherence (pill count) 72.6 23.9
     DM (n=91) 75.3 25.2
     HTN (n=210) 77 23.9
     DYS (n=126) 76.8 24.5
     DEP (n=23) 79.56 28.1
Medication Adherence: Self-Report N %
Morisky, Overall (n=361)
     Adequate Adherence 254 70.4
     Low Adherence 107 29.6
Morisky, if Diabetes (n=171)
      Adequate Adhernece 119 69.6
      Low Adherence 52 30.4
Morisky, if Hypertension (n=309)
     Adequate Adhernece 216 69.9
     Low Adherence 93 30.1
Morisky, if Dyslipidemia (n=239)
     Adequate Adhernece 176 73.6
     Low Adherence 63 26.4
Morisky, if Depression (n=96) 
     Adequate Adhernece 49 51.0
     Low Adherence 47 49.0
Medication Adherence: Pill Count 
Medication Adherence Overall: Pill Count  (n=316)
     Adequate Adhernece (>=80%) 175 48.5
     Low Adherence (<80%) 141 39.1
     missing 45 12.5
Medication Adherence, if Diabetes (n=171)
     Adequate Adhernece (>=80%) 99 57.9
     Low Adherence (<80%) 43 25.2
     missing 29 17.0
Medication Adherence, if HTN (n=309)
     Adequate Adhernece (>=80%) 186 60.2
     Low Adherence (<80%) 87 28.2
     missing 36 11.7
Medication Adherence, if DYS (n=239)
     Adequate Adhernece (>=80%) 151 63.2
     Low Adherence (<80%) 59 24.7
     missing 29 12.1
Medication Adherence, if DEP (n=96)
     Adequate Adhernece (>=80%) 78 81.3
     Low Adherence (<80%) 6 6.3
     missing 12 12.5
Polypharmacy n=316
     <4 meds 252 79.8
     4 or more meds 64 20.3
Insulin (among those with Diabetes n=171)
     Yes 127 74.3
      No 44 25.7
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Table 2. Disease control and covariates by food security status	
  
 
Characteristics
Food Secure                
n=230 (63.7)
Food Insecure       
n=131 (36.3) P-value*
Mean(SD)
Age 61.3(0.7) 54.5(1.1) <0.001
Diabetes (n=171)
      A1c 7.3(1.6) 7.9(2.1) 0.06
DM without insulin (n=127)
     Mean A1c 7.1(1.4) 7.1(1.4) 0.98
DM with insulin (n=44)
     Mean A1c 8.4(1.98) 9.4(2.3) 0.14
HTN (n=309)
     Mean SBP 131.7(16.14) 129.3(16.8) 0.22
DYS (n=239)
     Mean non-HDL-C 130.3(40.3) 149.1(40.7) 0.001
     Mean LDL-C 102.3(35.1) 115.2(45.2) 0.02
DEP (n=96)
      PHQ_score 2.4(0.3) 7.3(0.7) <0.001
BMI score 31.8(0.5) 32.7(0.8) 0.33
Social Stress Score 2.97(0.2) 7.4(0.4) <.001
Monthly household income (all sources) 1185.89(45.0) 1128.48(74.0) 0.48
Income (Equialence Scale) 1014.2 (527.5) 978.0 (565.4 0.56
Social support overall 4.4(0.1) 3.6(0.1) <.001
n(%)
Diabetes (DM) (n=171)
      Controlled (<7) 56(49.6) 27(46.6) 0.37
      Uncontrolled (>7) 53(46.9) 26(44.8)
DM without insulin (n=127)
     Controlled (<7) 52(57.1) 23(63.9) 0.7
     Uncontrolled (>7) 35(38.5) 11(30.6)
DM with insulin (n=44)
     Controlled (<7) 4(18.2) 4(18.2) 0.33
     Uncontrolled (>7) 18(81.8) 15(68.2)
Hypertension (n=309)
     Controlled (<140) 143(71.1) 76(70.4) 0.89
     Uncontrolled (>140) 58(28.9) 32(26.6)
Dyslipidemia (n=239)
     Controlled (non-HDL-C<130) 80(50.3) 26(32.5) 0.02
     Uncontrolled (non-HDL-C>130) 68(42.8) 50(62.5)
      Controlled (LDL-C<100) 79(49.7) 30(37.5) 0.1
     Uncontrolled (LDL-C>100) 68(42.8) 46(57.5)
Depression (Clinical Diagnosis) (n=96)
      No Depression 181(78.7) 84(64.1) 0.003
     Depression 49(21.3) 47(35.9)
Depression Screen (PHQ-9)
      No Depression 195(84.8) 74(56.5) <0.001
      Depression 35(15.2) 56(42.8)
Insulin (among those with diabetes)
     No insulin 91(39.6) 36(27.5) 0.03
     Insulin 22(9.6) 22(16.8)
BMI 
      <30 (not obese) 95(41.3) 50(38.2) 0.43
       >30 (obese) 122(53.0) 69(52.7)
Tobacco User
     No 144(62.6) 58(44.3) 0.001
     Yes/Current 83(36.1) 73(55.7)
Alcohol Use
     No 182(79.1) 98(74.8) 0.54
      Yes/Current 44(19.1) 29(22.1)
Food Security
*Two sample t-test or Chi square test, as appropriate
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Table 2. Disease control and covariates by food security status (continued) 
	    
 
 
 
 
Characteristics
Food Secure                
n=230 (63.7)
Food Insecure       
n=131 (36.3) P-valuea
n(%)
Ethnicity
     White 26 (11.3) 14(10.7) <0.001
     African American 49(21.3) 36(27.5)
     Vietnamese 75(32.6) 22(16.8)
     Russian-speaking 54(23.5) 9(6.9)
     Latino 26(11.3) 50(38.2)
Gender
     Male 99(43.0) 53(40.5) 0.63
     Female 131(57.0) 78(59.5)
Educational Level
     <High School 95(41.3) 45(34.4) 0.03
      High School Degree (or GED) 78(33.9) 35(26.7)
     Some college+ 56(24.4) 51(38.9)
      Missing 1(.43) 0(0)
Employment
     Not employed 186(80.9) 117(89.3) 0.1
     Part/full-time employed 43(18.7) 14(10.7)
SNAP
     No SNAP 70(30.4) 41(31.3) 0.86
     SNAP 160(69.6) 90(68.7)
Health Literacy
     Adequate Health Litearcy 138(60.0) 89(67.9) 0.13
      Low Health Literacy 92(40.0) 42(32.1)
Partner/Household Status
       Living single/not partnernered 135(58.7) 88(67.2) 0.11
       Living with partner/family 95(41.3) 43(32.8)
Homeless
      Not homeless 219(95.2) 112(85.5)
      Homeless 11(4.8) 19(14.5) 0.001
Language Spoken at Home
     English 85(37.0) 67(51.2) <.001
     Spanish 18(7.8) 34(26.0)
     Vietnamese 74(32.2) 22(16.8)
     Russian 53(23.0) 8(6.1)
Gap in Health Insurance
     No 207(90.0) 115(87.8) 0.78
     Yes 22(9.6) 15(11.5)
Barriers to Care-Cost
      No 214(93.0) 116(88.6) 0.19
      Yes 16(7.0) 14(10.7)
Barriers to Care-Transportation
     No 202(87.8) 85(64.9) <.001
     Yes 27(11.7) 45(34.4)
Barriers to Medication-Cost
     No 191(83.0) 78(59.5) <.001
     Yes 39(17.0) 52(39.7)
Barriers to Medication-Transportation 
     No 216(93.9) 95(72.5) <.001
     Yes 14(6.1) 35(26.7)
*Two sample t-test or Chi square test, as appropriate
Food Security
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Table 3. Food insecurity and covariates by disease control 
 
 
 
Controlled (n=83) Uncontrol (n=79) Controlled (n=219) Uncontrol (n=90) Controlled (n=106) Uncontrolled (n=118)
(HbA1c < 7%) (HbA1c>7%) (SB<140 mmHg) (SB>140 mmHg) (non-HDL<130) (non-HDL>130)
Categorical Measures N(%) N(%) p value* N(%) N(%) p value* N(%) N(%) p value*
Food Insecurity 
     Food Secure 56 (67.5) 53(67.1) 0.52 143(65.3) 58(64.4) 0.9 80(75.5) 68(57.6) 0.06
     Low Food Security 16 (19.3) 16(20.3) 47(21.5) 21(23.3) 15(14.2) 33(28.0)
     Very low food security 11(13.3) 10(12.7) 29(13.2) 11(12.2) 11(10.4) 17(14.4)
     Food Insecure 27(32.5) 26(32.9) 0.37 76(34.7) 32(35.6) 0.89 26(24.5) 50(42.4) 0.016
Social Stress (TAPS)
     Low Stress (0-1 stressors) 23(27.7) 26(32.9) 0.72 59(26.9) 22(24.4) 0.6 35(33.0) 30(25.4) 0.12
     Some Stress (2-4 stressors) 29(34.9) 23(29.1) 69(31.5) 32(35.6) 41(38.7) 39(33.1)
     Moderate Stress (5-7 stressors) 15(18.1) 17(21.5) 46(21.0) 14(15.6) 17(16.0) 24(20.3)
     High Stress (8+ stressors) 16(19.3) 13(16.5) 45(20.6) 22(24.4) 13(12.3) 25(21.2)
Health Literacy
      Adequate Health Litearcy 53(63.9) 47(59.5) 0.79 139(63.5) 55(61.1) 0.7 67(63.2) 69(58.5) 0.66
     Low Health Literacy 30(36.1) 32(40.5) 80(36.5) 35(38.9) 39(36.8) 49(41.5)
Depression (Medical Diagnosis)
     No Depression 61(73.5) 63(79.8) 0.24 167(76.3) 67(74.4) 0.74 83(78.3) 92(78.0) 0.98
      Depression 22(26.5) 16(20.3) 52(23.7) 23(25.6) 23(21.7) 26(22.0)
Depression (PHQ-9)
      No Depression 62(74.7) 56(70.9) 0.84 164(74.9) 65(72.2) 0.28 83(78.3) 93(78.8) 0.87
     Depression 21(25.3) 22(27.9) 55(25.1) 24(26.7) 22(20.8) 25(21.2)
       Missing 0(0) 1(1.3) 0(0) 1(1.1) 1(.94) 0(0)
Medication Adherence: Morisky (self-report)
     Adequate Adherence 58(69.9) 55(69.6) 0.98 157(71.7) 59(65.6) 0.29 90(84.9) 77(65.3) 0.002
      Low Adherence 25(30.1) 24(30.4) 62(28.3) 31(34.4) 16(15.1) 41(34.7)
Disease-specific Adherence (Pill Count) 
     DM medications >=80% adhernece 51(61.5) 43(54.4) 0.87
      DM medications<80% adherence 19(22.9) 21(26.6)
     missing 13(15.66) 15(19.0)
     HTN medications >=80% adhernece 145(66.2) 41(45.6) 0.003
     HTN medications<80% adherence 52(23.7) 35(38.9)
      missing 22(10.1) 14(15.6)
     DYS medications >=80% adhernece 67(63.2) 75(63.5) 0.86
      DYS medications<80% adherence 27(25.5) 27(22.9)
      missing 12(11.3) 16(13.6)
Overall Adherence (Pill Count) 
     Adequate Adhernece (>=80%) 43(51.8) 33(41.8) 0.55 115(52.5) 35(38.9) 0.076 58(54.7) 56(47.5) 0.8
     Low Adherence (<80%) 27(32.5) 31(39.2) 82(37.4) 41(45.6) 36(34.0) 46(39.0)
     missing 13(15.7) 15(19.0) 22(10.1) 14(15.6) 12(11.3) 16(13.6)
Polypharmacy
      <4 viable medications 43(51.8) 39(49.4) 0.57 148(67.6) 66(73.3) 0.045 58(54.7) 86(72.9) 0.002
     4 or more viable medications 27(32.5) 25(31.7) 49(22.4) 10(11.1) 36(34.0) 16(13.6)
       missing 13(15.7) 15(19.0) 22(10.1) 14(15.6) 12(11.3) 16(13.6)
Insulin 
     No insulin 75(90.4) 46(58.2) <0.001 84(38.4) 24(26.7) 0.06 45(42.5) 35(29.7) 0.003
     Insulin 8(9.6) 33(41.8) 21(9.6) 15(16.7) 21(19.8) 10(8.5)
      missing 114(52.1) 51(56.7) 40(37.7) 73(61.9)
DYS Control (n=239; 15 missing)Diabetes Control (n=171; 9 missing) HTN Control (n=309)
*Chi square or Fisher's Exact test, as appropriate
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Table 3. Food insecurity and covariates by disease control (continued)  
 
 
 
Controlled (n=83) Uncontrol (n=79) Controlled (n=219) Uncontrol (n=90) Controlled (n=106)) Uncontrolled (n=118)
(HbA1c < 7%) (HbA1c>7%) (SB<140 mmHg) (SB>140 mmHg) (non-HDL<130) (non-HDL>130)
Categorical Measures N(%) N(%) p value* N(%) N(%) p value* N(%) N(%) p value*
Gender
     Male 32(38.6) 34(43.0) 0.77 90(41.1) 43(47.8) 0.28 47(44.3) 53(44.9) 0.69
     Female 51(61.5) 45(57.0) 129(58.9) 47(52.2) 59(55.7) 65(55.1)
Race/ethnicity
     white 4(4.8) 8(10.1) 0.13 31(14.2) 6 (6.7) 0.15 13(12.3) 14(11.9) 0.03
     African American 18(21.7) 17(21.5) 48(21.9) 29(32.2) 19(17.9) 24(20.3)
      Vietnamese 30(36.1) 22(27.9) 56(25.6) 23(25.6) 51(48.1) 34(28.8)
      Russian-speaking 8(9.6) 14(17.7) 39(17.8) 18(20.0) 9(8.5) 24(20.3)
      Latino 23(27.7) 18(22.8) 45(20.6) 14(15.6) 14(13.2) 22(18.6)
Educational Level
     <High School 33(39.8) 36(45.6) 0.49 81(37.0) 34(37.8) 0.8 50(47.2) 50(42.4) 0.34
      High School Degree (or GED) 22(26.5) 25(31.7) 72(32.9) 26(28.9) 33(31.1) 34(28.8)
      Some college+ 28(33.7) 18(22.8) 65(29.7) 30(33.3) 22(20.8) 34(28.8)
      missing 1(.46) 0(0) 1(.9) 0(0)
Partner/Household Status
     Living single/not partnernered 50(60.2) 48(60.8) 0.96 139(63.5) 59(65.6) 0.73 62(58.5) 67(56.8) 0.23
     Living with partner/family 33(39.8) 31(39.2) 80(36.5) 31(34.4) 44(41.5) 51(43.2)
Homeless
     No Shelter 79(95.2) 68(86.1) 0.12 205(93.6) 82(91.1) 0.44 100(94.3) 111(94.1) 0.51
      Yes Shelter 4(4.8) 11(13.9) 14(6.4) 8(8.9) 6(5.7) 7(5.9)
Language Spoken at Home
      English 30(36.1) 32(40.5) 0.36 95(43.4) 41(45.6) 0.8 37(34.9) 45(38.1) 0.01
      Spanish 15(18.1) 12(15.2) 31(14.2) 9(10.0) 10(9.4) 16(13.6)
     Vietnamese 30(36.1) 22(27.9) 55(25.1) 23(25.6) 50(47.2) 34(28.8)
     Russian 8(9.6) 13(16.5) 38(17.4) 17(18.9) 9(8.5) 23(19.5)
BMI (dichotomous)
     <30 (not obese) 35(42.2) 22(27.9) 0.02 79(36.1) 37(41.1) 0.22 49(46.2) 50(42.4) 0.98
     >30 (obese) 41(49.4) 55(69.6) 121(55.3) 50(55.6) 50(47.2) 59(50.0)
     missing 7(8.4) 2(2.5) 19(8.7) 3(3.3) 7(6.6) 9(7.6)
Tobacco User
      No 43(51.8) 49(62.0) 0.65 120(54.8) 54(60) 0.54 66(62.3) 71(60.2) 0.3
      Yes/Current 39(47.0) 29(36.7) 98(44.8) 35(38.9) 40(37.7) 45(38.1)
      Missing 1(1.2) 1(1.3) 1(.46) 1(1.1) 0(0) 2(1.7)
Alcohol Use
       No 70(84.3) 66(83.5) 0.99 172(78.5) 70(77.8) 0.87 80(75.5) 100(84.8) 0.35
       Yes/Current 11(13.3) 11(13.9) 43(19.6) 19(21.1) 23(21.7) 17(14.4)
       missing 2(2.4) 2(2.5) 4(1.8) 1(1.1) 3(2.8) 1(.85)
Gap in Health Insurance
      No 73(88.0) 69(87.3) 0.67 197(90.0) 77(85.6) 0.27 100(94.3) 111(94.1) 0.001
      Yes 9(10.8) 10(12.7) 20(9.1) 13(14.4) 5(4.7) 7(5.9)
      Don't know 1(1.2) 0(0) 2(.91) 0(0) 1(.9) 0(0)
Barriers to Care-Cost
     No 77(92.8) 73(92.4) 0.84 199(90.9) 79(87.8) 0.25 102(96.2) 111(94.1) <.001
     Yes 5(6.0) 6(7.6) 20(9.1) 10(11.1) 4(3.8) 7(5.9)
     Don't know 1(1.2) 0(0) 0(0) 1(1.1) 0(0) 0(0)
Barriers to Care-Transportation
     No 67(80.7) 65(82.3) 0.85 174(79(5) 73(81.1) 0.73 87(82.1) 98(83.1) 0.62
     Yes 15(18.1) 14(17.7) 44(20.1) 16(17.8) 17(16.0) 20(17.0)
     Don't know 1(1.2) 0(0) 1(.5) 1(1.1) 2(1.9) 0(0)
Barriers to Medication-Cost
     No 62(74.7) 60(76.0) 0.8 169(77.2) 62(69.0) 0.23 86(81.1) 92(78.0) 0.04
     Yes 21(25.3) 18(22.8) 49(22.4) 28(31.1) 20(18.9) 25(21.2)
     Don't know 0(0) 1(1.3) 1(.5) 0(0) 0(0) 1(.85)
Barriers to Medication-Transportation 
     No 73(88.0) 68(86.1) 0.61 193(88.1) 75(83.3) 0.2 95(89.6) 106(89.8) 0.25
     Yes 9(10.8) 11(13.9) 26(11.9) 14(15.6) 10(9.4) 12(10.2)
     Don't know 1(1.2) 0(0) 0(0) 1(1.1) 1(.9) 0(0)
*Chi square test or Fisher's Exact Test, as appropriate
Diabetes Control (n=171; 9 missing) HTN Control (n=309) DYS Control (n=239; 15 missing)
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Table 3. Food insecurity and covariates by disease control (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Controlled (n=83) Uncontrol (n=79) p value* Controlled (n=219) Uncontrol (n=90) p value* Controlled (n=106) Uncontrolled (n=118) p value*
(HbA1c < 7%) (HbA1c>7%) (SB<140 mmHg) (SB>140 mmHg) (non-HDL<130) (non-HDL>130)
Continous Measures Mean (SD) Mean (SD) P Mean (SD) Mean (SD) P Mean (SD) Mean (SD) P
Food Insecurity 1.4(1.9) 1.4(2.0) 0.85 1.5(2.0) 1.3(1.8) 0.58 1.1(1.8) 1.7(1.9) 0.03
Social Stressors 4.3(4.0) 4.0(3.6) 0.55 4.51(4.0) 4.5(4.0) 0.89 3.7(4.1) 4.4(3.9) 0.19
Social Stressors-weighted 8.3(9.3) 7.4(8.1) 0.53 8.8(9.0) 9.3(9.6) 0.64 6.8(9.1) 8.8(8.7) 0.11
PHQ_score 4.2(6.6) 4.1(6.2) 0.94 4.06 (6.3) 4.4 (6.8) 0.67 3.1(5.4) 3.8(6.3) 0.33
Morisky Medication Adherence Score (self-report) 1.9 (0.68) 1.9 (0.73) 0.61 1.93 (.70) 1.9 (.77) 0.73 2.1(.63) 1.9(.76) 0.02
DM medications mean adhernece (pill count) 74.8(28.1) 75.9(23.0) 0.84
HTN medication mean adhernece (pill count) 79.8 (22.4) 70(63.3) 0.007
DYS medication mean adherence (pill count) 80.4(20.1) 74.0(26.9) 0.14
Age 60.0(9.8) 60.0(10.7) 0.99 59.4(11.2) 60.0(10.9) 0.63 62.5(10.9) 60(11.6) 0.13
Monthly household income 1,065(563.9) 1,078(689.3) 0.89 1217.05(765.03) 1153.04(809.77) 0.51 1135.20(755.95) 1144.96(725.91) 0.92
Income (Equialence Scale) 921(433.5) 919.5(512.4) 0.98 1047.67(971.96) 1001.64(870.58) 0.53 971.02(568.34) 969.59(550.63) 0.98
Social support overall 4.2(1.2) 4.2(1.2) 0.95 4.2(1.1) 4.2(1.2) 0.76 4.4(1.1) 4.1(1.1) 0.03
BMI score 32.4(8.7) 34.1(8.1) 0.2 32.5(8.0) 32.9(8.1) 0.74 31.2(8.0) 31.9(8.2) 0.54
*Two sample t-test 
Diabetes Control (n=171; 9 missing) HTN Control (n=309) DYS Control (n=239; 15 missing)
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Table 4a: Food insecurity and diabetes control logistic regression models 
 
 
 
Table 4b: Food insecurity and hypertension control logistic regression models 
 
 
 
Table 4c: Food insecurity and dyslipidemia control (non-HDL-C) logistic regression models 
 
 
Table 4d: Food insecurity and dyslipidemia control (LDL-C) logistic regression models 
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Table 5a: Food insecurity and diabetes control linear regression models 
 
 
Table 5b: Food insecurity and hypertension control linear regression models 
 
 
 
Table 5c: Food insecurity and dyslipidemia control (non-HDL-C) linear regression models 
 
 
Table 5d: Food insecurity and dyslipidemia control (LDL-C) linear regression models 
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DM Level of Control (n=162)
A1c
Unadjusted (n=162) Insulin             
(n=159)
Model A  
(n=156)
Model B         
(n=151)
Beta  95% CI Beta 95% CI Beta 95% CI Beta 95% CI
Food Insecure 0.56 -.03, 1.16 .29 -.26, .85 .44 -.25,1.13 .27 -.41, .95
Insulin: Adjusted for Insulin
Model B-Parsiomonious: Adjusted for age, education, social support, cost of medicationss, transportation to pharmacy and homelessness
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, number of diseases, depression, BMI, 
social support, smoking status, cost of meds, transportation to pharmacy and homelessness 
SBP Level of Conrol (n= 309 )
SBP (continuous)
Unadjusted (n=162) Model A           
(n=156)
Model B  
(n=151)
Beta  95% CI Beta 95% CI Beta 95% CI
Food Insecure -2.42 -6.27, 1.43 .24 -4.17, 4.65 -1.22 -5.19, 2.76
Model B-Parsimonious: Adjusted for age, insurance gaps and smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance, number of 
diseases, depression, BMI, social support and smoking status
Non-HDL Level of Control (n= 224 )
SBP (continuous)
Unadjusted (n=162) Model A         
(n=156)
Model B  
(n=151)
Beta  95% CI Beta 95% CI Beta 95% CI
Food Insecure 18.73 7.49, 29.97 15.45 3.25, 27.66 13.32 1.72, 24.92
Model B- Parsimonious: Adjusted for number of diseases and social support
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance, number of 
diseases, depression, BMI, social support and smoking status
LDL Level of Control (n= 224 )
SBP (continuous)
Unadjusted  
(n=162)
Model A         
(n=156)
Model B 
(n=151)
Beta  95% CI Beta 95% CI
Food Insecure 12.89 2.08, 23.69 10.18 -1.43, 21.78 9.02 -2.22, 20.26
Model B-Parsimonious: Adjusted for number of diseases and social support and smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance, number of 
diseases, depression, BMI, social support and smoking status
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Table 6. Mean pill count adherence by self-reported Morisky medication adherence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Self-Reported 
Adequate 
Adherence
Self-Reported 
Low Adherence
Overall (n=284) 75.0 (21.4) 65.6 (29.1) 0.004
Diabetes (n=91) 79.2(19.9) 63.6(48.6) 0.01
Hypertension (n=210) 77.6(22.8) 75.0(27.5) 0.51
Dyslipidemia (n=126) 78.3(22.9) 71.1(29.8) 0.18
Co-morbid Depression (n=23) 86.9(18.0) 71.5(35.3) 0.2
T-test of continous pill count % mean adherence by low/adeequate self-reported Morisky adherence
Mean Pill Count Adherence
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Tables 7-10: Effect modification analyses 
Table 7a: Logistic regression of food insecurity and diabetes control by BMI (<30 vs. >=30) 
 
Table 7b: Logistic regression of food insecurity and hypertension control by BMI (<30 vs. >=30) 
 
Table 7c: Logistic regression of food insecurity and dyslipidemia control (non-HDL-C) by BMI 
(<30 vs. >=30) 
 
Table 7d: Logistic regression of food insecurity and dyslipidemia control (LDL-C) by BMI (<30 
vs. >=30) 
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Table 8a: Linear regression of food insecurity and diabetes control by BMI (<30 vs. >=30) 
 
 
 
Table 8b: Linear regression of food insecurity and hypertension control by BMI (<30 vs. >=30) 
 
 
 
Table 8c: Linear regression of food insecurity and dyslipidemia control (non-HDL-C) by BMI 
(<30 vs. >=30) 
 
 
 
Table 8d: Linear regression of food insecurity and dyslipidemia control (LDL-C) by BMI (<30 
vs. >=30) 
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Table 9a: Logistic regression of food insecurity and diabetes control by depression (not depressed 
vs. depressed) 
 
Table 9b: Logistic regression of food insecurity and hypertension control by depression (not 
depressed vs. depressed) 
 
 
Table 9c: Logistic regression of food insecurity and dyslipidemia control (non-HDL-C by 
depression (not depressed vs. depressed) 
 
 
Table 9d: Logistic regression of food insecurity and dyslipidemia control (LDL-C by depression 
(not depressed vs. depressed) 
 
 
 
 
 
Unadjusted  
(n=175)
Adjusted 
(n=172)
Unadjusted (n=49) Adjusted 
(n=49)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Food Security Status
     Food Secure 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
     Food Insecure 2.07 1.07, 4.01 1.72 .82, 3.64 3.12 .96, 10.15 5.75 .62, 53.09
DYS Uncontrolled
non-HDL>=130
No Depression Dx Depression Dx
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Table 10a: Linear regression of food insecurity and diabetes control by depression (not depressed 
vs. depressed) 
 
 
 
Table 10b: Linear regression of food insecurity and hypertension control by depression (not 
depressed vs. depressed) 
 
 
Table 10c: Linear regression of food insecurity and dyslipidemia control (non-HDL-C by 
depression (not depressed vs. depressed) 
 
 
Table 10d: Linear regression of food insecurity and dyslipidemia control (LDL-C by depression 
(not depressed vs. depressed) 
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Figure 3. Medication Adherence, Health Literacy and Cultural Health Beliefs (RxHL) Study 
Activities and Timeline 
 
 
	
 
 
 
 
 
Figure 4. Study enrollment for RxHL and the current study, Social Determinants of 
Cardiometabolic Disease Control  
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Medical Chart Abstraction
Pill Count
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• Pill Count
• 8-item Morisky Medication 
Adherence Scale 
Qualitative data collection (subset of total RxHL sample)
• In-depth interviews (n=50)
• Home/Pharmacy Observations (n=38)
• Chronic Disease Diaries (n=30)
January
2014
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2018
Screening (N= 771)
Screening/enrollment via EMR, 
patient registries, provider and self-
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Eligible n=705 
91% of screened
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(Comorbid depression (n=96, 27%))
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(as of 1.2017)
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Figure 5. Odds ratios of uncontrolled disease among food insecure versus food secure  
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Figure 6. Mean difference in disease outcome among food insecure versus food secure 
 
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.56
0.29 0.27
-0.42
-0.22
-0.02
0.18
0.38
0.58
0.78
0.98
1.18
Food
Insecure
Food
Insecure
Food
Insecure
Diabetes: A1c
Crude Insulin Model B
Food Security Status
M
EA
N
 D
IF
FE
R
EN
C
E 
 in
 A
1c
 %
 (
95
%
 C
I)
18.73
13.32
0
2.5
5
7.5
10
12.5
15
17.5
20
22.5
25
27.5
30
Food
Insecure
Food
Insecure
Dyslipidemia: Non-HDL-C
Crude Model B
Food Security Status
-2.42
-1.22
-6.5
-5.5
-4.5
-3.5
-2.5
-1.5
-0.5
0.5
1.5
2.5
3.5
4.5
Food
Insecure
Food
Insecure
Hypertension: SBP
Crude Model B
Food Security Status
M
EA
N
 D
IF
FE
R
EN
C
E 
in
 S
BP
 m
m
H
g 
(9
5%
 C
I)
M
EA
N
 D
IF
FE
R
EN
C
E 
 m
gd
L 
(9
5%
 C
I)
	 88	
Figure 7. Unmediated Model 
 
		  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Food Insecurity
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SBP mmHg
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Figure 8. Mediated Model: Food insecurity and Non-HDL-C by medication adherence  
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Figure 9. Mediated Model: Food insecurity and LDL-C by medication adherence  
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APPENDIX 1 
 
SOCIAL DETERMINANTS OF HEALTH-DEFINITIONS BY HP2020, NAM (IOM), AHA, 
AND NACHC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Healthy People 2020:                                                                                
Social Determinants of Health
National Academy of Medicine (formerly IOM): Capturing 
Social and Behavioral Domains in EMR-Phase 2 (2014)
American Heart Association-Scientific Statement: Social 
Determinants of Risk and Outcomes for CVD
National Associaiton of Community Health Centers:                                                                                                                                          
Protocol for Responding to and Assessing Patients' Assets, Risks, 
and Experiences  (PRAPARE)
Economic stability Sociodemographic Domains Socioeconomic Position (SEP) Personal Characteristics
Poverty Sexual Orientation Income/income inequality 1. Are you Hispanic or Latino?
Employment Race and ethnicity Education (level of education, health literacy) 2. Which race(s) are you?
Food security Country of origin/U.S. born or non-U.S. born Occupation (employment, unemployment, job loss) a. Asian
Housing stability Education Race/Ethnicity b. Pacific Islander
Education Employment Racism c. American Indian/Alaskan Native
High school graduation Financial resource strain: Food and housing insecurity Discrimination d. Native Hawaiian
Enrollment in higher education Psychological Domains Health care provider bias/stereotype e. Black/African American
Language and literacy Health literacy Low quality provider-patient communication f. White
Early childhood education and development Stress Social Support g. Choose not to answer. 
Social community context Negative mood and affect: Depression and anxiety Social support 3. At any point in the past 2 years, has seasonal or migrant farm work 
been your or your family's main source of income?
Social cohesion Psycholocial Assets: conscientiousness, patient 
engagement/activation, optimism, self-efficacy
Social networks 4. Have you been discharged from the armed forces of the US?
Civic participation Behavioral Domains Access to medical care 5. What language are you most comfortable speaking?
Perceptions of discrimination and equity Dietary Patterns Approachability a. English
Incarceration/institutionalization Physical Activity Acceptability b. Language other than Englsih.
Health and health care Tobacco use and exposure Availability and accomodation c. Choose not to answer
Access to health care Alcohol use Affordability Family & Home
Access to primary care Individual-level Social Relationships and Living Conditions 
Domains
Appropriateness 6. How many family members, including yourslef, do you currently 
live with?
Health literacy Social connections and social isolation Residential Environment 7. What is your housing situation today?
Neighborhood and built environment Exposure to violence Neighborhood socioeconomic disadvantage/deprivation a. I have houseing
Access to healthy foods, Neighborhoods and Communities Neighborhood built/physical environment b. I do not have housing (staying with others, in a hotel, in a chleter, 
living outside on the street, on a beach, in a car, or in a park)
Quality of housing Neighborhood and community compositional characteristics Neighborhood social environment c. I choose not to answer this question
Crime and violence Culture and language 8. Are you worried about loosing your housing?
US DHHS (2013): National Standards for Culturally and 
Linguistically Appropriate Services in Health and Health Care
9. What address do you live at? Include street and zipcode)
Requires language services to be provided to those indivudials 
with limited English proficiency and/or other communication 
needs at no cost to facilitate access to health care servicds
Money & Resources
Community Health Workers-bring language and cultural needs of 
patients and provider care teams
10. What is the highest level of school that you have finished?
a. less than high school degree
b. high school diploma or GED
c. More than high school
d. I choose not to answer this question
11. What is your curent work situation?
a. Unemployed and seeking work
b. Part time or temporary work
c. Full time work
d. Otherwise unemployed but not seekign work (e.g., student, retired, 
disabiled, unpaid primary care giver)______________
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APPENDIX 2 
U.S. HOUSEHOLD FOOD SECURITY SURVEY MODULE: SIX-ITEM SHORT FORM, 
ECONOMIC RESEARCH SERVICE, USDA, SEPTEMBER 2012 
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APPENDIX 3 
 U.S. HOUSEHOLD FOOD SECURITY SURVEY MODULE (6-ITEM) SUMMARY (USDA, 
2012) 
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
	
 
Question 
(Last 12 months)
Function Score & 
Categorization
1. Running out of food 1-3: Screen of food 
insecurity 
Categorical
Raw score: 0-1 
• High/marginal food 
security
Raw score 2-4: 
• Low food security
Raw score 5-6:
• Very low food 
security
Dichotomous
Raw score: 0-1
• High/marginal food 
security
Raw score 2-6:
• Food insecure
2. Eating balanced meals
3. Meals cut/skipped
4. Frequency of skipped 
meals
4-6: Degree of food 
insecurity 
5-6. Eating practices 
based on lack of money
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CHAPTER 3 
 
SOCIAL STRESSORS, MEDICATION ADHERENCE AND CARDIOMETABOLIC 
DISEASE CONTROL: AN	ECOSOCIAL	APPROACH		
 
 
INTRODUCTION 
 
3.1. Introduction: Cardiometabolic Disease Control 
 
As previously discussed in the Introduction and Chapter 1, cardiovascular disease (CVD) 
is the leading cause of death in the United States (CDC, 2016). Three cardiometabolic diseases—
diabetes mellitus, high blood pressure (hypertension) and high blood cholesterol (hyperlipidemia) 
have been identified as modifiable risk factors for CVD (AHA, 2016).  Effective management of 
each of these cardiometabolic diseases is fundamental to preventing morbidity and mortality 
associated with disease progression, to reduce the risk of CVD events (e.g., heart attack and 
stoke). Additionally, control of one of these diseases can possibly prevent the onset of one 
another.  
 
3.1.2.Social Stressors 
3.1.2.1. History of Social Stress Research 
Since its introduction into the medical literature by Austrian-Canadian endocrinologist Hans 
Selye in 1936, abundant scientific evidence has accrued to support the idea that stress  is 
associated with higher risk of disease and progression of disease (Selye, 1955; Selye, 1973; 
Selye, 1976; Chrousos, 1997; APA, 2016; RWJ, 2016). Selye famously stated in an attempt to 
define stress: “Everybody knows what stress is and nobody knows what it is” (Selye, 1973, p. 
692). Nearly forty years after its introduction, Selye came to define stress as “the nonspecific 
response of the body to any demand made upon it” (Selye, 1973, p.692). The term “nonspecific” 
refers to the fact that no matter the stimulus of the stress response, the body is faced with needing 
to adapt to the problem and return to normal or homeostasis. Selye’s work affirmed that the 
nonspecific nature of the response is central to understanding the phenomenon of stress and its 
	 96	
effect on the body and disease. During these early stages of scientific examination of stress to 
define it and its biological mechanisms, an important distinction was made between stress and 
stressors, wherein stress is identified as the response or reaction and stressors are the factors that 
trigger stress response (Selye, 1955; 1973). Stressors have a range of origins including, but not 
limited to, biological, emotional, physical, or social.   
  With increasing attention to the social/environmental underpinnings of health disparities 
in health care research, social stressors have been identified as factors in a patient’s social and 
environmental context that interfere with their ability to comply with complex medical regimens 
(Rothberg et. al., 2011). Social stressors, akin to social determinants of health (SDoH), include 
factors such as socioeconomic disadvantage, financial strain or poverty, homelessness or unstable 
housing, food insecurity, social conflict (e.g., problems with family, friends, and/or significant 
others), family responsibilities, discrimination, exposure to violence (e.g., victimization, trauma), 
lack of transportation, and others (Rothberg et al., 2011; HP2020, 2010). Given the range of 
social stressors identified, they can be acute or chronic in nature and can result in acute and/or 
chronic stress (Rothberg et al., 2011), which may impede or complicate disease prevention or 
management, including adherence to treatment plans. 
A psychosocial theoretical framework focuses on biological responses to human 
interactions, the role of stress in the biologic mechanisms, and on how people manage or behave 
in the presence of stress (Krieger, 2001, p. 670). Psychosocial theoretical frameworks primarily 
examine the relationship between (social) stressors and their effect on health and on the role of 
social integration or social support and health outcomes (Krieger, 2001; Berkman, 1985; Cohen, 
1988; Cohen & Syme, 1985). Social integration and support have been found to be inversely 
associated with morbidity and mortality and positively associated with health maintenance, 
(Berkman et al., 2014) while factors like depression and discrimination have been found to 
exacerbate outcomes. Psychosocial factors including but not limited to depression and chronic 
life stress have been linked with cardiovascular disease (Rozanski et al., 1999). Psychosocial 
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theory in social epidemiology has emerged in part from the combination of John Cassel’s 
exploration of the role of the social environment on the experience of stress and its effect on 
disease (1964, 1976) and Selye and Wolf’s focus on the biological effects of stress on the body 
(1973).   As these concepts emerged, so did new terms for “states of being”. For instance, 
“allostasis”—the body’s ability to “achieve balance” amidst a changing environment, a concept 
akin to homeostasis (Cannon, 1935; 1941), and “allostatic load”—the long-term effect of 
stressors on physiologic systems (Sterling & Eyer, 1988; Krieger, 2001)—were introduced. 
Though the relationship between the social environment and health status is now commonly 
explored across a range of disciplines including social epidemiology, the ecosocial model 
(Krieger, 2001) is one unifying theory through which to explore mechanisms that may link the 
social environment, including social stressors, to health outcomes (Krieger, 2001; Marmot et al., 
2006; Cohen, 1988). These models situate the individual and his/her/their behavior downstream 
of social/environmental contexts and associated stressors.  
 
3.1.2.2.Results from 2 Recent Population Surveys 
Since 2007, the American Psychological Association (APA) has administered an annual national 
“Stress in America” survey. The top five sources of stress (stressors) among adults in 2015 were: 
1) money (67%; top source of stress since 2007); 2) work (65%; 2nd top source of stress since 
2007); 3) family responsibilities (54%); 4) personal health concerns (51%); tied for 5th) health 
problems affecting the family (50%); and the economy (50%) (APA, 2016). Over 51% of adults 
report having at least one chronic illness, 13% report having a diagnosis of depression and 16% a 
diagnosis of anxiety disorder. The 2015 survey indicated that stress is a health disparity (APA, 
2016) and assessed	stress	associated	with	discrimination,	where	experience	with	discrimination	
was	measured	as	day-to-day	and	as	major	forms	of	discrimination	across	several	subgroups	
including	by	age,	race/ethnicity,	gender,	disability,	sexual	orientation	and	gender	identity	(APA,	
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2016).	Sixty-nine	percent	of	respondents	reported	experiences	of	discrimination.	This	includes	
61%	who	reported	day-to-day	discrimination	such	as	being	treated	impolitely	or	disrespectfully,	
receiving	inadequate	services	compared	to	others,	and/or	experiencing	threats	or	harassment	
(APA,	2016).	Nearly	1	in	2	(47%)	of	respondents	reported	experiencing	major	forms	of	
discrimination	such	as	being	stopped	unfairly	by	police,	being	discouraged	to	pursue	an	
education,	or	having	an	unfair	health	care	experience	(APA,	2016). 
 In 2014, a collaboration between National Public Radio (NPR), Robert Wood Johnson 
Foundation (RWJF) and the Harvard School of Public Health conducted a Burden of Stress in 
America Survey (N=2,505) to examine the role of stress in people’s lives. Of the 49% who 
reported having had a major stressful event or experience in the last year, health-related issues 
(43%) were the primary source of stress. Among those who reported a great deal of stress in the 
last month, the most commonly reported stress-related experiences were having too many 
responsibilities (54%), problems with finances (53%), work problems (53%), health problems 
(38%), health problems with family (37%) and problems with family members (32%) (RWJ, 
2014). Among those with a chronic illness or disability and who reported a great deal of stress in 
the past month, over half reported that stress exacerbated symptoms (53%) or complicated their 
ability to manage their chronic illness or disability (52%) (RWJ, 2014).  In summary, these two 
population stress reports indicate between 49% to 67% report experiencing a major stressor and, 
among those, between 43% to 51% were due to health-related issues. Among those with chronic 
illness, stress impedes chronic disease management (RWJ, 2014).  
 
3.1.3. Ecosocial/Physiologic Mechanisms 
As discussed in Chapter 1, three broad areas have been hypothesized as links between social 
conditions and health outcomes: 1) social/built environments; 2) health behaviors; and 3) stress 
and cognitive/affective processes (Kubzansky et al., 2014, p.512). Additionally, based on a recent 
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and summative review conducted by the American Heart Association, there are three primary 
biologic pathways that link SDoH specifically to cardiovascular health. The pathways include: 1) 
socioeconomic disadvantage leads to higher burden of risk factors; 2) on-going social and 
environmental stressors lead to cumulative stress on the biologic systems or allostatic load; and 3) 
lifecourse exposure to low socioeconomic position (SEP; e.g., in utero and during critical 
windows of development) can have long term effects on risk for CVD in adulthood (AHA & 
Havranek et al., 2015).  
The brain integrates perceptions of stress and coordinates responses to stress (McEwen, 
2008). The brain assesses potential stressors, whether they are acute or chronic in nature, and 
determines the physiological and behavioral responses to the stressors (McEwen, 2008). As 
defined earlier, stress is a physiologic response and when the stress response is to 
social/environmental demands (social, family, work, neighborhood) (Selye, 1955, 1973) it has 
been suggested as a mechanism by which social factors are literally incorporated (Krieger, 2001) 
into the body (Kubzansky et al., 2014; Krieger, 2001a; Krieger, 2001b; Krieger, 2004). A range 
of physiologic responses have been associated with the stress response, including higher heart 
rate and blood pressure, (McEwen, 2008), inflammatory biomarkers, (e.g., interleukin-6 and C-
reactive protein), stress biomarkers (e.g. higher catecholamines and cortisol levels), and higher 
blood glucose levels (Cesari et al, 2003; Kubzansky et al., 2014). When the stress response, 
precipitated in the brain, is triggered by a chronic stressor rather than an acute one, the result can 
be chronically higher heart rate, blood pressure, and other physiological markers of being 
“stressed”. When the body is responsive to daily routine stressors, it is able to experience a 
stressor, go through a stress response, but then return to normal. This process is described as 
allostasis, defined as “achieving stability through change” (Sterling & Eyer 1988; McEwin, 
2008). However, when the stressor is chronic, like living in poverty or experiencing social 
stressors like food insecurity or low health literacy on a regular basis over the long-term, the body 
has a prolonged stress response. This has been described as allostatic load and is defined as “the 
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wear and tear that results from either too much stress or from inefficient management of 
allostasis” (McEwen, 2008, p. 175) and this may lead to higher risk for morbidity and mortality. 
Figure 1 illustrated in Chapter 1 is a conceptual framework that draws from an ecosocial 
approach and from Marmot’s SDoH theoretical framework to illustrate the physiologic link via 
the stress response/allostatic load of social/environmental factors to cardiometabolic disease 
control.  
 
3.1.4. Epidemiologic Evidence 
Based on the current emphasis of SDoH in health care and prevention and management initiatives 
like HP2020 to eliminate health disparities, social stressors can be thought of as the 
social/environmental exposures that can trigger a stress response. There are several commonly 
used and well known scales to measure stress. They include the Holmes and Rahe Stress Scale 
(Holmes, 1967); the Perceived Stress Scale (Cohen et al.; 1983); the Depression Anxiety Stress 
Scales (Lovibon et al, 1983; 1993); and the Standard Stress Scale (Gross et al., 2014).  In 
addition, several disease-specific stress scales are also commonly used including the HIV-Stress 
Scale (Pakenham et al., 2002); the Diabetes Distress Scale (DDS) (Polonsky et al., 2005); the 
Questionnaire on Stress in Patients with Diabetes (QSD-R) (Duran et al.,1995); and Problem 
Areas in Diabetes Scale (PAID) (Polonsky et al., 1995). The body of research on the association 
between life events, stress and chronic disease is abundant and dates back over seven decades 
(Selye, 1955; Dodge et al, 1970; Holmes et al, 1974; Rahe et al., 1992). A more recent and 
rapidly expanding area of this body of research is racial discrimination and health disparities 
research and addresses the relationship between psychosocial stressors, life events, stress and 
health outcomes (Sternthal et al., 2011; Lantz et al, 2005; Albert et al, 2011; Williams et al., 
2012; Krieger, 2014; 2012; 2005).  
Within the context of the Affordable Care Act and the emergence of regulatory 
requirements for primary health care providers (e.g., Federally Qualified Community Health 
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Centers) to become Patient-Centered Medical Homes and to meet population health quality 
improvement benchmarks (NCQA; AHRQ), efforts to embed the assessment of social stressors 
and specifically SDoH within the clinical primary care setting emerged. However, research to 
examine the association between clinically-assessed social stressors/SDoH and health outcomes, 
particularly among community health center patients, is still in its infancy.  
In response to the common but challenging observation among health care providers that 
many of the barriers to chronic disease prevention and management occur outside of the clinical 
visit, a clinical research team from Baystate Medical Center in Springfield, Massachusetts, 
developed a scale—the Tool for Assessing Patient Stressors (TAPS) (Rothberg, 2011; Welch et 
al., 2015). The aim of this tool was to facilitate provider care teams to be able to quickly assess 
social/environmental barriers to self-management within the clinical visit and use the information 
to identify opportunities for linking patients with community resources that mitigate the identified 
barriers (e.g., if the TAPS identifies a patient does not have sufficient food, then linking to her to 
a food panty may improve her insulin adherence and overall diabetes control). Given the scope of 
this study, the following is an epidemiologic review of studies that have used the TAPS5. A 
detailed description of the TAPS including the number and content of questions, types of 
stressors assessed, and scoring is described in detail in the Exposure Assessment section and in 
Table 13.  
A cross-sectional study using the newly developed social stress scale (TAPS) enrolled 
250 patients with diabetes were surveyed by telephone. The social stressor scale was found to 
have acceptable internal consistency		 Social	Stressor:	Chronbach1s	2	0.8   (Rothberg et al., 
2011). Of the 20 items, the top five sources of stress were: 1) depression or anxiety; 2) sickness, 
																																																						
5	Given the focus of the current study and the timing of the research, the TAPS was included in 
the RxHL study (see Study Method) to assess SDoH and associated stress in the study population. 
The instrument development phase of RxHL pre-dated the PRAPARE tool (NACHC, 2016), an 
emerging SDoH measurement tool coming into wider use in FQHC and other primary care 
settings in the U.S.   
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disability, or death in the family; 3) affording food, housing or clothes; 4) family’s needs and 
problems; and 5) affording to send money back home (Rothberg et al., 2011). There was a 
positive association between social stressors and depression (assessed using the Patient Health 
Questionnaire (PHQ-9 )(Pearson’s r=0.60, p<0.0001) (Rothberg et al., 2011).  
 A case-control study was conducted by the same research group to assess the effect of 
social distress on diabetes control among 246 patients with a diagnosis of diabetes for at least one 
year. Cases were defined as those patients with HbA1c>9% and controls were those patients with 
HbA1c<7%. In addition to social stressors, diabetes self-care and knowledge, depression and 
clinical measures were also assessed. Social stressor scores were higher among those with 
uncontrolled diabetes (6.9 vs. 5.7, P=0.03) (DuVal et al., 2011). After adjusting for age, 
employment status, and BMI, every one-unit increase in social stress was associated with a 33% 
higher odds of having uncontrolled HbA1c (DuVal et al., 2011).  Self-care, depression and 
diabetes knowledge were all examined as possible mediators but did not change the association 
(DuVal et al., 2011). The HbA1c differed significantly among patients on the stress scale on two 
items: 1) difficulty paying for medications, doctor’s visits or medical equipment (HbA1c<7 %: 
34%, HbA1C>9%: 50%, p=0.015); and 2) lack of affordable local transportation (HbA1c<7%: 
24%, HbA1C>9%: 43%, p=0.001) (DuVal et al., 2011). The median number of stressors also 
differed by glycemic control status (HbA1c<7% median stressors=5, HbA1C>9% median 
stressors=7, p=.002) (DuVal et al., 2011). There was a positive association between stress score 
and HbA1c such that for every one-unit increase in stress score there was a statistically 
significant 0.08% higher HbA1c (p=0.04) after controlling for age, employment status and BMI 
(Duval et al., 2011).   
 Since its development, several other cross-sectional studies have utilized the 20-item 
TAPS social stressor scale to examine the relationship between social stressors and chronic 
disease control. The first was a study to examine social stressors over the past month (in contrast 
to over the past week as the scale was originally designed) and medication adherence among 192 
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English- and Spanish-speaking low-income patients with diabetes. A mean of 4.8 stressors were 
reported by the sample. Only 13% reported no stressors while nearly 50% reported between 1-5 
stressors and 30% reported 6-10 stressors. The five most common stressors reported were: 1) 
sickness or disability in the family or self (57.3%); 2) not having enough money for food, 
rent/mortgage, or clothes (56.3%); 3) problems with depression or anxiety (48.7%); 4) difficulty 
paying for medications, doctor’s visits or medical equipment (48.2%); and 5) taking care of 
family’s different needs and problems (45.3%). A higher number of stressors reported was 
associated with a higher number of depressive symptoms using the PHQ-9 (rho=0.54, p<0.001). 
Additionally, higher number of stressors was also associated with lower medication adherence 
(6 = −0.36, < < 0.001). After adjusting for depression symptoms, social stressors remain 
independently associated with lower medication adherence; however, this association remained 
only among those with the highest medication adherence scores (Osborn et al., 2014).  
 In another cross-sectional study using the same sample of patients, social support was 
examined to determine if it buffered or exacerbated the association between social stressors and 
depressive symptoms and medication nonadherence (e.g., social support as a possible effect 
modifier) (Mayberry et al., 2015). Independent associations between social stressors and 
medication nonadherence, and between depressive symptoms and medication nonadherence, were 
stronger at higher levels of obstructive family behaviors. The investigators found no evidence of 
the buffering hypothesis for social support. Unexpectedly, they found that stronger depressive 
symptoms were associated with medication nonadherence among those with higher family 
support (Mayberry et al., 2015). The investigators suspect this unexpected finding may either be 
attributed to the cross-sectional study design or how social support was measured (Mayberry et 
al., 2015).  
 Lastly, a recent randomized controlled trial was conducted to examine the effect of a 
patient-centered, comprehensive diabetes team care model on social distress (another term used to 
describe social stressors) among Latino patients with T2D from two community health centers in 
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Western Massachusetts (Allen et al., 2017). The 6-month intervention included five individually 
and culturally-tailored diabetes education sessions delivered one-on-one with either a diabetes 
nurse or diabetes dietician. Social distress (referred to this way in the article but is the same as 
social stressors) was assessed using the 20-item TAPS. Over 90% of participants reported at least 
one stressor in the prior week and the top three stressors reported were: 1) problems with 
depression or anxiety in my family or myself (65.6%); 2) taking care of my family’s different 
needs and problems (57.0%); and 3) difficulty affording the cost of travel to visit friends and 
family (52.0%). Both the control (6.8 to 6.2) and intervention groups (7.2 to 5.6) experienced a 
decline in the number of stressors reported from baseline to 6-months follow-up, and the 
difference between control and intervention groups from baseline to 6-months differed 
significantly (p=0.01). Based on the stressors identified, the intervention team provided clinical-
community linkages to connect patients to local resources and social services—a primary aim of 
patient-centered, coordinated care. This program appears to have been successful in reducing 
social stressors within 6-months compared to usual care (Allen et al., 2017).  
 
3.1.4.1 Summary 
In summary, several cross-sectional studies, a case-control study and a randomized controlled 
trial have been conducted to examine social stressors and chronic disease outcomes. All have 
used the TAPS to measure social stressors.  Having more than one stressor in the last week or last 
month is common, with a mean of 4.8 to 6 stressors reported (Osborn et al., 2014; Rothberg et al., 
2011) and with between 50% to 90% of respondents having at least one stressor (Osborn et al., 
2014; Allen et al, 2015).  Several studies with participants of similar socioeconomic status being 
served in community health centers have identified the following stressors as the most commonly 
reported: 1) taking care of my family’s needs and problems; 2) not having enough money for 
food, housing or clothes; 3) sickness, disability or death in the family; 4) problems with 
depression or anxiety (Rothberg et al., 2011; Osborn et al., 2014; N. Allen et al., 2015). Higher 
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number of social stressors was associated with poorer glycemic control (Duval et al., 2011), with 
higher number of depressive symptoms (Rothberg et al., 2011; Osborn et al., 2014) and with 
lower medication adherence as measured by the adherence to refills and medications scale for 
diabetes (ARMS-D) (Osborn et al. 2014). Patient-centered, care coordination that identifies social 
stressors and then links individuals with corresponding social resources may reduce social 
stressors over time (Allen et al., 2015).   
 
3.1.5. Hypotheses and Specific Aims 
Preliminary findings using this sub-set of data from the RxHL study have identified statistically 
significant associations between social stressors and inadequate medication adherence, as 
assessed by self-report (Huebner Torres et al., 2015). This study expanded those analyses to 
assess social stressors, medication adherence (as a possible mediator) and cardiometabolic disease 
control, and to assess two possible effect modifiers (depression and social support).  
Specific Aims 
1: To examine the relationship between social stressors and cardiometabolic disease control. We 
hypothesized that patients with higher social stressor scores would have:  
1a) poorer cardiometabolic disease control as measured by their respective clinical 
marker of disease control (HbA1c, SBP, non-HDL/LDL);  
2. To examine if medication adherence mediates the association between social stress and 
cardiometabolic disease control. Based on Marmot’s model of SDoH, we hypothesized social 
stress would be: 
2a) negatively associated with medication adherence (higher social stress would be 
associated with lower medication adherence); 
And, that lower medication adherence would be: 
2b) positively associated with poorer cardiometabolic disease control.   
	 106	
3. To evaluate whether the association between social stressors and cardiometabolic disease 
control varies by: a) depression status; and b) social support. Based on Marmot’s model of SDoH, 
we hypothesized that the association between social stressors and cardiometabolic disease control 
would: 
3a) be stronger among those with depression or higher levels of depressive symptoms, 
compared to ….; and  
3b) be weaker among those with higher levels of social support, compared to those with 
low levels of social support.  
 
3.2. Methods 
3.2.1. Study Design and Population 
The proposed study assessed the association between social stressors and cardiometabolic disease 
control using a subset of the cross-sectional data from the Medication Adherence, Health Literacy 
and Cultural Health Beliefs mixed-methods study (RxHL) study as described in Chapter 1 (Figure 
1, Chapter 1). 
 
3.2.2. Exposure Assessment 
Social stress was measured using the 20-item Tool for Assessing Patients’ Stressors (TAPS; 
Table 1) (Rothberg, DuVal, Luciano, Frederici & Welch, 2011). The TAPS was developed by a 
team of medical providers and investigators at Baystate Medical Center in Springfield, 
Massachusetts. They conducted focus groups with physicians, nurses and diabetes educators who 
work with patients at an academic urban health center that serves a similar patient population—
high percentage of low income and racially/ethnically diverse—as for this study. They created a 
20-item measure of social stressors in English and Spanish. The stressors identified for the scale 
were commonly reported by the patient population served—specifically, low income, ethnically 
diverse and urban dwelling. After pilot testing with target subjects, the scale was modified for 
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clarity. For each item, the interviewer asks the participant: “In the past week, have any of the 
following family issues been stressful to you?” Examples of the stressors include, “Not enough 
money for food, rent or mortgage, or clothes for my family or myself,” and “Problems with 
depression or anxiety in family or myself,” and “Family members experiencing discrimination or 
racism at work or in public”. The scale includes a family focus because it was developed in an 
area that serves a large Puerto Rican population and other patient populations known to inter-
depend on family and social networks for resources and support and a process of collective 
caregiving (Evans et al., 2017; Ino et al., 2002). Therefore, family issues and or stressors become 
stressors for the individual and vice versa. 
Response options were 1=yes and 0=no. The TAPS is scored by summing all “yes” 
responses resulting in a social stressor score ranging from 0 to 20, which represents the number of 
stressors identified as stressful in the past week. The score ranged from 0-20. The originators of 
the scale suggested expanding the scale from including a dichotomous yes/no (e.g., 0/1) response 
option to include a categorical response option. Therefore, we added a 3-point Likert expanded 
response option for those who reply 1=yes. They are then asked “How stressful was it?” and the 
response options include: “a little stressful, somewhat stressful, a lot stressful, and refused”. As a 
continuous measure, the score ranged from 0-60 wherein the latter range represents a weighted 
score to include the level of stress (little, somewhat, a lot).  
 The TAPS was translated by a professional translation company into Russian and 
Vietnamese. The professional translations were reviewed by health center staff who are native 
speakers of the languages to address any additional revisions needed. Bilingual/bicultural, trained 
interviewers administered surveys containing the 20-item TAPS to assess the exposure. 
Participants were interviewed in the language of their choice (Russian, Vietnamese, Spanish, or 
English) either at the health center or in their home depending on their preference. The measure 
was designed to assess the number of social stressors and degree of stress experienced by the 
participant in the past week.  
	 108	
3.2.2.1. Validity of exposure assessment 
The 20-item TAPS has been demonstrated to be have sound reliability (KD-20=0.8)6 among 
English- and Spanish-speaking community health center patients (Rothberg et al., 2011; Welch et 
al., 2011). The most commonly reported stressors have been very similar across multiple studies 
with similar patient populations (Mayberry et al., 2015). Addition of the likert scale has not been 
assessed for validity. 
 
3.2.3. Outcome Assessment and Validity 
The outcomes of interest are cardiometabolic disease control (dichotomous) and level of control 
(continuous) in patients with diabetes, hypertension and/or dyslipidemia and are described in 
detail in Chapter 2. Briefly, we defined control using dichotomous cut-points for each disease. 
They are defined for diabetes as: HbA1c <7.0%; for hypertension as: SBP<140 mmHg; and for 
dyslipidemia as: non-HDL-C <130 gm/dL; LDL-C <100 mg/dL.  The cardiometabolic disease 
outcomes were modeled as both dichotomous and continuous measures.  
 
3.2.4. Covariate Assessment 
Sociodemographic and clinical variables known to be associated with social stressors and 
cardiometabolic disease control were included. Measurement and categorization were discussed 
in detail in Chapter 2. They include age, gender, race/ethnicity, educational level, monthly 
household income, language spoken at home, employment status, health literacy level and 
depressive symptoms. Sociocultural factors included primary language spoken at home, partner 
status, and social support. Clinical data including diagnosis of diabetes, hypertension, 
dyslipidemia and depression, oral medications, insulin use, tobacco and alcohol use, BMI, and 
																																																						
6	Kudar-Richardson Formula 20: Same as Cronbach’s alpha but interpreted as KD-20 for 
dichotomous response options.	
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health insurance were collected from the electronic medical record (EMR). Prior studies 
demonstrating a significant association between social stressors as measured by the TAPS 
(Rothberg et al. 2011) and poor cardiometabolic disease control have included these covariates as 
well in their analyses (Rothberg et al., 2011; DuVal et al., 2011; Osborn et al., 2014; Mayberry et 
al., 2015).  
 Medication adherence was assessed as a possible mediator of the association between 
social stressors and cardiometabolic disease control using the same method described in Chapter 
2. Depression and social support were assessed as possible moderators of the association between 
social stressors and cardiometabolic disease control as described in Chapter 2.  
 
3.2.5. Statistical Analysis  
 
We conducted statistical analyses using Stata 12.1 (STATA Corporation, College Station, Texas). 
Two-sided P values of less than 0.05 were considered to be statistically significant. 
Descriptive analyses indicated the social stress score using both the 0-20 dichotomous 
version and the weighted 0-60 expanded Likert version of the scale were positively skewed and 
had similar response distributions. As such, we chose to focus the analyses on the 0-20 version 
only.  To address the skewed distribution, two categorical versions of the variable were created. 
First, based on the frequency distribution of the 20-item social stress score, the variable was 
categorized into four groups: Low=0 to1 stressors; Some=2 to 4 stressors; Moderate=5 to 7 
stressors; and High = 8 or more stressors (Table 11). Additionally, because the distribution of 
social stress scores differed significantly by racial/ethnic group and given that self-reported social 
stress is a subjective measure, we also created a relative stress variable using ethnicity-specific 
cut points. We created the ethnic-specific cut-points to address 1) how the scale items may be 
culturally perceived/understood differently in the different racial/ethnic groups; and 2) that 
“objective” stressors may be more or less present in each of the cultural groups. To do so, within 
each cultural group, we used the frequency distributions of the 20-item social stress to define 
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approximate tertiles of social stress (Figure 10). Participants were thus classified as having low, 
medium and high social stress based on the distribution of score in their specific cultural group 
(Table 12. Ethnic-group specific social stress scores).    
 We followed the same univariate and bivariate analyses as presented in Chapter 2. In 
summary, we calculated the number and percent or mean and standard deviation of categorical 
and continuous variables, respectively. Categorical covariates were cross-tabulated with both the 
exposure and the outcome variables using chi-square or Fisher’s Exact tests accordingly and 
corresponding P-values were reported. For continuous variables, T-tests and analysis of variance 
(ANOVA) were calculated and mean and standard deviations were presented for both the 
exposure and outcome variables.  Based on the literature, covariates known to be associated with 
social stressors and cardiometabolic disease control were identified a priori and included as 
potential confounders on this basis. To assess covariates as potential confounders, T-tests, 
ANOVA, chi-square or Fisher’s Exact Tests were used to assess continuous and categorical 
covariates, respectively. We assessed a priori identified and other covariates as potential 
confounders following the same procedure as presented in Chapter 2. 
Separate unadjusted logistic regression models were built to examine the cross-sectional 
independent relationship between social stressors and cardiometabolic disease control. Separate 
unadjusted linear regression models were also built to examine the independent cross-sectional 
relationship between social stressors and the cardiometabolic disease outcomes as continuous 
measures.  
 Two adjusted models were built for each exposure-outcome relationship. First, we built a 
saturated model (Model A) and adjusted for variables identified a priori in the literature as 
associated with the exposure and outcome (age, gender, race/ethnicity, education, income, 
employment, health insurance, comorbidities/number of diseases, and depression, BMI, social 
support, tobacco use). In this model, we also included additional confounders identified as 
associated with the exposure or outcome based on having a p-value of p<0.25 (alcohol use, 
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homelessness, cost barriers to care and medications, transportation barriers to care and pharmacy, 
and social stress). Second, we then built a parsimonious model (Model B) and adjusted for only 
those covariates whose inclusion in the model resulted in more than 10% change in estimate or 
had a likelihood ratio test or F-partial test with a p-value of <0.05 for logistic and linear 
regression models, respectively.  
 Possible effect modification by depression was assessed by stratifying the multivariate 
logistic regression model of social stressors and cardiometabolic disease control by depression 
(depressed, not depressed). If the odds ratios of each stratum differ significantly from one another 
and from the overall odds ratio as measured by Mantel-Haenszel test of homogeneity, we 
included a multiplicative interaction term (depression X social stressors) in our multivariate 
models and used likelihood ratio or F-partial tests to determine if the interaction term was 
statistically significant in the logistic or linear regression model, respectively. If it was, we 
presented stratum-specific odds ratios to describe the association between social stressors and 
cardiometabolic disease control. 
We followed the same procedure to assess the relationship between social support (e.g., 
low social support/high social support) as a possible effect modifier in the association of social 
stressors and cardiometabolic disease control. 
 
3.3. Results 
Participant characteristics for the study sample of 361 community health center patients are 
described in Chapter 2 and shown in Table 1a. 
 
3.3.1. Social Stressors  
A mean (SD) of 4.6 (4.1) and a median of 4.0 stressors were reported by the sample. Only 15.5% 
of the sample reported no stressors, while 31% reported 2-4 stressors, 19.7% reported 5-7 
stressors, and 22.7% report 8 or more stressors (Table 11). Of the twenty items, the top four 
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reported stressors were: 1) taking care of my family’s different needs and problems (50.6%); 2) 
problems with depression or anxiety in my family or myself (48.3%); sickness or disability in 
myself or my family, or death in the family (43.3%); and not enough money for food, rent or 
mortgage, or clothes for my family or myself (42.9%) (Table 13).  
 Social stress differed significantly by racial/ethnic group (p<0.001) with higher levels of 
social stress reported by Latino and African American participants (moderate/high stress 73.7% 
and 56.5%, respectively; row totals) and lower levels of social stress reported by Vietnamese and 
Russian-speaking participants (moderate/high stress 19.6% and 20.6%, respectively; row totals). 
Compared to those with low or some stress, those with moderate or high stress had higher levels 
of education (p=0.03), lived alone (p=0.02), reported being homeless (p<0.001), and spoke 
English or Spanish at home (<0.001). Those reporting high stress also reported transportation 
barriers to care and to medication (p<0.001) and cost barriers to medication (p<0.001). Smoking 
was highest among those who reported high stress (p=0.002). Those reporting high stress had the 
highest mean depression score of 9.2 (9.5) as measured by PHQ-9 (<0.001) and the highest 
proportion with a medical diagnosis of depression (41.5%) (p<0.001) (Table 14).  
 Univariate disease prevalence and control as well as bivariate association with covariates 
were discussed in detail in Chapter 2 (Table 1a & 3, respectively).  
 
3.3.2. Dyslipidemia Control  
3.3.2.1. Social Stress & non-HDL-C  
Social stress (categorical: 0/1 stressor=low stress; 2-4 stressors=medium stress; 5-7 
stressors=moderate stress; 8+ stressors = high stress)) and non-HDL-C (continuous) were 
independently associated (p=0.0498). There was a significant positive association between high 
social stress (8+ stressors) and non-HDL-C though the confidence intervals were wide 
(MD=16.8; 95% CI= 0.38, 33.25). After adjusting for age, gender, race/ethnicity, education, 
income, employment, gaps in insurance coverage, multimorbidity, depression, BMI, social 
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support, and smoking status (Model A-Saturated), this association was attenuated and, while the 
point estimate remains substantial from a clinical perspective, the confidence interval became 
wider and included the null (MD=14.1; 95% CI -6.6, 34.7) (Table 15a). In the trim model (Model 
B), the point estimate increased but the confidence interval remained wide and included the null 
(MD=19.7, 95% CI= -0.08, 39.5). 
Using the same exposure categorization and non-HDL-C dichotomized (controlled vs. 
not controlled), no association was observed at any level in the unadjusted or adjusted 
(parsimonious model) logistic regression models (Tables 5c). 
 
3.3.2.2. Social Stress & LDL-C 
Social stress (categorical) and LDL-C (continuous) were also independently associated 
(p=0.046). A significant positive association was observed between moderate stress (5-7 
stressors) and LDL-C (MD=17.6; 95% CI 2.3, 32.9). The positive association remained 
significant for LDL-C in both the saturated model (MD=18.1; 95% CI 0.68, 35.6) and the 
parsimonious model (MD=23.2; 95% CI= 7.1, 39.4). After adjusting for race/ethnicity, BMI, 
depression and smoking status, participants reporting moderate social stressor (5-7 stressors) had 
LDL-C levels 23.2 points units higher than those reporting 0 or one social stressor. In addition, 
there was a significant positive association between high social stress and LDL-C in the 
parsimonious model (MD=20.6; 95% CI= 2.2, 39.0) (Table 16a). Those reporting high social 
stress (8+ stressors) had LDL-C levels 20.6 units higher than those reporting no or one social 
stressor.  
For analyses of LDL control, there was no association at any level in the unadjusted 
(OR=1.49; 95% CI 0.67, 3.34) or adjusted (parsimonious model) logistic regression models (High 
Social Stress: OR=2.42; 95% CI 0.88, 6.64) (Tables 16c).  
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3.3.2.3. Ethnic-specific Social Stress & Non-HDL-C 
Using the ethnic-specific social stressor variable categorized to reflect absolute low, medium and 
high stress in pooled analyses and relative stress in ethnic-specific analyses, there were no 
associations with continuous non-HDL-C observed at any level in the pooled unadjusted and 
pooled adjusted (saturated model) linear regression analyses (Table 15b). There were also no 
associations observed in each of the ethnic-specific unadjusted and adjusted models.  
Using the same ethnic-specific social stressor variable and dichotomous non-HDL-C, 
there were no associations observed at any level in unadjusted and adjusted logistic regression 
models (Table 15d). There were also no associations observed in each ethnic-specific model. 
Using the ethnic-specific social stressor variable and continuous LDL-C, there was no 
observed association at any level in the pooled unadjusted model. There was, however, a 
significant positive association in the pooled adjusted (saturated model) linear regression analyses 
(High Stress compared to Low Stress: MD= 14.7% CI 1.6, 27.7) (Table 16b). In pooled adjusted 
logistic regression analysis (parsimonious model) the confidence interval crossed the null but was 
slightly (High Stress compared to Low Stress: OR 2.03; 95% CI 0.98, 4.2) (Table 16d). Due to 
the wide confidence interval, these results are difficult to interpret. There were no observed 
associations among the other ethnic-specific models. 
 
3.3.3. Diabetes Control  
3.3.3.1. Social Stress & A1c 
We did not observe an independent association between social stress (categorical) and A1c 
(continuous) (p=0.30) and no association was observed at any level in unadjusted or adjusted 
models (Table 17a).  
Using the same exposure categorization and dichotomous A1c, no association was 
observed at any level in the unadjusted or adjusted logistic regression models (Table 17c). 
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Though we did not find statistically significant associations of social stress with level of A1c, we 
did observe a positive linear trend in higher A1c with higher levels of social stress. 
 
3.3.3.2. Ethnic-specific Social Stress & A1c 
Using the ethnic-specific social stressor variable, there were no associations with continuous A1c 
observed at any level in the pooled unadjusted and pooled adjusted linear regression analyses 
(Table 17b). In the African-American ethnic-specific adjusted model (Model D-results not 
shown), a significant positive association was observed (MD=2.16; 95% CI=0.17, 4.16). Among 
African Americans, after adjusting for BMI, depression and smoking status, those who report 
high social stress (8+ stressors) compared to those who report low social stress (0-2 stressors) 
have a significant 2.16 unit higher A1c. Using the same ethnic-specific social stressor variable 
and dichotomous A1c, there were no associations observed at any level in unadjusted and 
adjusted logistic regression analyses (Table 17d). There were no associations observed in each 
ethnic-specific model. 
 
3.3.4. Hypertension Control 
3.3.4.1. Social Stress & SBP 
We did not observe an independent association between social stress (categorical) and SBP 
(continuous) (p=0.16) and no association was observed at any level in unadjusted or adjusted 
models (Table 18a). Using the same exposure categorization and dichotomous SBP, there was no 
association at any level in the unadjusted or adjusted logistic regression analyses (Table 18c).  
 
3.3.4.2. Ethnic-specific Social Stress & SBP 
Using the ethnic-specific social stressor variable, there were no associations with continuous SBP 
observed at any level in the pooled unadjusted  and pooled adjusted linear regression analyses 
(Table 18b). There were no associations observed in each of the ethnic-specific model. Using the 
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same ethnic-specific social stressor variable and dichotomous SBP, there were no associations 
observed at any level in unadjusted and adjusted logistic regression analyses (Table 18d). There 
were also no associations observed in each ethnic-specific model. 
 
3.3.5. Evaluation of Potential Mediation by Medication Adherence 
We observed an independent association between social stress and dyslipidemia control (non-
HDL-C: MD=16.81, 95% CI=0.38, 33.25; LDL-C: MD=17.6, 95% CI=2.3, 32.9). The 
unmediated model (Step 1) is illustrated in Figures 13. We found that social stress was 
independently associated with self-reported medication adherence (Step 2; Figures 14-15) such 
that those with high stress compared to those with low or no stress have a 2.25 lower medication 
adherence score (MD= -2.25, 95% CI= -2.7, -1.8). There was not, however, a similar independent 
association between social stress and medication adherence as measured by pill count. Lastly, we 
determined there was an independent association between self-reported medication adherence and 
dyslipidemia control (non-HDL-C: MD -21.6, 95% CI -33.77, -9.41; LDL-C: MD = -17.61, 95% 
CI -29.3, -6.0) (Step 3; Figures 14-15). Compared to those with inadequate medication adherence, 
those with adequate medication adherence had a 21.6 lower non-HDL-C and a 21.6 lower LDL-
C.  
 The final mediation analysis examined the association between social stress, self-reported 
medication adherence (i.e., the Morisky method) and dyslipidemia control using both non-HDL-C 
and LDL-C, as illustrated in Figures 14 and 15. After including medication adherence in our 
regression model and controlling for race/ethnicity, depression, BMI and smoking status, there 
was no longer an independent association between social stress and dyslipidemia control as 
measured by non-HDL-C (MD= 14.07, 95% CI=-4.3, 32.4) suggesting the association is partially 
mediated—though only minimally—by medication adherence (Figure 14).  We observed a 
slightly attenuated independent association between social stress and dyslipidemia control as 
measured by LDL-C once medication self-reported adherence was added to the model and 
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adjusted for race/ethnicity, depression, BMI and smoking status (MD = 18.7, 95% CI = 2.6, 34.7) 
suggesting self-reported medication adherence was a partial mediator of this association as well 
(Figure 15). 
 
3.3.6. Potential Effect Modification  
3.3.6.1. Depression 
We assessed whether the association between social stress and each of the cardiometabolic 
outcomes was modified by prevalent depression (not depressed vs. depressed) or social support 
(low social support vs. high social support (Tables 19a-b). After identifying differing stratum-
specific estimates from linear regression models for social stress and dyslipidemia control among 
those with no diagnosis of depression, we tested a social stress X depression interaction term and 
found no evidence of effect modification of the social stress-dyslipidemia control relationships by 
depression.  
 
3.3.6.2. Social Support 
After identifying differing stratum-specific estimates from linear regression models for social 
support and dyslipidemia control as measured by non-HDL-C, we tested a social stress X social 
support interaction term and found no evidence of effect modification of the social stress-
dyslipidemia control relationships by social support (Table 20).  
 
3.4. Discussion 
The relationship between stress and chronic disease is well documented (Selye, 1956; Dodge et 
al, 1970; Homes et al, 1974; Rahe et al., 1992; Sternthal et al., 2011; Lantz et al, 2005; Albert et 
al, 2011; Williams et al., 2012; Krieger, 2014; 2012; 2005). In the current context of health care 
reform, examining the role of social determinants on health outcomes (and other factors like 
health care utilization and cost) has emerged as a priority focus area in the fields of public health, 
	 118	
implementation science, and medicine. However, to date, research examining the association 
between social stressors—or the perceived stress associated with social determinants of health—
and chronic disease have been limited (Allen et al., 2015; Mayberry et al., 2015; Osborn et al., 
2014; Rothberg et al., 2009; DuVal et al., 2009). In this analysis of a culturally diverse population 
of community health center patients with chronic disease, we aimed to examine the association 
between social stressors and uncontrolled cardiometabolic disease using Marmot’s social 
determinant of health theoretical framework.  
We found a significant positive association of social stress with risk of uncontrolled 
dyslipidemia as measured by LDL-C. Those patients reporting moderate- or high-levels of social 
stress compared to those with no/low social stress had significantly higher LDL-C levels in in 
adjusted models. Using this categorization of social stress, we did not find significant associations 
between social stressors and diabetes or hypertension control. This is in contrast to prior research 
that has identified lower glycemic control among those reporting higher levels of social stressors 
(Duval et al., 2011). Similar to other prior studies, we also found higher social stress associated 
with depression (Rothberg et al., 2011; Osborn et al., 2014) and with lower medication adherence 
(Osborn et al., 2014).  Though we did not find statistically significant associations of social stress 
with level of A1c, we did observe a similar positive linear trend in higher A1c with higher levels 
of social stress as demonstrated in the literature. This may be due to limited sample size.  
Prior research has referred to the burdensome nature of the stressors in the TAPS and that 
having multiple may indicate a substantial level of social/environmental life stress (Osborn et al., 
2014). Similar to prior research (Osborn et al., 2014; Rothberg et al., 2011), participants reported 
a mean of 4.6 (SD=4.1) social stressors, reflecting the high prevalence of barriers often reported 
among patients of federally qualified community health centers. We found the number of social 
stressors reported differed significantly by cultural group with higher mean social stressors 
reported among African Americans and Latinos compared to Vietnamese and Russian-speaking 
patients. This finding contributes to fill a gap in the literature regarding how social stress is 
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perceived and reported across diverse patient populations. It is possible the difference in number 
of social stressors reported by African Americans and Latinos compared to Vietnamese and 
Russian-speakers may reflect objective differences in the level of burden from social stressors 
experienced between groups or it may reflect cultural differences in the perception/interpretation 
of social stressors as measured with TAPS.  In an effort to assess the latter, we created an ethnic-
specific social stressor variable (Table 12) to assess cultural differences in the relationship social 
stressors and chronic disease control. We identified the threshold for high stress was substantially 
higher among African Americans (>8 stressors) as compared to white (>6 stressors) or 
Vietnamese and Russian-speakers (>4 stressors).  Among African Americans with diabetes, we 
identified a significant 2.2% higher A1c (95% CI 0.17, 4.16) among those with high social stress 
(8+ stressors) compared to those with low social stress (0-2 stressors). Among Russian-speaking 
patients with dyslipidemia, we identified significantly higher LDL-C levels among those with 
high stress (4+ stressors) compared to those with low stress (0-1 stressor).  
We did not identify any significant associations between relative or absolute ethnic-
specific social stress and hypertension control.  
 We also identified self-reported medication adherence as measured by the 8-item 
Morisky scale as a fairly small partial mediator of the association between social stress and 
uncontrolled dyslipidemia as measured by LDL-C. These findings, though modest, may help to 
inform the development of targeted clinical interventions among patient populations with 
uncontrolled dyslipidemia tailored to address the role of social stressors. 
 We did not find depression or social support to act as effect modifiers of the association 
between social stress and dyslipidemia control.  
 
3.4.1. Strengths and Limitations 
In addition to the strengths described in Chapter 1, this study broadened the existing literature on 
social stressors allowing examination of social stress across five diverse cultural groups and 
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identified culturally variable levels of social stress. This is timely given the current changes in 
health care and attention to the role of SDoH on health outcomes, health care utilization and 
health care costs. With improved awareness of the distribution of stress associated with 
social/environmental factors as captured in the TAPS, culturally tailored interventions and 
resources can be developed and implemented.  
 The present analysis of social stress has similar limitations as those described in detail in 
Chapter 1, including the cross-sectional design and associated lack of temporality, small sample 
size, and possible measurement error associated with a self-reported exposure and with laboratory 
disease control measures. Additionally, the TAPS is a newer instrument (Rothberg, 2009) and 
few studies have used it. The TAPS does not measure all sources of stress, it may be more or less 
culturally relevant for different people or groups, different people or groups may be more or less 
likely to report presence and/or severity of social stressors. It is possible that some of the meaning 
was lost in translation into Vietnamese and/or Russian as this was the first time it was used in 
these groups. The time frame measured was only the past week, which may not be best for 
chronic conditions and cumulative measures such as our outcomes. The scale only asks for a 
“yes” if the social stressor was experienced as stressful rather than just having been experienced. 
Within the context of SDoH and stress research,  an important debate has emerged in research on 
racial discrimination and health about whether racial discrimination should be asked/reported 
explicitly versus implicitly (Krieger et al., 2011; Shariff-Marco et al., 2011; Krieger et al., 2013). 
Lastly, the wording and possible overlap between certain items may warrant additional 
assessment. For instance, items 2) Not enough money for food, rent…, and 3)Sickness or 
disability in myself or my family; may be difficult for the participant to disentangle from item 1) 
Taking care of my family’s different needs and problems. And, item 6) Family members 
experiencing discrimination or racism at work or in public; does not include the participant’s 
account of experiencing discrimination or racism. Based on the APA (2016) finding that 61% of 
the adult study sample reported experiences stress associated with discrimination, the wording in 
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the TAPS may have impacted the low reports of discrimination across all groups.  and wording of 
some questions (e.g., discrimination question); and experienced in last week???-verify 
 Keeping these possible limitations in mind, prior studies that used the TAPS  were 
similarly set in a FQHC serving low income, African American and Latino patients with chronic 
disease and, using the past month as the time frame, identified a similar set of top-reported social 
stressors (Mayberry et al., 2015). Furthermore, the reported validity and reliability in English and 
Spanish is sound (Rothberg 2011; Welch, 2011).  
The outcome variables were all collected from the electronic medical record (EMR). 
While documentation in the EMR is a standard practice, quality improvement initiatives at the 
research site indicate that EMR data can be flawed. This can be related to either human error in 
measurement as is possible with blood pressure measurement. Or, this can be related to 
documentation errors such that information is either improperly entered or documented in 
incorrect fields and therefore may appear to be missing. While this could lead to nondifferential 
misclassification of outcome, we addressed these potential limitations by ensuring that members 
of the care team responsible for collecting blood pressure are properly trained, by conducting a 
rigorous and comprehensive cleaning of the data to identify potential errors or outliers, and by 
verifying that missingness was less than 10% in any variable.   
An important question that has emerged from these findings is why we observed 
associations between social stressors and dyslipidemia (LDL-C and non-HDL-C) but not with the 
diabetes (A1cs) or hypertension (SBP)? It is possible that effect size for hypertension and 
diabetes is smaller than for dyslipidemia and therefore more difficult to detect particularly with 
smaller sample sizes. A known limitation of the study, the relatively small overall and disease-
specific model sample sizes, may have resulted in Type 2 errors—effects that were undetected—
due to lack of power. Or, it is possible that social stressors—or these specific types of stress 
measured by the TAPS—affects cholesterol differently than A1cs and SBP.  
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There are several other possible limitations to the study. The wide confidence intervals 
are due to small sample sizes and warrant careful consideration when interpreting the results. 
Though it is most likely that the imprecision is due to the small sample size, we took many steps 
to ensure it was not due to other factors. We conducted a thorough data cleaning procedure to 
ensure that the variability observed was not related to possible outliers or missingness. We 
considered alternative hypotheses and conducted a range of sensitivity analyses to eliminate this 
possibility. We considered the non-normal distribution of social stress and created a categorical 
variable based on these assessments. However, it is possible that the cut points may not be at 
optimal places to detect an association between the exposure and outcome. After each of these 
steps, the variability remained. Given the cultural diversity of the groups, it is possible that the 
level of variation as evidenced by the very wide confidence intervals may indicate the actual level 
of variability in this particular study sample, which due to the small sample size, was unable to be 
further parsed out through stratification. However, we also created an ethnic-specific social stress 
variable to get at the absolute and relative reports of social stress per cultural group (Table X). 
This step resulted in the identification of an independent association between social stress and 
level of A1c among African Americans with diabetes and level of LDL-C among Russian-
speakers with dyslipidemia. These findings indicate that it is possible thresholds for stress per 
cultural group vary and should be taken into consideration when addressing social determinants 
of health as they relate to cardiometabolic disease control.  There appears to be variability across 
groups with more social stressors reported among African Americans and Latinos as well as 
possibly a higher threshold for social stressors among these groups as compared to Vietnamese 
and Russian-speakers. However, additional research is warranted to determine whether these  
differences are due to differences between groups’ perception of stressors, objective experience 
of stressors, or are more an artifact of limited power and sample size.  
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3.4.2. Confounding 
 
We evaluated potential confounders known to be associated with social stressors and 
cardiometabolic disease control as identified in the literature. These included age, gender 
race/ethnicity, educational level, employment status, household income, partner status, language 
spoken at home, insurance, social support, medication adherence, depression (symptoms or 
diagnosis), body mass index, comorbid conditions, smoking status, alcohol status, medications 
prescribed for diabetes (including oral and insulin), hypertension, dyslipidemia. There were 
several possible confounders recognized in the literature that were not available in our dataset. 
They were household size (with which to assess poverty), duration of diagnoses, length of stay in 
the U.S., acculturation, and exercise. Potential confounders not measured in the study could lead 
to residual confounding and could bias the results in either direction. It is also possible that we 
have inadequately measured one or more of our other confounders. If this were to have occurred, 
the residual confounding could lead to either an over- or under-estimate of the effect estimate and 
bias the results toward or away from the null.  
We have considered the possible role of unmeasured, residual confounding and took 
several steps to reduce this possibility. First, though household size was not collected, we created 
an income equivalence variable to account for reported single/partnered status and divided 
household income by the square root of 2 for those reporting partnered status. Additionally, we 
conducted model building procedures (both saturated to trim and trim to saturated) using 
likelihood ratio testing to select the appropriate covariates to include in each model.  
 
3.5. Significance 
We identified a significant positive association between X amount of social stress and elevated 
LDL-C level. We detected self-reported medication adherence as a partial mediator of this 
association. We identified a non-significant positive linear trend between the level of social stress 
and   A1c. Finally, we identified some evidence of cultural variability in the perception, reporting 
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and possibly the experience of social stressors. From an ecosocial approach, this study lends some 
important evidence toward the role of social stressors in cholesterol control among federally 
qualified health center patients and suggest efforts to address SDoH in the prevention and 
management of chronic disease is warranted, especially among groups disproportionately 
burdened by health disparities.  
Patient-centered care coordination that identifies social stressors and then links 
individuals with corresponding social resources may reduce social stressors over time (Allen et 
al., 2015).   The recent roll-out of Medicaid ACOs, including at the research site, has included a 
wide-spread, health system integration of SDoH screening and on-going payment reform 
assessments to address SDoH.  Existing initiatives at the research site are currently being spread 
to other health centers within the ACO, including the integration of community health workers 
into primary care and clinical-community linkage to social services and navigational resources. 
The integration of these innovative initiatives indicate practice transformation steps aimed at 
addressing SDoH to improve health outcomes from an ecosocial approach. Future research aims 
to continue to examine the association between social determinants of health, stress, and chronic 
disease prevention and management.  
Based on the findings from this study and the current health systems reforms, next 
research steps aim to examine self-reported SDoH screening data, stress and inflammation 
biomarker data, and chronic disease management among a larger, culturally diverse Medicaid 
population. Replication is needed to determine that these findings and trends are robust across 
different and/or larger samples of patients from similar settings. Future research needs to also 
examine whether in fact there are ethnic differences in the objective and perceived experience of 
social stressors or SDoH-related barriers as well as differences across disease endpoints. 
Additionally, future research should examine similar questions in a wider study including patients 
without prevalent cardiometabolic disease. Once replicated, if these findings are found to be 
robust, the cultural variability and the suggestion of independent association between social stress 
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and lipid levels but not A1c or SBP warrant continued and thoughtful consideration by 
interdisciplinary investigators and practitioners of possible methodologic, statistical, clinical, and 
theoretical reasons for the findings and the associated implications.  
 
 
3.5.1. Generalizability 
 
The results of this study may be generalized to other similar populations of low-income 
individuals with cardiometabolic diseases, particularly those served in community health center 
environments. However, it is possible that the ecosocial mechanism through which social 
stressors may impact disease control can vary by region or cultural group. It is possible that 
among groups with higher or lower support or access to resources, cultural perceptions and 
objective reports of social stressors may vary.  
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Table 11. Univariate distribution of social stressors (Tool for Assessing Patient Stressors 
(TAPS))  
 
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Social Stressors N=361
Categorical n(%)
Social Stress
      Yes 305(84.5)
      No 56(15.5)
Social Stress
     0-1 stressor 95(26.3)
     2-4 stressors 113(31.3)
     5-7 stressors 71(19.7)
     8 or more stressors 82(22.7)
Ethnic-specific Social Stress
     Low 131(36.3)
     Medium 114(31.6)
     High 116(32.1)
Continuous Mean(SD) Median Range
     20-item scale (0-20) 4.6(4.1) 4.0 0-20
     20-item weighted scale (0-60) 9.1(9.5) 6.0 0-54
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Table 12. Ethnic-group specific stress scores 
 
 
 
White African 
American
Vietnamese Russian-
speaking
Latino
Low 0-2 0-2 0-1 0-1 0-5
Medium 3-5 3-7 2-3 2-3 6-8
High 6+ 8+ 4+ 4+ 9+
Absolute Stress (Range)
Re
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(te
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Table 13. Distribution of responses to individual social stress items on TAPS 20-item scale 
	
 
 
 
 
 
Stressor Item Stressful in last 
week?Yes A little Somewhat A lot
n(%) n(%) n(%) n(%)
1 Taking care of my family’s different needs and problems. 182 (50.6) 71(39.0) 61(33.5) 48(26.4)
2 Not enough money for food, rent or mortgage, or clothes for my family or myself. 154 (42.9) 51(31.8) 49(31.8) 56(36.4)
3 Problems with alcohol or drug abuse in my family or myself. 44 (12.2) 15(34.1) 12(27.3) 17(38.6)
4 Problems with violence or physical abuse in my family or myself. 24 (6.7) 14(58.3) 1(4.2) 9(37.5)
5 Sickness or disability in myself or my family, or death in the family. 155 (43.3) 43(27.7) 48(31.0) 64(41.3)
6 Family members experiencing discrimination or racism at work or in public. 32 (8.9) 13(40.6) 9(28.1) 9(28.1)
7 Problems with depression or anxiety in my family or myself. 174 (48.3) 58(33.3) 56(32.2) 58(33.3)
8 Problems reading or understanding written information (newspapers, bills, official forms, letters). 111 (30.8) 52(46.9) 32(28.8) 27(24.3)
9 Difficulty paying for medications, doctor’s visits, or medical equipment for my family or myself. 70 (19.4) 28(40.0) 20(28.6) 22(31.4)
10 Lack of affordable local transport for my family or myself (car, bus, taxi,). 89 (24.7) 29(32.6) 26(29.2) 34(38.2)
11 Having conflict or arguments among family members. 84 (23.3) 35(41.7) 27(32.1) 22(26.2)
12 Overcrowding or lack of privacy in the house. 49 (13.7) 17(34.7) 15(30.6) 16(32.7)
13 Family members working in unsafe, low paying, or stressful jobs, or being unemployed. 75 (20.8) 31(41.3) 22(29.3) 22(29.3)
14 Legal problems for my family or myself (fines, arrest, court appearances, immigration problems, detention or prison). 38 (10.6) 11(29.0) 11(29.0) 16(42.1)
15 Living in an unsafe neighborhood (crime, violence, conflict). 58 (16.1) 22(37.9) 14(24.1) 22(37.9)
16 Our neighborhood looks run down and neglected. 52 (14.4) 18(34.6) 14(26.9) 19(36.5)
17 Problems at school for your children or teens (poor conduct, grades, or attendance). 17 (4.7) 7(41.2) 3(17.7) 5(29.4)
18 Difficulty affording to send money or gifts back home to friends and family. 80 (22.2) 33(41.3) 20(25.0) 27(33.8)
19 Difficulties adjusting to American culture or language. 61 (17.0) 25(41.0) 13(21.3) 23(37.7)
20 Difficulty affording the cost of travel back home to visit friends and family. 107 (29.6) 30(28.0) 27(25.2) 49(45.8)
If yes, how stressful?
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Figure 11. Frequency distribution of social stressors by race/ethnicity 
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Table 14. Distribution of covariates by social stress (categorical) (N=361) 
 
 
 
 
Low Stress Some Stress Moderate Stress High Stress p value*
(0-1 stressor) (2-4 stressors) (5-7 stressors) (8+ stressors)
mean(SD)
Age 62.3(10.5) 62.3(11.2) 57.1(10.1) 51.6(11.0) <.001
Income (Equialence Scale) 969.5(397.1) 992.4(600.3) 1166.2(753.7) 906.6(462.9) 0.03
Social Support 3.9(1.1) 3.5(1.1) 3.0(1.1) 3.1(1.7) <.001
PHQ_Score 0.76(2.1) 2.7(4.7) 5.1(6.2) 9.2(8.5) <.001
Morisky Medication Adherence 
Score 2.3(0.6) 2.0(0.7) 1.7(0.7) 1.5(0.6) <.001
BMI Score 30.9(6.5) 32.0(7.6) 32.6(8.1) 33.5(9.6) 0.18
n(%)
Gender
     Male 45(47.4) 49(43.4) 26(36.6) 32(39.0) 0.50
     Female 50(52.6) 64(56.6) 45(63.4) 50(61.0)
Ethnicity
      White 9(9.5) 14(12.4) 10(14.1) 7(8.5) <.001
       African American 19(20.0) 18(15.9) 15(21.1) 33(40.2)
       Vietnamese 38(40.0) 40(35.4) 14(19.7) 5(6.1)
       Russian-speaking 24(25.3) 26(23.0) 7(9.9) 6(7.3)
       Latino 5(5.2) 15(13.3) 25(35.2) 31(37.8)
Employment
     Not employed 78(82.1) 95(84.1) 59(83.1) 71(86.6) 0.77
     Part/full-time employed 16(16.8) 18(15.9) 12(16.9) 11(13.4)
     missing 1(1.1) 0(0) 0(0) 0(0)
Educational Level
     <High School 42(44.2) 48(42.5) 22(31.0) 28(34.2) 0.03
      High School Degree (or GED) 37(39.0) 33(29.2) 21(29.6) 22(26.8)
     Some college+ 15(15.8) 32(28.3) 28(39.4) 32(39.0)
      Missing 1(1.0) 0(0) 0(0) 0(0)
Health Literacy
     Adequate Health Litearcy 56(59.0) 66(58.4) 51(71.8) 54(68.9) 0.23
      Low Health Literacy 39(41.0) 47(41.6) 20(28.2) 28(34.1)
Partner/Household Status
       Living single/not partnernered 50(52.6) 64(56.6) 51(71.8) 58(70.7) 0.02
       Living with partner/family 45(47.4) 49(43.4) 20(28.2) 24(29.3)
Homeless
      Not homeless 87(91.6) 110(97.4) 68(95.8) 66(80.5) <.001
      Homeless 8(8.4) 3(2.6) 3(4.2) 16(19.5)
Social Stress 
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Table 14. Distribution of covariates by social stress (categorical) (N=361) (continued) 
 
 
Low Stress Some Stress Moderate Stress High Stress p value*
(0-1 stressor) (2-4 stressors) (5-7 stressors) (8+ stressors)
n(%)
Language Spoken at Home
      English 30(31.6) 39(34.5) 33(46.5) 50(61.0) <.001
       Spanish 3(3.2) 10(8.9) 17(23.9) 22(26.8)
       Vietnamese 38(40.) 39(34.5) 14(19.7) 5(6.1)
      Russian 24(25.2) 25(22.1) 7(9.9) 5(6.1)
Social support 
     High 64(67.4) 64(56.6) 25(40.2) 33(40.2) <.001
     Low 31(32.6) 49(43.4) 46(64.8) 49(59.8)
Gap in Health Insurance Coverage
      No 87(91.6) 104(92.0) 65(91.6) 66(80.5) 0.11
      Yes 8(8.4) 9(8.0) 5(7.0) 15(18.3)
     missing 0(0) 0(0) 1(1.4) 1(1.2)
Barriers to Care-Cost
      No 92(96.8) 100(88.5) 66(93.0) 72(87.8) 0.16
      Yes 3(3.2) 13(11.5) 5(7.0) 9(11.0)
     missing 0(0) 0(0) 0(0) 1(1.2)
Barriers to Care-Transportation
     No 91(95.8) 101(89.4) 48(67.6) 47(57.3) <.001
     Yes 4(4.2) 10(8.9) 23(32.4) 35(42.7)
      missing 0(0) 2(1.8) 0(0) 0(0)
Barriers to Medication-Cost
      No 87(91.6) 91(80.5) 49(69.0) 42(51.2) <.001
      Yes 8(8.4) 22(19.5) 21(29.6) 40(48.8)
     missing 0(0) 0(0) 1(1.4) 0(0)
Barriers to Medication-
Transportation 
     No 91(95.8) 107(94.7) 60(84.5) 53(64.6) <.001
     Yes 4(4.2) 5(4.4) 11(15.5) 29(35.4)
     missing 0(0) 1(0.9) 0(0) 0(0)
Depression (Dx)
      No Depression 84(88.4) 87(77.0) 46(64.8) 48(58.4) <.001
     Depression 11(11.6) 26(23.0) 25(35.2) 34(41.5)
Depression Screen (PHQ-9)
      No Depression 89(93.7) 94(83.2) 46(64.8) 40(48.8) <.001
      Depression 6(6.3) 19(16.8) 25(35.2) 41(50.0)
      Missing 0(0) 0(0) 0(0) 1(1.2)
Insulin (among those with diabetes)
     No insulin 39(41.1) 43(38.1) 25(35.2) 20(24.4) 0.35
     Insulin 11(11.6) 13(11.5) 10(14.1) 10(12.2)
     missing 45(47.3) 57(50.4) 36(50.7) 52(63.4)
BMI 
      <30 (not obese) 43(45.3) 45(39.8) 27(38.0) 30(36.6) 0.28
       >30 (obese) 49(51.6) 59(52.2) 41(57.8) 42(51.2)
      missing 3(3.1) 9(8.0) 3(4.2) 10(12.2)
Smoking Status
     No 62(65.3) 74(65.5) 35(49.3) 31(37.8) 0.00
     Yes 32(33.7) 38(33.6) 36(50.7) 50(61.0)
     missing 1(1.0) 1(0.9) 0(0) 1(1.2)
Alcohol Use
     No 79(83.2) 90(79.7) 55(77.5) 56(68.3) 0.14
      Yes 13(13.7) 23(20.3) 14(19.7) 23(28.1)
     missing 3(3.1) 0(0) 2(2.8) 3(3.6)
Social Stress (Categorical)
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Tables 15a-d. Social stress and dyslipidemia (non-HDL-C; N=224) 
 
Table 15a. Unadjusted and adjusted mean differences (95% CI) of Non-HDL-C and social stress (categorical) (n=224) 
 
 
 
Table 15b.  
Unadjusted and adjusted mean differences (95% CI) of Non-HDL-C and social stress (ethnic-specific) (n=224) 
 
 
 
 
 
 
 
 
N(%) Unadjusted  Model A Model B
MD 95% CI MD  95% CI MD  95% CI
Social Stress Level
     Low (0-1 stressor) 65(29.02) 0.00 Referent 0.00 Referent 0.00 Referent
     Some (2-4 stressors) 80(35.71) -1.23 -14.67, 12.22 -2.86 -17.0, 11.3 -1.20 -14.98, 12.56
     Moderate (5-7 stressors) 41(18.30) 13.87 -2.18, 29.92 14.37 -3.96, 32.71 16.28 -1.02, 33.58
     High (8+ stressors) 38(16.96) 16.81 0.38, 33.25 14.07 -6.6, 34.7 19.71 -0.08, 39.49
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, 
number of diseases, depression, BMI, social support and smoking status. 
N(%) Unadjusted   Model B  
MD 95% CI MD  95% CI
Social Stress Level
     Low 91(40.62) 0.00 Referent 0.00 Referent
     Medium 67(29.91) -4.97 -18.0, 8.06 -5.14 -19.06, 8.78
     High 66(29.46) 9.52 -3.57, 22.61 12.74 -1.27, 26.75
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 15c. Unadjusted and adjusted odds ratios (95% CI) of non-HDL-C and social stress  (categorical) (n=224) 
 
 
Table 15d. Unadjusted and adjusted odds ratios (95% CI) of non-HDL-C and social stress  (ethnic-specific) (n=224) 
 
 
Table 16a-d: Social stress and dyslipidemia (LDL-C; N=224) 
 
Table 16a. Unadjusted and adjusted mean differences (95% CI) of LDL-C and social stress (categorical) (n=224) 
Cases 
(n=118)
Unadjusted   Model A   Model B  
N(%) OR 95% CI OR  95% CI OR  95% CI
Social Stress Level
     Low (0-1 stressor) 30(25.4) 1.00 Referent 1.00 Referent 1.00 Referent
     Some (2-4 stressors) 39(33.1) 1.11 0.58, 2.14 0.89 0.42, 1.89 1.13 0.56, 2.28
     Moderate (5-7 stressors) 24(20.3) 1.65 0.75, 3.63 1.48 0.54, 4.03 1.85 0.76, 4.50
     High (8+ stressors) 25(21.2) 2.24 0.98, 5.14 1.28 0.42, 3.96 2.11 0.77, 5.81
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, 
number of diseases, depression, BMI, social support and smoking status. 
Cases 
(n=118)
Unadjusted   Model B
N(%) OR 95% CI OR  95% CI
Social Stress Level
     Low 46 (39.0) 1.00 Referent 1.00 Referent
     Medium 32 (27.1) 0.89 0.48, 1.68 0.94 0.46, 1..90
     High 40 (33.9) 1.51 0.79, 2.86 1.68 0.82, 3.45
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 16b. Unadjusted and adjusted mean differences (95% CI) of LDL-C and social stress (ethnic-specific) (n=224) 
	  
 
 
 
 
 
 
 
 
N(%) Unadjusted  Model A  Model B 
MD 95% CI MD  95% CI MD  95% CI
Social Stress Level
     Low (0-1 stressor) 64 (28.70) 0.00 Referent 0.00 Referent 0.00 Referent
     Some (2-4 stressors) 80 (35.87) -1.00 -13.82, 11.81 -1.18 -14.3, 11.9 -0.03 -12.90, 12.83
     Moderate (5-7 stressors) 41 (18.39) 17.58 2.30, 32.87 21.30 4.3, 38.3 23.23 7.09, 39.37
     High (8+ stressors) 38 (17.04) 10.78 -4.86, 26.43 15.15 -4.0, 34.3 20.60 2.16, 39.04
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, number 
of diseases, depression, BMI, social support and smoking status. 
N(%) Unadjusted   Model B 
MD 95% CI MD  95% CI
Social Stress Level
     Low 90 (40.36) 0.00 Referent 0.00 Referent
     Medium 67 (30.04) -6.11 -18.49, 6.26 -7.57 -20.60, 5.44
     High 66(29.60) 9.27 -3.16, 21.71 14.65 1.57, 27.73
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 16c. Unadjusted and adjusted odds ratios (95% CI) of LDL-C and social stress  (categorical) (n=224)  
 
 
 
Table 16d. Unadjusted and adjusted odds ratios (95% CI) of LDL-C and social stress  (ethnic-specific) (n=224) 
 
	  
 
 
 
 
 
 
Cases 
(n=114)
Unadjusted  Model A  Model B 
N(%) OR 95% CI OR  95% CI OR  95% CI
Social Stress Level
     Low (0-1 stressor) 29(25.44) 1.00 Referent 1.00 Referent 1.00 Referent
     Some (2-4 stressors) 40(35.09) 1.21 0.62, 2.33 1.23 0.6, 2.7 1.39 0.68, 2.83
     Moderate (5-7 stressors) 24(21.05) 1.7 0.77, 3.76 1.95 0.7, 5.1 2.3 0.94, 5.67
     High (8+ stressors) 21(18.42) 1.49 0.67, 3.34 1.9 0.6, 5.7 2.42 0.88, 6.64
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, number 
of diseases, depression, BMI, social support and smoking status. 
Cases 
(n=114)
Unadjusted   Model B  
N(%) OR 95% CI OR  95% CI
Social Stress Level
     Low 45(39.47) 1.00 Referent 1.00 Referent
     Medium 30(26.32) 0.81 0.43, 1.53 0.83 0.40, 1.70
     High 39(34.21) 1.44 0.76, 2.74 2.03 0.98, 4.21
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 17a-d: Social stress and diabetes (HbA1c; N=162) 
 
Table 17a. Unadjusted and adjusted mean differences (95% CI) of A1c and social stress (categorical) (n=162) 
 
 
Table 17b. Unadjusted and adjusted mean differences (95% CI) of A1c and social stress (ethnic-specific) (n=162) 
 
 
 
 
 
 
 
 
 
N(%) Unadjusted  Model A  Model B
MD  95% CI MD 95% CI MD 95% CI
Social Stress Level
     Low (0-1 stressor) 49 (30.25) 0.00 Referent 0.00 Referent 0.00 Referent
     Some (2-4 stressors) 52 (32.10) -0.17 -0.88, 0.54 -0.19 -0.95, 0.58 -0.16 -0.92, 0.60
     Moderate (5-7 stressors) 32 (19.75) 0.37 -0.44, 1.19 0.41 -0.54, 1.37 0.15 -0.74, 1.03
     High (8+ stressors) 29 (17.90) 0.54 -0.30, 1.38 -0.02 -1.16, 1.13 0.33 -0.72, 1.39
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, 
number of diseases, depression, BMI, social support and smoking status. 
N(%) Unadjusted  Model B    
MD  95% CI MD 95% CI
Social Stress Level
     Low 70 (43.21) 0.00 Referent 0.00 Referent
     Medium 44(27.16) -0.14 -0.84, 0.55 -0.23 -0.99, 0.53
     High 48 (29.63) 0.12 -0.55, 0.80 0.15 -0.56, 0.85
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 17c. Unadjusted and adjusted odds ratios (95% CI) of A1c and social stress  (categorical) (n=162)  
 
 
 
Table 17d. Unadjusted and adjusted odds ratios (95% CI) of A1c and social stress  (ethnic-specific) (n=162) 
 
 
 
 
 
 
 
 
 
 
 
Cases (n=79) Unadjusted  Model A Model B     
N(%) OR  95% CI OR 95% CI OR 95% CI
Social Stress Level
     Low (0-1 stressor) 26 (32.91) 1.00 Referent 1.00 Referent 1.00 Referent
     Some (2-4 stressors) 23 (29.11) 0.7 0.32, 1.54 0.87 0.34, 2.21 0.92 0.38, 2.20
     Moderate (5-7 stressors) 17 (21.52) 1 0.41, 2.45 2.1 0.64, 6.90 1.26 0.45, 3.51
     High (8+ stressors) 13 (16.46) 1.13 0.65, 1.98 0.96 0.23, 3.94 1.06 0.31, 3.59
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, 
Cases (n=79) Unadjusted  
(n=162)
Model B     
(n=151)
N(%) OR  95% CI OR 95% CI
Social Stress Level
     Low 36 (45.57) 1.00 Referent 1.00 Referent
     Medium 19 (24.05) 0.72 0.34, 1.53 0.87 0.36, 2.10
     High 24 (30.38) 0.94 0.45, 1.97 1.15 0.51, 2.59
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 18a-d: Social stress and hypertension (SBP; N=309) 
 
Table 18a. Unadjusted and adjusted mean differences (95% CI) of SBP and social stress (categorical) (n=309) 
 
 
 
Table 18b. Unadjusted and adjusted mean differences (95% CI) of SBP and social stress (ethnic-specific) (n=309) 
 
 
 
 
 
 
 
 
N(%) Unadjusted   Model A   Model B  
MD 95% CI MD  95% CI MD  95% CI
Social Stress Level
     Low (0-1 stressor) 81(26.21) 0.00 Referent 0.00 Referent 0.00 Referent
     Some (2-4 stressors) 101(32.69) 1.01 -3.78, 5.81 1.83 -3.31, 6.98 1.25 -3.74, 6.25
     Moderate (5-7 stressors) 60(19.42) -4.58 -10.06, 0.89 0.39 -5.98, 6.75 -2.23 -8.11, 3.65
     High (8+ stressors) 67(21.68) 1.03 -4.27, 6.35 5.27 -1.60, 12.14 3.04 -3.18, 9.27
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnicity, education, income (equivalence scale), employment, insurance 
gaps, number of diseases, depression, BMI, social support and smoking status. 
N(%) Unadjusted   Model B  
MD 95% CI MD  95% CI
Social Stress Level
     Low 112(36.25) 0.00 Referent 0.00 Referent
     Medium 97(31.39) -0.56 -5.05, 3.93 0.001 -4.83, 4.83
     High 100(32.36) -0.51 -4.97, 3.94 0.01 -4.74, 4.76
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 18c. Unadjusted and adjusted odds ratios (95% CI) of SBP and social stress  (categorical) (n=309) 
 
 
Table 18d. Unadjusted and adjusted odds ratios (95% CI) of SBP and social stress  (ethnic-specific) (n=309) 
 
 
 
 
 
 
 
 
 
 
 
 
Cases 
(n=90)
Unadjusted  Model A   Model B  
N(%) OR 95% CI OR  95% CI OR  95% CI
Social Stress Level
     Low (0-1 stressor) 22 (24.44) 1.00 Referent 1.00 Referent 1.00 Referent
     Some (2-4 stressors) 32 (35.56) 1.24 0.65, 2.37 1.32 0.64, 2.72 1.22 0.62, 2.41
     Moderate (5-7 stressors) 14 (15.56) 0.82 0.38, 1.77 1.2 0.48, 3.01 0.92 0.40, 2.09
     High (8+ stressors) 22 (24.44) 1.31 0.65, 2.66 1.67 0.64,4.32 1.46 0.64, 3.35
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Model A-Saturated: Adjusted for age, gender, race/ethnicity, education, income (equivalence scale), employment, insurance 
gaps, number of diseases, depression, BMI, social support and smoking status. 
Cases 
(n=90)
Unadjusted   Model B 
N(%) OR 95% CI OR  95% CI
Social Stress Level
     Low 31 (34.44) 1.00 Referent 1.00 Referent
     Medium 28 (31.11) 1.06 0.58, 1.94 1.04 0.54, 2.00
     High 31 (34.44) 1.17 0.65, 2.12 1.21 0.64, 2.29
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 19a: Effect modification of social stress and dyslipidemia (LDL-C) by depression 
  Dyslipidemia (LDL-C) 
   No Depression (N=174)     Depression (N=49)   
    Model B     Model B   
 N(%) Beta 95% CI N(%) Beta 95% CI 
Social Stress Level           
     Low (0-1 stressor) 59(33.91) 1.00 Referent 5(10.20) 1.00 Referent 
     Some (2-4 stressors) 65(71.26) 0.06 -13.84, 13.96 15(30.61) 14.42 -36.74, 65.58 
     Moderate (5-7 stressors) 27(15.52) 25.44 6.67, 44.22 14(28.57) 30.70 -26.20, 87.59 
     High (8+ stressors) 23(13.22) 7.73 -14.14, 29.60 15(30.61) 42.27 -17.48, 102.03 
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status 
 
 
Table 19b: Effect modification of social stress and dyslipidemia (non-HDL-C) by depression 
  Dyslipidemia (non-HDL-C) 
   No Depression (N=174)     Depression (N=49)   
    Model B     Model B   
 N(%) Beta 95% CI N(%) Beta 95% CI 
Social Stress Level           
     Low (0-1 stressor) 60(34.29) 1.00 Referent 5(10.20) 1.00 Referent 
     Some (2-4 stressors) 65(37.14) -3.22 -17.64, 11.21 15(30.61 32.39 -23.66, 88.45 
     Moderate (5-7 stressors) 27(15.43) 17.72 -1.78, 37.22 14(28.57 43.05 -19.29, 105.39 
     High (8+ stressors) 23(13.14) 10.52 -12.41, 33.45 15(30.61) 57.95 -7.52, 123.43 
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status 
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Table 20: Effect modification of social stress and dyslipidemia (non-HDL-C) by social support 
  Dyslipidemia (non-HDL-C) 
  Low Social Support (N=116)   High Social Support (N=108)   
    Model B     Model B   
 N(%) Beta 95% CI N(%) Beta 95% CI 
Social Stress Level           
     Low (0-1 stressor) 27(23.28) 1.00 Referent 38(35.19) 1.00 Referent 
     Some (2-4 stressors) 39(33.62) -1.50 -22.29, 19.29 41(37.96) -2.84 -21.48, 15.80 
     Moderate (5-7 stressors) 28(24.14) 10.23 -13.09, 33.55 13(12.04) 12.37 -15.04, 39.78 
     High (8+ stressors) 22(18.97) 25.53 -1.51, 52.56 16(14.81) -5.79 -35.85, 24.27 
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status 
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Figure	10:	Frequency	distributions	of	social	stress	(1-20)	by	cultural/ethnic	group.	
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Figure 12. Mean difference and 95% CI in disease outcome by social stress (categorical) 
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Figure 13. Unmediated Model: Social stress and cardiometabolic disease control 
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Figure 14. Mediated Model: Social stress, self-reported medication adherence, and Non-
HDL-C control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Self-report Adequate 
Medication Adherence:
8-item Morisky
High Social Stress              
(compared to no/low social stress)
Note: Final mediated model included all a priori covariates. Solid arrows indicate statistically significant associations.
Adj. Beta 19.7% CI -0.08, 39.5
DYS: 
Non-HDL >130,
Adj Beta 14.1 95% CI  -4.3, 32.4
	 146	
Figure 15. Mediated Model: Social stress, self-reported medication adherence, and LDL-C 
control 
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CHAPTER 4 
 
RACIAL/ETHNIC DIFFERENCES IN SOCIAL DETERMINANTS OF HEALTH, 
MEDICATION ADHERENCE AND CARDIOMETABOLIC DISEASE 
CONTROL:AN ECOSOCIAL APPROACH 
 
 
 
4.1. Introduction 
Cardiovascular disease (CVD) is the leading cause of death in the United States (CDC, 2016). 
Three cardiometabolic diseases—diabetes mellitus, high blood pressure (hypertension) and high 
blood cholesterol (hyperlipidemia) –have been identified as modifiable risk factors for CVD 
(AHA, 2016).  As discussed in detail in Chapters 1 to 3, effective management of each of these 
cardiometabolic diseases, including medication adherence, is fundamental to preventing 
morbidity and mortality associated with disease progression and to reduce the risk of CVD events 
(e.g., heart attack and stoke). Social determinants of health—defined in detail in the Introduction 
Chapter—include socioeconomic status (education and income), food security, housing, 
transportation and other social and environmental factors that are upstream of individual 
behaviors—have been associated with downstream health outcomes (Marmot et al., 2006).  
 Health disparities research has well established racial/ethnic differences in health 
outcomes in diabetes (CDC, 2016; Kaplan et al., 2013; Egede et al., 2011; Egede et al., 2010), 
hypertension (Fryar et al., 2017; Ferdinand et al., 2017), and dyslipidemia (CDC, 2017; Frank et 
al., 2014; ). Research to examine the role of social determinants in health disparities and, 
specifically, on cardiometabolic disease outcomes is expanding (Walker et al., 2014; Walker et 
al., 2016; Williams et al., 2002; Adler et al., 2008; Marmot et al., 2014; ) and examine possible 
mechanisms of these relationships.  
However, fewer studies have examined racial/ethnical ethnic differences among 
community health center populations where SDoH-related barriers and cardiometabolic diseases 
are both prevalent (Shaw et al., 2018) and are a primary focus of current health care reform 
initiatives.  This is important for two primary reasons. First, community health centers are 
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charged with two often competing goals of providing tailored, patient-centered care while also 
meeting population health quality benchmarks. Better understanding how these factors differ by 
race/ethnicity can help to target policy and practice efforts in both patient-centered and 
population health-focused care. Second, most health disparities research is framed as comparing 
all populations to the white population. However, based on the findings presented in Chapters 2 
and 3, we have observed differences by race/ethnicity that may indicate opportunities to both 
target resources and tailored service delivery to better address unmet needs and capture and learn 
from the strengths of populations not commonly included in health disparities research.    
 Fifteen years after the Institute of Medicine’s seminal reported racial/ethnic health 
disparities (Smedley et al., 2003) and nearly ten years after Healthy People 2010 (CDC, 2018) 
first identified eliminating racial/ethnic disparities, racial/ethnic disparities in the prevalence and 
management of cardiometabolic diseases persist and remain a public health priority (NCHS, 
2018). Racial/ethnic differences in medication adherence to treat cardiometabolic diseases have 
also been identified (Ferdinand et al., 2017; Kaplan et al., 2013). Much less is known about 
cardiometabolic disease control among racially/ethnically diverse populations with multimorbid 
cardiometabolic disease.  
   As is common in most national studies in the United States, non-Hispanic white 
participants are used as the reference group to whom each other racial/ethnic group is compared. 
Often, the racial/ethnic categorizations are based on census categories. From an epidemiologic 
and statistical perspective, the referent group is usually selected based on being either the largest 
group in the study or the group with the highest prevalence to optimize power to detect effects. 
Tracking racial/ethnic disparities in this manner has identified groups that are disproportionately 
burdened by disease, morbidity and mortality and these data are used to inform the development 
of policies and distribution of resources aimed at eliminating disparities. Furthermore, this 
method of comparison is warranted to illustrate the lifecourse effects of historical, political, 
economic and social injustice embedded into the social structures and institutions of education, 
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health care, and housing, to name a few, on racial/ethnic minority populations’ health and life 
expectancy in the United States as compared to whites independent of socioeconomic status.   
As a result of this common practice that is both statistically and historically warranted, 
less is known about how racial/ethnic minority groups differ from each other particularly in 
environments where census-based racial categorizations may result in overly heterogeneous 
groups and where socioeconomic status is relatively homogeneous.  One important situation in 
which this occurs is in community health centers that serve a diverse U.S- and foreign-born 
immigrant and refugee patient population.  
  
4.1.1. Hypotheses and Specific Aims 
This study aims to examine racial/ethnic differences in social determinants of health, 
medication adherence and cardiometabolic disease outcomes among community health center 
patients with cardiometabolic disease.  
 
Specific Aims 
1: To examine the relationship between race/ethnicity and social determinants, specifically food 
insecurity and social stressors.  We hypothesized that there are differences between groups in 
these SDoH. 
 
2. To examine the relationship between race/ethnicity and medication adherence as measured by 
self-report (8-item Morisky Medication Adherence Scale (MMAS)) and by pill count.  We 
hypothesized that there are differences between groups in both medication adherence 
measurement approaches. 
 
3. To examine the relationship between race/ethnicity and cardiometabolic control including 
diabetes (A1c), hypertension (SBP), and dyslipidemia (non-HDL-C and LDL-C).  We 
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hypothesized that there are differences between groups in all four cardiometabolic disease 
control. 
An ultimate goal of research in this area is to evaluate how findings from these three aims 
are interconnected. However due to sample size constraints, conclusions about interrelationships 
in this study will be qualitative rather than quantitative. Future research aims to examine possible 
mediators to assess the interrelationships. 
 
4.2. Methods 
4.2.1. Study Design and Population 
The study assessed the association between race/ethnicity, SDoH, medication adherence, and 
cardiometabolic disease control using a subset of the cross-sectional data from the Medication 
Adherence, Health Literacy and Cultural Health Beliefs mixed-methods study (RxHL) study as 
described in Chapter 1 (Figure 1, Chapter 1). 
 
4.2.2. Exposure Assessment 
4.2.2.1. Self-reported race/ethnicity 
The exposure in this study was self-reported race/ethnicity. Participants in the study self-
identified as non-Hispanic U.S.-born white, non-Hispanic U.S.-born African American, Latino, 
Russian-speaking or Vietnamese. Because the larger RxHL study is in large part examining the 
effect of cultural health beliefs and practices on medication adherence and disease management, 
an effort was made to decrease the heterogeneity of culture represented by each racial/ethnic 
group. Therefore, the RxHL study defines white as U.S. born. In this way, white is distinguished 
from Russian-speaking based on the difference in culture and language. Similarly, African 
American was also defined as U.S. born. Therefore, this group does not include individuals who 
self-identify as Black African or Black Caribbean. Again, this was done in an effort to limit the 
heterogeneity of culture and language among the self-identified African American group. Based 
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on the location of the study, Latinos are primarily U.S.-born Puerto Rican. The research team is 
aware that these study groups do not reflect the usual Census-derived racial/ethnic categories. 
 
4.2.3. Outcome Assessment and Validity 
The outcomes of interest are two social determinants of health measured in the RxHL Study (PI 
Shaw) including food insecurity and social stressors, self-reported and pill count medication 
adherence, and cardiometabolic disease control (dichotomous) and level of control (continuous) 
in patients with diabetes, hypertension and/or dyslipidemia. Each of these measures was 
described in detail in Chapters 1 and 2.  
 
4.2.4. Covariate Assessment 
Sociodemographic and other self-reported variables (e.g., educational level, income, depression 
symptoms (PHQ-9)) were collected by a bicultural/bilingual interviewer administered survey in 
the participant’s preferred language. Clinical variables (e.g., diagnoses, lab results, body mass 
index) were abstracted from the electronic medical record.  
 
4.2.5. Statistical Analysis  
 
We conducted statistical analyses using Stata 12.1 (STATA Corporation, College Station, Texas). 
Two-sided P values of less than 0.05 were considered to be statistically significant.   
We presented univariate distributions of all factors in Chapters 1 and 2. Categorical 
covariates were cross-tabulated with both the exposure and the outcome variables using chi-
square tests or Fisher’s Exact Test as appropriate. Corresponding p-values were reported. For 
continuous variables, mean and standard deviations were presented for both the exposure and 
outcome variables using Student T test and ANOVA.  Based on the literature, covariates known 
to be associated with race/ethnicity, SDoH, medication adherence, and cardiometabolic disease 
control were identified a priori.  To assess covariates as potential confounders, T-tests, ANOVA, 
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and chi-square or Fisher’s Exact tests were used to assess continuous and categorical covariates, 
respectively. P-values were reported for both.  
Separate unadjusted linear regression models and logit regression models were built to 
examine the cross-sectional independent relationship between race/ethnicity, SDoH, medication 
adherence and cardiometabolic disease control.  
Parsimonious adjusted linear and logit regression models were built for each exposure-
outcome relationship. First, we built an unadjusted model. Then we tested each of the variables 
identified a priori in the literature as potentially associated with the exposure and outcome (age, 
income equivalence, education, depression, gender, employment, comorbidities/number of 
diseases, and BMI). Age, income equivalence, education, and depression were included in the 
final adjusted model regardless of the outcome of the likelihood ratio test (logit regression 
models) or F Partial Test (linear regression models) based on the literature. For the remaining 
covariates, those that resulted in more than 10% change to the relative risk or beta coefficient or 
for which the model test produced a p-value of <0.05 were retained in the final adjusted model.  
 To be aligned with the majority of health disparities research, we chose to use white 
participants as the reference group, though the small sample size of this group would limit 
statistical power. However, the primary aim of this study was to examine differences in outcomes 
variables between each group rather than in comparison to white participants.  Thus, we also 
evaluated specific differences between groups by plotting adjusted differences and 95% 
confidence intervals and conducting pairwise comparisons, with ten pairwise comparisons per 
model. We used the Sidak correction to correct for multiple comparisons among unbalanced 
groups.  
We followed the same procedure for the logit regression models to examine the adjusted 
predictive probabilities (predicted prevalence) of each dichotomous outcome.  
For the model examining race/ethnicity and social stressors—an ordinal outcome—we 
conducted a proportional odds model to examine predicted prevalence of self-reported higher 
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social stress. We examined the association of race/ethnicity with the ordinal social stressor 
outcome variable ((1) no/low social stress, (2) 2-4 social stressors; (3) 5-6 social stressors; (4) 8+ 
social stressors) and adjusted for covariates. We tested the proportional odds assumption—“that 
the relationship between each pair of outcome groups is the same” (IDRE, 2018, p. 10)—using 
the two recommended methods of a likelihood ratio test and the Brant Test.  We then conducted a 
margins plot and ten pairwise comparisons with the Sidak correction for multiple comparisons to 
examine the adjusted predicted prevalence of self-reporting a higher level of social stress by 
race/ethnicity. Given the proportional odds assumption, the predicted probability results of the 
pairwise comparisons test for Social Stressor Level 1 apply to each of the four levels of the 
ordinal social stressor outcome variable.  
 
4.3. Results 
Participant characteristics for the study sample of 361 community health center patients are 
described in Chapter 1 (Chapter 1, Table 1).  Associations of disease prevalence and control with 
covariates were discussed in detail in Chapter 1 (Table 1a & 3, respectively).  
 
4.3.1. Race/Ethnicity  
Among the 361 study participants, 26.9% were Vietnamese, 23.6% were African American, 
21.1% were Latino, 17.5% were Russian-speaking and 11.1% were white (Table 1). 
 
4.3.2. Bivariate Analysis 
4.3.2.1. Uncontrolled Cardiometabolic Disease 
Uncontrolled cardiometabolic disease was prevalent in all five groups. Mean A1c, SBP and lipids 
as well as the proportion of uncontrolled cardiometabolic disease differed significantly by 
race/ethnicity (Table 2a).  
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 Among those with clinically diagnosed diabetes, Vietnamese participants had a clinically 
and statistically significant lower mean A1c compared to the other four groups; wherein clinical 
significance is indicated by a minimum 0.5% difference (Campbell et al., 2012). Uncontrolled 
A1c was higher among white and Russian-speaking participants and lower among Latino 
participants. Among those with clinically diagnosed hypertension, mean SBP levels differed 
significantly by group and was highest among Russian-speakers and African Americans and 
lowest among white participants. African Americans had the highest rate of uncontrolled 
hypertension while white participants had the lowest.  Russian-speakers, followed by Latino 
participants, had substantially higher mean non-HDL-C. Russian-speakers also had substantially 
higher LDL-C levels while the other four groups were fairly comparable.  
 
4.3.2.2.  Medication Adherence: Self-reported Morisky (MMAS) and Pill Count 
Self-reported low medication adherence was highest among Latino and African Americans 
participants and lowest among Russian-speakers and Vietnamese participants. In contrast, based 
on pill count, low medication adherence (<80%) was highest among Russian-speakers, Latinos 
and African Americans and lowest among White participants. African Americans (44.7% vs. 
40%) and Latinos (48.7% vs. 42.1%) had similarly low medication adherence rates based on the 
two methods of adherence measurement. In contrast, pill count adherence revealed an 
approximate 3-fold lower adherence rate compared to self-report among Vietnamese (self-
reported 12.4% vs. pill count 37.1%) and Russian-speakers (self-reported 15.1% vs. pill count 
42.9%) (Table 1b).  White participants’ self-reported and pill count low medication adherence 
were more similar (self-reported 25% vs. pill count 30%), however, self-reported adherence was 
also an underestimate. 
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4.3.2.3. Social Determinants: Food Insecurity and Social Stress 
Food insecurity was substantially higher than the 12% national average among all but the 
Russian-speaking participants. Food insecurity was highest among Latinos, at five times the 
national average, followed by African Americans and white participants. Food insecurity was 
lower—though still nearly double the national rate—among Vietnamese participants and lowest 
among Russian-speakers. In contrast, while SNAP also differed significantly by ethnicity 
(p=0.03), unlike food insecurity, it was highest among Vietnamese participants (30.4%) followed 
by African American (25.6%), Latinos (17.6%), Russian-speaking (16.0%) and white (10.4%) 
participants. The proportion of participants who self-reported high levels of social stressors (8+ 
stressors in the past week) was at least 4-times higher among Latinos and African Americans 
compared to Russian-speakers and Vietnamese participants (Table 2c).  
 
4.3.2.4. Factors of Socioeconomic Status (SES): Income and Education 
Russian-speakers had the highest reported monthly income from all sources ($1469.97, SD 
817.44) and Vietnamese participants reported the lowest ($864.13, SD 296.13). Using the 
equivalence income measure7, highest mean income from all sources was reported among white 
participants ($1130.94, SD 672.66) and the lowest among Vietnamese participants ($753.20, SD 
299.28). Having less than a high school education was highest among Vietnamese participants 
(50%) and lowest among white participants (4%). Vietnamese and Russian-speaking participants 
had significantly higher levels of low health literacy compared to the other groups (Table 2d). 
 
4.3.3. Multivariable Model Results:  
4.3.3.1. Race/Ethnicity and Cardiometabolic Disease Outcomes 
																																																						
7	Equivalence	income	measure:	The	monthly	income	from	all	sources	divided	by	the	square	root	
of	2	for	those	participants	who	report	living	with	a	partner.	
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4.3.3.1.2. Diabetes 
Among those with clinical diagnosis of diabetes, Vietnamese participants had a significantly and 
clinically lower mean A1c compared to whites and African Americans (Table 3a). In contrast, 
Russian-speakers had a significantly and clinically higher A1c compared to Vietnamese 
participants (Table 3a).  
White participants had the highest predicted prevalence of uncontrolled diabetes and 
Vietnamese participants had the lowest (Table 3b). There were no significant pairwise 
comparisons of the predicted prevalence of uncontrolled diabetes (Table 3b).  
 
4.3.3.1.3. Hypertension 
Russian-speakers and African Americans had a significantly higher mean SBP compared to white 
and Vietnamese participants (Table 4a).   
African Americans had the highest predicted prevalence of uncontrolled SBP and white 
participants had the lowest but differences were not significant (Table 4b).  
 
4.3.3.1.4. Dyslipidemia Non-HDL-c 
Russian-speakers had a substantially higher non-HDL-C compared to white, Vietnamese and 
African American participants (Table 5a).    
 Russian-speakers also had the highest predicted prevalence of uncontrolled non-HDL-C 
while Vietnamese participants had the lowest and this difference was significant (Table 5b).  
 
4.3.3.1.5. Dyslipidemia LDL-c 
Russian-speaking participants had a significantly higher LDL-C compared to white participants 
and Vietnamese participants (Table 6a). 
 Russian-speakers had the highest predicted prevalence of uncontrolled LDL-C and 
Vietnamese participants had the lowest. African American, white and Latino participants had 
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similar predicted prevalence of uncontrolled LDL-C.  Russian-speakers’ predicted prevalence of 
uncontrolled LDL-C was significantly higher compared to Vietnamese participants (Table 6b).  
 
4.3.3.4. Race/Ethnicity and Medication Adherence 
4.3.3.4.1. Morisky Adherence (self-report) 
African Americans and Latinos had a significantly lower self-reported mean medication 
adherence score compared to white participants. Additionally, Russian-speakers and Vietnamese 
participants had a significantly higher self-reported adherence compared to African Americans 
(Table 7a). 
 The predicted prevalence of adequate self-reported medication adherence was highest 
among Russian-speakers and Vietnamese participants and lowest among African Americans and 
this difference was significant between Russian-speakers compared to African American 
participants (Table 7b).  
 
4.3.3.4.2. Pill Count Adherence 
Russian-speakers and African Americans had a significantly lower mean medication adherence 
by pill count percent compared to white participants. Pairwise comparisons indicated no 
additional statistically significant differences between racial/ethnic groups (Table 8a).  
 Latinos had the highest predicted prevalence of low adherence by pill count followed by 
Russian-speakers. Vietnamese participants and African American participants had similar 
predicted prevalence and White participants had the lowest. However, predicted prevalence of 
low adherence by pill count did not significantly between any of the racial/ethnic groups (Table 
8b).  
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4.3.3.5. Race/Ethnicity and Social Determinants of Health 
4.3.3.5.1. Food Insecurity 
Latino participants had a significantly higher mean food insecurity score compared to white 
participants while Vietnamese participants had significantly lower food insecurity score 
compared to white participants. Russian-speakers had a significantly lower food insecurity score 
compared to both Latinos and African Americans  (Table 9a). 
The predicted prevalence of food insecurity was highest among Latinos and African 
Americans  followed by Vietnamese and white participants. Russian-speakers had the lowest 
predicted prevalence of food insecurity. Latino participants’ predicted prevalence of food 
insecurity was significantly higher compared to Russian-speakers (Table 9b).  
 
4.3.3.5.2. Social Stressors 
Latinos and African Americans had significantly higher mean social stressors compared to whites 
and Latinos had higher mean social stressor scores compared to Vietnamese and Russian-
speakers. Vietnamese and Russian-speakers had significantly lower mean social stressor scores 
compared to white and African American participants  (Table 10a).  
 Using a proportional odds model, both the likelihood ratio test (c2(2)=0.56, p=0.76) and 
the Brant Test (c2(2)=0.54, p=0.76) were not significant indicating the proportional odds 
assumption was not violated. We found that Latinos had a significantly higher odds of reporting a 
higher level of social stressors compared to whites and a significantly higher predicted prevalence 
of higher stressors compared to Russian-speakers and Vietnamese participants. Russian-speakers 
and Vietnamese participants reported substantially higher predicted prevalence of low social 
stressors compared to African Americans (Table 10b).  
 
 
	 159	
4.4. Discussion 
The aim of this study was to address a gap in health disparities research in the United States to 
better understand differences in SDoH, medication adherence and cardiometabolic disease 
outcomes among racially/ethnically diverse community health center patients. Understanding 
differences compared to non-Hispanic whites as well as compared to each other is important 
because standard racial/ethnic categorizations may result in overly heterogeneous groups. For 
example, based on traditional categorization, Russian-speakers would likely be categorized as 
non-Hispanic white. As a health care environment charged with providing culturally and 
linguistically appropriate services (CLAS; MADPH, 2018) and in the midst of implementing a 
Medicaid Accountable Care Organization (ACO), capturing the cultural and ethnic differences 
between groups plays a central role in the delivery of efficient and comprehensive quality care.  
This study provides insights into the current state of SDoH, medication adherence and 
cardiometabolic disease control among an ethnically diverse community health center population 
and includes two groups less frequently included in health disparities research—Vietnamese and 
Russian-speakers. Several important patterns of racial/ethnic differences emerged. First, 
race/ethnicity was independently associated with each of the cardiometabolic control measures 
(continuous A1c for Diabetes), medication adherence, and SDoH outcomes adjusting for age, 
education, income, and depression and in some cases additional variables such as BMI and 
number of comorbid chronic conditions (Tables 3-10).  
Second, we also identified that for all factors excluding pill count medication adherence, 
there were additional significant differences between the racial/ethnic minority groups detected 
with the pairwise comparisons. Russian-speakers fared significantly worse on all clinical 
outcomes compared to Vietnamese and on non-HDL-C compared to African Americans. 
Vietnamese had significantly lower A1c compared to African Americans.  
In contrast to the clinical outcomes, Russian-speakers reported the lowest SDoH-related 
factors. Latinos and African Americans had substantially higher food insecurity and social 
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stressors. Vietnamese and white participants were in the middle on both SDoH factors. Possible 
explanations of lower SDoH factors among the two foreign-born groups have been initially 
explored using qualitative data in the larger mixed-methods RxHL study (PI Shaw). Participants 
have reported strict requirements for  newly arriving refugees to have documented family 
sponsors. These requirements may result in Russian-speaking and Vietnamese participants having 
well-developed community, family and social support networks (Shaw et al., 2018). Though we 
do not have measure of length of stay in the U.S., it appears long-standing social networks may 
mitigate gaps in food resources and manage social stressors.  
Third, medication adherence rates were relatively low across all groups and differed 
significantly by group, however, the two methods of medication adherence measurement had 
substantially different results. The differences in low medication adherence as measured by self-
report versus pill count (Table 2) suggest that Russian-speakers and Vietnamese participants were 
not accurately captured by the self-report. In contrast, African Americans and Latinos had fairly 
comparable adherence rates captured by both methods of measurement (Table 2). There is 
currently no gold standard for medication adherence. Pill count is, however, considered an 
objective measure of medication adherence and, based on these findings, may be an overall more 
accurate capture of medication adherence for all participants. Multimeasure approach is 
recommended and, depending on the feasibility of conducting pill counts, this study provides 
insights as to the comparability between measures and the differences between the two methods 
among diverse patient populations (Korchmaros et al., 2018).  
White participants in this study comprised the smallest group (n=40) which presents a 
potential challenge to their use as the referent group. White participants in this study were also 
patients of the community health center, low-income and most were managing multiple chronic 
diseases. Though it is likely that the white participants benefit over the lifecourse from white 
privilege, based on their membership in a low-income urban environment, it is also possible that 
they are negatively impacted by policies that have historically benefited whites (Malat et al., 
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2018). While we identified significant differences among the racial/ethnic minority group 
participants compared to the non-Hispanic white participants in the linear and logit regression 
models, the differences indicated both worse and better outcomes compared to whites. 
Furthermore, the pairwise comparisons helped to highlighted additional differences by explicitly 
making the comparison between each group; differences that would have been still true if 
comparing to whites but may not have been as readily recognizable by an interdisciplinary public 
health audience. The differences identified in this study underscore the need for more granular 
breakout of racial/ethnic groups beyond the more standard categorizations that ignore the role of 
cultural and ethnic identity and assume homogeneity among racial groupings. From a 
community-responsive research and implementation science perspective, these differences may 
help to inform the translation of research into historically/politically relevant, culturally-
meaningful interventions that build on the strengths, assets, or other important factors identified 
among racial/ethnic minority groups.  
In related research, social epidemiologists have developed the subjective social status 
(SSS). SSS was developed toward a goal of “more fully captur[ing] the cumulative influences of 
social hierarchy on health by taking into account people’s earlier life circumstances, group 
experiences, family history and perceived future trajectories” (Wolff et al., 2009, p.561). The SSS 
is a new measure in health disparities research and, while it is newer and validity studies are still 
needed, findings have indicated that perception of social status differs across groups and that 
selection of the referent group does matter (Wolf et al., 2009). This further highlights the 
importance of using self-reported racial/ethnic categories based on culture, language, and country 
of origin. In this way, groupings were more homogeneous regarding their historical/political, 
social and economic context compared to if we had used census-based race/ethnicity 
categorizations. Additional community responsive research strategies for conducting research 
with racially/ethnically and culturally diverse groups have been reported by the investigator team 
(Shaw et al., 2018). 
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The findings in this study are also responsive to a health equity call to action that public 
health and health care policy, messaging, and systems not inadvertently reify social biases. 
Though statistical procedures are not in and of themselves biased, they can represent human 
biases when they incorporate socially-determined risk factors, when they prescribe what or who 
we “ought” to be like as a standard, or when data are presented without social, historical, political 
and economic context. In a recent National Public Radio and TED Talk segment, Cathy O’Neil, a 
mathematician and data scientist, warned that algorithms and analytics used in “big data” 
reproduce inequality by embedding social bias in analytic code—a process she argued can 
“codify bias and bigotry” (O’Neil, 2017).  Some state- and regional public health entities have 
taken action to develop health equity statements to be included when presenting racial/ethnic 
health disparities data. The health equity statements contextualize racial/ethnic health disparities 
data as being rooted in the historical, social, political and economic injustices that are upstream of 
the group-based disparities and that are independent of individual behaviors (Colorado DPH, 
2018; PHIWMA, 2018; Phelan et al., 2004; Phelan et al., 2010). As public health scientists and 
educators, we are positioned and charged with a responsibility to translate research findings into 
actionable opportunities for improvements in the community. Therefore, framing health 
disparities research to better detect possible strengths and assets among racial/ethnic minorities is 
an important contribution to this process.  
 
4.4.1. Strengths and Limitations 
In addition to the strengths described in Chapter 1, this study broadened the existing literature on 
racial/ethnic differences in SDoH, medication adherence and cardiometabolic outcomes  by 
examining patterns of health disparities between each racial/ethnic group among a diverse 
community health center patient population. The findings are timely given the current efforts in 
health care reform to identify opportunities for applied intervention that are responsive to SDoH-
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related barriers to care and self-management among racially/ethnically diverse low-income 
patients.  
 This study has similar limitations as described in detail in Chapter 1 including those 
related to cross-sectional design, small sample size, and measurement error associated with self-
report, electronic medical record data abstraction, and pill count.  Beyond these potential 
limitations, in this study it is also possible that perceptions of food insecurity, social stress, and 
medication adherence as captured in the instruments may differ across the groups and translation, 
particularly into Vietnamese and Russian, may not fully capture the intended meaning of the 
concepts being measured based. We reduced the likelihood of this by using professional 
translators and then having native bicultural/bilingual staff including the research interviewers at 
the health center review the translations to provide additional feedback to ensure the translations 
were accurate and representative of the regional dialects represented in the patient population. 
The investigator team is examining a similar question as it relates to the health literacy measure 
(Shaw et al., 2018) and will continue to consider cultural, educational, language, and other related 
factors and qualitative themes that impact conducting research with U.S.-born, immigrant and 
refugee patient populations.    
 
4.4.2. Confounding 
 
We evaluated potential confounders known to be associated with race/ethnicity and each of the 
outcome variables as identified in the literature. Potential confounders not measured in the 
study—exercise, length of time in U.S., household size, date of disease onset—could lead to 
residual confounding and could bias the results in either direction. It is also possible that we have 
inadequately measured one or more of our other confounders. For instance, if there was 
measurement with BMI it may be limited in its ability to control for adiposity. If this were to have 
occurred, the residual confounding could lead to either an over- or under-estimate of the effect 
estimate and bias the results toward or away from the null. Given the relatively minimal 
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confounding detected overall (including in Chapters 2 and 3), additional consideration as to the 
role and impact of confounding (measured and unmeasured) within the social determinants of 
health theoretical (and causal) framework merits additional consideration.  
We have considered the possible role of unmeasured, residual confounding and took 
several steps to reduce this possibility. First, though household size was not collected, we created 
an income equivalence variable to account for reported single/partnered status and divided 
household income by the square root of 2 for those reporting partnered status. Additionally, we 
conducted model building procedures (both saturated to trim and trim to saturated) using 
likelihood ratio testing and F Partial Tests to select the appropriate covariates to include in each 
model.  
 
4.5. Significance & Next Steps 
While limited by small sample size to examine the interrelationship between SDoH, medication 
adherence and cardiometabolic disease outcomes through mediation and effect modification 
analyses, several important qualitative patterns have been identified that raise additional questions 
for future research. First, African American and Latino participants’ high levels of SDoH, 
relatively low medication adherence, and relatively poor cardiometabolic disease control may 
indicate a pattern illustrated in Marmot’s SDoH theoretical framework (Marmot et al., 2006)—the 
guiding theoretical framework in Chapters 1 and 2. In contrast, Russian-speakers’ lower levels of 
SDoH, low medication adherence, and uncontrolled disease suggest a need to further explore 
factors upstream of medication adherence that are culturally, historically/politically relevant to 
this group.  Vietnamese participants’ low social stress and moderate food insecurity, low 
medication adherence, and relatively better disease control suggest there may be other upstream 
factors that should be further explored that are influencing individual-level behaviors beyond 
medication adherence (e.g., exercise, ethnic density) that are positively impacting 
cardiometabolic disease outcomes. These may be social, cultural, or other environmental factors 
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and may serve as important protective factors that could be further explored and possibly tailored 
to expand to other racial/ethnic groups. The emerging patterns highlight possible differences 
between U.S.-born racial/ethnic groups and immigrant/refugee groups as well as differences 
between the immigrant/refugee groups. Based on the emerging patterns, factors such as 
racism/discrimination, historical/political contexts and experiences, patient/provider 
communication, trust, social support, ethnic density and neighborhood factors, cultural health 
beliefs and related protective factors may be important to consider in future research.  
Continued identification of qualitative themes are needed to further explain the findings. 
Additional research in similarly diverse community health center patient populations where 
SDoH-related barriers and unmanaged cardiometabolic disease is prevalent is also needed. Use of 
pairwise comparisons across all groups in addition to using non-Hispanic white as the referent 
group can facilitate identifying differences that may otherwise go unidentified. Identification of 
possibly protective features or strengths among racial/ethnic minority groups can be used to 
develop historically/politically and culturally relevant interventions, practice improvements, and 
policy.   
 
4.5.1. Generalizability 
The results of this study may be generalized to other similar populations of low-income 
individuals with cardiometabolic diseases, particularly those served in community health center 
environments. Though there is low likelihood of finding this specific grouping of community 
health center patients in other geographic regions, it is likely that racial/ethnic differences and 
patterns will emerge among other ethnically diverse low-income patient populations. This may be 
particularly true in environments that include culturally/linguistically diverse populations 
including U.S.-born (e.g., African American and Puerto Rican populations) and foreign-born 
immigrant and refugee groups and where there is less variability in socioeconomic status.  
	
	 166	
4.6. Overall SDoH and Cardiometabolic Disease Project Summary 
We had unexpected null findings in the relationship between SDoH and glycemic control among 
those with a clinical diagnosis of diabetes and SBP control among those with a clinical diagnosis 
of hypertension. Food insecure participants had significantly higher lipid levels. Those with 
moderate/high social stressors had significantly higher lipid levels. Self-reported medication 
adherence partially mediates the association of SDoH and lipid levels. There is a higher 
correspondence between self-reported and pill count medication adherence among African 
Americans and Latinos, and a lower correspondence between the two measures among Russian-
speakers and Vietnamese participants.  
SDoH factors—food insecurity and social stressors—are significantly higher among 
Latinos and African Americans compared to white, Vietnamese and Russian-speakers. Russian-
speakers had the poorest disease outcomes and African Americans had significantly higher SBP 
despite being patients in an environment where they have similar access to care and medications 
compared to whites and other racial/ethnic groups. Significant differences between racial/ethnic 
minority groups and between U.S.-born/foreign-born may indicate opportunity to examine 
strengths/assets among cultural groups to inform policy, practice interventions/improvements. 
All of the conditions in this study – HTN, DM and Dyslipidemia – are affected by diet 
and therefore, by extension, we expected would also be impacted by food insecurity. Our null 
findings with diabetes and hypertension and our independent association with dyslipidemia 
control may indicate that dyslipidemia is potentially more sensitive to diet or to the actual dietary 
content of this sample versus the other conditions. Fatty foods (e.g., fast foods and high density, 
low nutrient foods) could affect dyslipidemia more than HTN or DM and therefore may provide 
insight to the patterns we detected.  
In addition to combining all medications to calculate a mean percent medication 
adherence, we established disease-specific pill-count medication adherence and found those with 
dyslipidemia had slightly higher adequate adherence (63.2%) compared to those with diabetes 
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(57.9%) and those with hypertension (60.2%).  For each disease control model, we adjusted for 
number of comorbid diseases. However, it is possible that in the disease-specific modeling and 
adherence analyses, there may have been individuals with comorbid disease for which they were 
not prescribed or not taking medications. Next steps include consideration of multimorbidity and 
multimorbid disease-specific medication adherence. 
Given the public health programming and initiatives focused specifically on diabetes and 
hypertension prevention and management at the community health center research site and 
throughout the region, it is also possible that 1) people were more aware of their diabetes and 
hypertension; 2) understood the self-management requirements for diabetes and hypertension 
better than dyslipidemia; and/or 3) consider hypertension and diabetes to be more important.  
There were several limitations in this study. This was a  cross-sectional design and 
therefore we are unable to assess temporality among the observed relationships or capture time-
varying/cyclic variables. We had relatively small sample size and wide confidence intervals 
which may have limited our ability to assess mediation and effect modification.  It is possible that 
measurement error was an issue based on using self-reported variables and EMR lab data. There 
may be possible residual confounding from certain factors not measured such as exercise, onset 
of disease, household size, and length of time in U.S. Additionally, there may be unknown 
social/cultural factors, unknown cultural differences in meaning, interpretation, social 
desirability. These factors may impact translation and scale validity—an issue we are examining 
closely in the larger RxHL study as it relates to health literacy. 
There were several strengths of the study as well. Our study includes a unique US- and 
foreign-born racially/ethnically diverse patient population. It includes immigrant/refugee groups 
that are less frequently included in SDoH and health disparities research. It includes a community 
health center population where cardiometabolic disease and SDoH are prevalent and are the focus 
of applied efforts in health care reform. 
	 168	
The research is conducted based on a community-responsive research approach with an 
interdisciplinary, interprofessional research team and with a strong commitment to translation of 
findings inform applied, sustainable interventions and to spearhead next-steps in research. 
According to Carter-Pokras et al. Jay Kaufman (2012), our research approach contributes to the 
need and call for “epidemiologists to encompass the complexity of health disparities and address 
contextual social determinants that contribute to disease, and the foundation of successful health 
equity strategies that can reduce and/or eliminate health disparities”. 
In future community-responsive research, we aim to analyze the current data using the 
revised AHA/ACA hypertension control guideline of 130/80 mmHg. Also in response to the 
ACC/AHA guidelines, we aim to consider ASCVD risk and statin use (with statin intensity) 
among those at risk, for instance among the food insecure; and among those with high social 
stress.  
From a method perspective, we aim to assess and implement culturally acceptable 
methods to measure biomarkers of stress and inflammation and to examine stress using self-
reported and biomarker as possible mediators of SDoH and cardiometabolic disease control. 
Ideally, a prospective research design would allow us to address temporality and the time varying 
factors. Additionally, we aim to use multilevel modeling for cluster analysis of neighborhood-
level factors like ethnic density.  
We aim to increase our sample size and associated power to detect effects. Two goals to 
achieve this are to possibly collaborate on research initiatives with the newly formed ACO 
Medicaid patient population and to establish a multi-site and/or multi-community health center 
research collaborative or network.  
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Table 21. Number and percent of racial/ethnic groups  
 
Race/Ethnicity N (%) 
African American 85( 23.6) 
Latino 76 (21.1) 
Vietnamese 97 (26.9) 
Russian-speaking 63 (17.5) 
White 40 (11.1) 
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Table 22.Cllinical outcome variables by race/ethnicity  
 
 
 
 
Table 23. Medication adherence outcome variables by race/ethnicity  
 
 
 
 
 
 
 
 
African American Latino Vietnamese Russian-speaking white p-value
Diabetes
     Uncontrolled (N, %) 17 (48.6) 18 (40.9) 22 (41.5) 14 (56.0) 8 (57.1) 0.1
     A1c (Mean, SD) 7.9 (2.4) 7.8 (2.0) 6.9 (1.0) 7.8 (2.0) 8.0 (2.2) 0.04
Hypertension
    Uncontrolled (N, %) 29 (37.7) 14 (23.7) 23 (25.6) 18 (31.6) 6 (16.2) 0.03
    SBP (Mean,SD) 133.0 (14.4) 127.5 (16.8) 129.7 (17.1) 137.0 (14.8) 125.1 (17.7) 0.002
Dyslipidemia
     Uncontrolled (N, %) 24 (49.0) 22 (57.9) 34 (38.6) 24 (66.7) 14 (50.0) 0.03
     non-HDL-C (Mean,SD) 133.0 (36.6) 145.9 (47.6) 125.6 (37.6) 159.8 (42.0) 136.9 (38.0) 0.001
Dyslipidemia
     Uncontrolled (N, %) 24 (49.0) 18 (47.37) 35 (39.8) 23 (63.9) 14 (50.0) 0.06
     LDL-C (Mean,SD) 108.1 (35.8) 109.8 (42.7) 98.0 (35.3) 129.2 (47.1) 100.7 (31.9) 0.003
Study Group
African American Latino Vietnamese Russian-speaking white p-value
Medication Adherence 
     Low Adherence (N, %) 38 (44.7) 37 (48.7) 12 (12.4) 10 (15.9) 10 (25.0) <0.001
     Morisky score (Mean,SD) 5.3 (2.1) 5.3 (1.8) 6.7 (1.2) 6.5 (1.3) 6.2 (1.5) <0.001
Medication Adhernece
     Low Adherence (<80%)(N, %) 34 (40.0) 32 (42.1) 36 (37.1) 27 (42.9) 12 (30.0) 0.004
     Pill Count (Mean,SD) 67.4 (28.8) 67.6 (27.5) 80.2 (14.9) 68.6 (23.7) 78.3 (20.0) 0.001
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Table 24. SDoH outcome variables by race/ethnicity  
 
 
African American Latino Vietnamese Russian-speaking white p-value
Food Security
     Food Insecure (N, %) 36(42.3) 50(65.8) 22(22.7) 9(14.3) 14(35.0) <0.001
    Food Security score (Mean, SD) 1.8(2.2) 2.7(2.1) 0.92(1.3) 0.52(1.0) 1.6(2.2) <0.001
Social Stress (N, %)
     0-1 Stressors 19(22.35) 5(6.58) 38(39.18) 24(38.10) 9(22.5) <0.001
     2-4 Stressors 18(21.18) 15(19.74) 40(41.24) 26(41.27) 14(35.00)
     5-7 Stressors 15(17.65) 25(32.89) 14(14.43) 7(11.11) 10(25.00)
     8+Stressors 33(38.82) 31(40.79) 5(5.15) 6(9.52) 7(17.50)
     Social Stressor Score (Mean, SD) 6.2(5.2) 6.8(3.6) 2.7(2.6) 2.78(2.9) 4.3(3.1) <0.001
Health Literacy
     Low Health Literacy (N, %) 23(27.1) 21(27.6) 54(55.7) 30(47.6) 6(15.0) <0.001
     Health Litearcy score (Mean, 14.8(4.0) 14.6(4.8) 11.1(6.1) 13.9(3.1) 16.1(3.4) <0.001
Study Group
	 172	
Table 25. Covariates by race/ethnicity 
  
African American Latino Vietnamese Russian-speaking white p-value
Gender 
     Male 35 (41.2) 38 (50.0) 34 (35.1) 19 (30.2) 26 (65.0) <0.003
    Female 50 (58.8) 38 (50.0) 63 (64.9) 44 (69.8) 14 (35.0)
Partner/living status 
     Living w partner/family 19 (22.4) 24 (31.6) 44 (45.4) 42 (66.7) 9 (22.5) <0.001
Homeless 
     Yes 13 (15.3) 11 (14.5) 4 (4.1) 1 (1.6) 1 (2.5) 0.02
Language
     English 85 (100) 24 (31.6) 1 (1.0) 2 (3.2) 40 (100) <0.001
     Spanish 52 (68.4)
     Vietnamese 96 (99.0)
     Russian 61 (96.8)
PHQ 
     PHQ score (Mean, SD) 4.8 (6.6) 7.8 (8.2) 1.6 (3.5) 3.1 (4.8) 3.6 (6.6) <0.001
     Depression symptoms (N, %) 27 (31.8) 34 (44.7) 9 (9.3) 14 (22.2) 7 (17.5) <0.001
BMI
     BMI score (Mean, SD) 34.5 (9.1) 33.1 (8.0) 26.3 (4.0) 35.2 (6.3) 34.3 (7.5) <0.001
     Obese (BMI>=30) (N, %) 58 (68.2) 45 (59.2) 16 (16.5) 44 (69.8) 28 (70.0) <0.001
Smoke 
     Yes 56 (65.9) 49 (64.5) 15 (15.5) 5 (7.9) 31 (77.5) <0.001
Alcohol 
     Yes 39 (45.9) 14 (18.4) 9 (9.3) 1 (1.6) 10 (25.0) <0.001
Insulin 
     Yes 12 (34.3) 14 (31.8) 10 (18.9) 2 (8.0) 6 (42.9) 0.04
Gap in Insurance (N, %)
     Yes 13 (15.3) 10 (13.2) 4 (2.1) 8 (12.7) 10 (13.2) 0.09
Cost barrier to care
     Yes 9 (10.6) 6 (7.9) 3 (3.1) 9 (14.3) 3 (7.5) 0.12
Transportation barrier to care
     Yes 30 (35.3) 21 (27.6) 10 (10.3) 2 (3.2) 9 (22.5) <0.001
Cost barrier to medication
     Yes 36 (42.4) 32 (42.1) 6 (6.2) 7 (11.1) 10 (25.0) <0.001
Trans. barrier to medication
     Yes 24 (28.2) 19 (25.0) 1 (1.0) 2 (3.2) 3 (7.5) <0.001
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Table 26a. Adjusted mean difference (95% CI) of A1c%, Adjusted Predicted A1c% (95% CI) and Adjusted Pairwise Comparisons 
 
 
 
 
 
Table 26b. Adjusted odds of uncontrolled DM (95% CI), Adjusted Predicted Prevalence Uncontrolled  
DM (95% CI) and Adjusted Pairwise Comparisons 
 
 
 
 
N(%) Adjusted Pairwise Comparisons
Mean Difference  95% CI A1c 95% CI p<0.05
Race Ethnicity
white 12 (7.4) 1 Referent 8.13 7.12, 9.15 ~
African American 35 (21.6) -0.04 -1.21, 1.13 8.10 7.47, 8.72 ~
Vietnamese 52(32.1) -1.50 -2.71, -0.30 6.63 6.06, 7.20 vs. African American
Russian-speaking 22(13.6) -0.10 -1.35, 1.15 8.03 7.28, 8.78 vs. Vietnamese
Latino 41 (25.3) -0.37 -1.55, 0.81 7.76 7.18, 8.34 ~
Adjusted Mean Difference-Parsimonious model: Adjusted for age, education, income (equivalence), 
depression.
Adjusted Mean Difference Adjusted Predicted A1c
Cases n=79 Adjusted Pairwise Comparisons
N(%) OR  95% CI Uncontrolled DM 95% CI p<0.05
Race Ethnicity
white 8 (10.1) 1.0 Referent 0.72 0.48, 0.97 ~
African American 17 (21.5) 0.41 0.10, 1.71 0.53 0.35, 0.71 ~
Vietnamese 22 (27.9) 0.22 0.05, 1.07 0.38 0.22, 0.55 ~
Russian-speaking 14 (17.7) 0.72 0.15, 3.35 0.66 0.46, 0.89 ~
Latino 18 (22.8) 0.29 0.07, 1.28 0.45 0.28, 0.61 ~
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, BMI.
Adjusted Odds Adjusted Predicted Prevalence
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Figure 16. Adjusted mean difference and 95 % CI in A1c by race/ethnicity 
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Figure 17. Adjusted Predicted A1c and Pairwise Comparisons by Race/Ethnicity 
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Table 27a. Adjusted mean difference (95% CI) of SBP mmHg, Adjusted Predicted SBP mmHg (95% CI) and Adjusted Pairwise 
Comparisons 
 
 
 
 
Table 27b. Adjusted odds of uncontrolled HTN (95% CI), Adjusted Predicted Prevalence Uncontrolled HTN (95% CI) and Adjusted 
Pairwise Comparisons 
 
 
N(%) Adjusted Pairwise Comparisons
Mean Difference  95% CI SBP 95% CI p<0.05
Race Ethnicity
white 37 (12.0) 1 Referent 125.70 120.34, 131.02 ~
African American 77 (24.9) 8.52 2.12, 14.92 134.21 130.44, 137.99 vs. white
Vietnamese 79 (25.6) 2.23 -4.98, 9.42 127.91 123.66, 132.17 ~
Russian-speaking 57 (18.4) 10.97 4.12, 17.81 136.66 132.34, 140.99 vs. white; vs. Vietnamese
Latino 59 (19.1) 2.77 -4.00, 9.55 128.47 124.12, 132.82 ~
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression.
Adjusted Mean Difference Adjusted Predicted SBP
Cases (n=90) Adjusted Pairwise Comparisons
N(%) OR  95% CI Uncontrolled HTN 95% CI p<0.05
Race Ethnicity
white 6 (6.7) 1.0 Referent 0.16 0.04, 0.28 ~
African American 29 (32.2) 3.19 1.17, 8.70 0.38 0.26, 0.49 vs. white
Vietnamese 23 (25.6) 2.16 0.71, 6.60 0.29 0.17, 0.41 ~
Russian-speaking 18 (20.0) 2.42 0.84, 7.01 0.32 0.19, 0.44 ~
Latino 14 (15.5) 1.6 0.53, 4.79 0.23 0.12, 0.35 ~
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression.
Adjusted Odds Adjusted Predicted Prevalence
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Figure 18. Mean Difference and 95% CI in SBP by Race/Ethnicity 
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Figure 19. Adjusted Predicted SBP and Pairwise Comparisons by Race/Ethnicity 
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Table 28a. Adjusted mean difference (95% CI) of non-HDL-C mm/dL, Adjusted Predicted non-HDL-C mm/dL (95% CI) and Adjusted 
Pairwise Comparisons 
 
 
 
 
Table 28b. Adjusted odds of uncontrolled DYS (95% CI), Adjusted Predicted Prevalence Uncontrolled DYS (95% CI) and Adjusted 
Pairwise Comparisons 
 
N(%) Adjusted Pairwise Comparisons
Mean Difference  95% CI non-HDL-C 95% CI p<0.05
Race Ethnicity
white 27 (12.1) 1 Referent 137.06 121.53, 152.58 ~
African American 43 (19.2) -4.28 -23.58, 15.02 132.77 120.39, 145.16 ~
Vietnamese 85 (37.9) -11.73 -31.37, 7.92 125.33 115.51, 135.15 ~
Russian-speaking 33 (14.7) 24.55 4.01, 45.08 161.60 147.38, 175.82 vs. white; vs. African American; vs. 
Vietnamese
Latino 36 (16.1) 7.99 -12.40, 28.38 145.05 131.55, 158.55 ~
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, number of 
comorbid chronic diseases.
Adjusted Mean Difference Adjusted Predicted Non-HDL-C
Cases (n=118) Adjusted Pairwise Comparisons
N(%) OR  95% CI Uncontrolled DYS 95% CI p<0.05
Race Ethnicity
white 14 (11.9) 1.0 Referent 0.52 0.32, 0.72 ~
African American 24 (20.3) 1.33 0.48, 3.70 0.59 0.43, 0.75 ~
Vietnamese 34 (28.8) 0.63 0.21, 1.90 0.41 0.28, 0.55 ~
Russian-speaking 24 (20.3) 2.58 0.83, 7.97 0.73 0.57, 0.89 vs. Vietnamese
Latino 22 (18.6) 1.6 0.53, 4.77 0.63 0.46, 0.80 ~
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, BMI, 
number of comorbid chronic diseases.
Adjusted Odds Adjusted Predicted Prevalence
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Table 29a. Adjusted mean difference (95% CI) of LDL-C mm/dL, Adjusted Predicted LDL-C mm/dL (95% CI) and Adjusted Pairwise 
Comparisons  
 
 
 
Table 29b. Adjusted odds of uncontrolled DYS (95% CI), Adjusted Predicted Prevalence Uncontrolled DYS (95% CI) and Adjusted 
Pairwise Comparisons 
 
 
 
 
N(%) Adjusted Pairwise Comparisons
Mean Difference  95% CI LDL-C 95% CI p<0.05
Race Ethnicity
white 27 (12.1) 1 Referent 102.14 87.29, 116.99 ~
African American 43 (19.3) 6.45 -12.01, 24.91 108.59 96.75, 120.43 ~
Vietnamese 85 (38.1) -5.47 -24.26, 13.33 96.67 87.27, 106.07 ~
Russian-speaking 32 (14.3) 29.58 9.83, 49.33 131.72 117.90, 145.53 vs. white; vs. Vietnamese
Latino 36 (16.1) 6.91 -12.59, 26.42 109.05 96.14, 121.95 ~
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, number of 
comorbid chronic diseases.
Adjusted Mean Difference Adjusted Predicted LDL-C
Cases (n=114) Adjusted Pairwise Comparisons
N(%) OR  95% CI Uncontrolled DYS 95% CI p<0.05
Race Ethnicity
white 14 (12.3) 1.0 Referent 0.54 0.34, 0.73 ~
African American 24 (21.1) 1.18 0.43, 3.25 0.58 0.41, 0.74 ~
Vietnamese 35 (30.7) 0.59 0.20, 1.77 0.41 0.28, 0.55 ~
Russian-speaking 23 (20.2) 2.66 0.85, 8.32 0.75 0.59, 0.91 vs. Vietnamese
Latino 18 (15.8) 0.91 0.31, 2.66 0.51 0.34, 0.69 ~
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression.
Adjusted Odds Adjusted Predicted Prevalence
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Figure 20. Adjusted Mean Difference and 95% CI in LDL-C by Race/Ethnicity 
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Figure 21. Adjusted Predicted LDL-C and Pairwise Comparisons by Race/Ethnicity 
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Table 30a. Adjusted mean difference (95% CI) of self-reported medication adherence, Adjusted Predicted self-reported medication 
adherence (95% CI) and Adjusted Pairwise Comparisons 
 
 
Table 30b. Adjusted odds of self-reported low adherence (95% CI), Adjusted Predicted Prevalence self-reported low adherence (95% CI) 
and Adjusted Pairwise Comparisons 
 
 
 
 
 
N(%) Adjusted Pairwise Comparisons
Mean Difference  95% CI MMAS 95% CI p<0.05
Race Ethnicity
white 40 (11.1) 1 Referent 6.38 5.89, 6.87 ~
African American 85 (23.6) -0.88 -1.46, -0.29 5.50 5.16, 5.84 vs. white
Vietnamese 97 (26.9) -0.05 -0.69, 0.59 6.33 5.97, 6.69 vs. African American
Russian-speaking 63 (17.5) -0.05 -0.67, 0.57 6.33 5.94, 6.72 vs. African American
Latino 76 (21.1) -0.76 -1.36, -0.15 5.62 5.26, 5.98 vs. white 
Adjusted Mean Difference Adjusted Predicted Adherence
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression.
Cases (n=107) Adjusted Pairwise Comparisons
N(%) OR  95% CI Low Adherence 95% CI p<0.05
Race Ethnicity
white 10 (9.4) 1.0 Referent 0.77 0.64, 0.90 ~
African American 38 (35.5) 0.40 0.16, 1.00 0.60 0.49, 0.70 ~
Vietnamese 12 (11.2) 1.33 0.42, 4.15 0.81 0.71, 0.92 ~
Russian-speaking 10 (9.4) 1.42 0.48, 4.19 0.82 0.72, 0.93 vs. African American
Latino 37 (34.6) 0.44 0.17, 1.11 0.62 0.51, 0.72 ~
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, BMI.
Adjusted Odds Adjusted Predicted Prevalence
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Figure 22. Adjusted Predicted Self-Reported Medication Adherence and Pairwise Comparisons by Race/Ethnicity 
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Table 31a. Adjusted mean difference (95% CI) of pill count medication adherence, Adjusted Predicted pill count medication adherence 
(95% CI) and Adjusted Pairwise Comparisons 
 
 
 
 
 
Table 31b. Adjusted odds of pill count low adherence (95% CI), Adjusted Predicted Prevalence pill count low adherence (95% CI) and 
Adjusted Pairwise Comparisons 
 
 
 
N(%) Adjusted Pairwise Comparisons
Mean Difference  95% CI Pill Count Adher. 95% CI p<0.05
Race Ethnicity
white 29 (10.2) 1 Referent 79.30 70.38, 88.21 ~
African American 69 (24.3) -10.48 -20.92, -0.05 68.82 63.0, 74.63 vs. white
Vietnamese 87 (30.6) -0.48 -11.72, 10.76 78.82 72.99, 84.64 ~
Russian-speaking 43 (15.1) -12.06 -23.47, -0.64 67.24 60.0, 74.48 vs. white
Latino 56 (19.7) -10.47 -21.44, 0.51 68.83 62.37, 75.29 ~
Adjusted Mean Difference Adjusted Predicted Adherence 
Cases (n=141) Adjusted Pairwise Comparisons
N(%) OR  95% CI Low Adherence 95% CI p<0.05
Race Ethnicity
white 12 (8.5) 1.0 Referent 0.34 0.18, 0.50 ~
African American 34 (24.1) 1.42 0.60, 3.36 0.42 0.30, 0.52 ~
Vietnamese 36 (25.5) 1.47 0.55, 3.88 0.42 0.29, 0.55 ~
Russian-speaking 27 (19.2) 2.18 0.84, 5.64 0.52 0.37, 0.67 ~
Latino 32 (22.7) 2.26 0.92, 5.58 0.53 0.40, 0.66 ~
Model A-Parsimonious model: Adjusted for age, gender, education, income (equivalence), depression, 
BMI.
Adjusted Odds Adjusted Predicted Prevalence
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Figure 24. Adjusted Mean Difference and 95% CI in Pill Count Medication Adherence by Race/Ethnicity 
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Figure 25. Adjusted Predicted Pill Count Medication Adherence and Pairwise Comparisons by Race/Ethnicity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79
.3
68
.8 7
8.
8
67
.2
68
.8
0
10
20
30
40
50
60
70
80
90
white African
American
Vietnamese Russian Latino
A
dj
us
te
d 
Pr
ed
ic
te
d 
M
ed
ic
at
io
n 
A
dh
er
en
ce
 %
	 188	
Table 32a. Adjusted mean difference (95% CI) of food insecurity, Adjusted Predicted food insecurity (95% CI) and Adjusted Pairwise 
Comparisons 
 
 
 
 
 
Table 32b. Adjusted odds of food insecurity (95% CI), Adjusted Predicted Prevalence food insecurity (95% CI) and Adjusted Pairwise 
Comparisons 
 
 
N(%) Adjusted Pairwise Comparisons
Mean Difference  95% CI Food Insecurity 95% CI p<0.05
Race Ethnicity
white 40 (11.1) 1 Referent 1.45 0.91, 1.98 ~
African American 85 (23.6) 0.08 -0.55, 0.72 1.53 1.16, 1.91 ~
Vietnamese 97 (26.9) 0.11 -0.59, 0.81 1.56 1.16, 1.95 ~
Russian-speaking 63 (17.5) -0.76 -1.44, -0.08 0.68 0.26, 1.11 vs. white; vs. African American
Latino 76 (21.1) 0.68 0.01, 1.34 2.13 1.72, 2.53 vs. white; vs. Russian
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, 
employment.
Adjusted Mean Difference Adjusted Predicted Food Insecurity
Cases (n=131) Adjusted Pairwise Comparisons
N(%) OR  95% CI Food Insecure 95% CI p<0.05
Race Ethnicity
white 14 (10.7) 1.0 Referent 0.32 0.18, 0.46 ~
African American 36 (27.5) 1.27 0.53, 3.04 0.36 0.26, 0.46 ~
Vietnamese 22 (16.8) 1.07 0.38, 2.99 0.33 0.21, 0.45 ~
Russian-speaking 9 (6.9) 0.41 0.14, 1.18 0.18 0.08, 0.28 ~
Latino 50 (38.2) 2.95 1.20, 7.27 0.54 0.43, 0.68 vs. white; vs. Russian
Adjusted Odds Adjusted Predicted Prevalence
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, BMI.
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Figure 26. Adjusted Mean Difference and 95% CI in Food Insecurity by Race/Ethnicity 
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Figure 27. Adjusted Predicted Food Insecurity and Pairwise Comparisons by Race/Ethnicity 
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33a. Adjusted mean difference (95% CI) of social stressors, Adjusted Predicted social stressors (95% CI) and Adjusted Pairwise 
Comparisons 
 
 
 
 
33b. Adjusted proportional odds of social stress level (95% CI), Adjusted Predicted Prevalence social stress level (95% CI) and Adjusted 
Pairwise Comparisons 
 
 
 
N(%) Adjusted Pairwise Comparisons
Mean Difference  95% CI Social Stressors 95% CI p<0.05
Race Ethnicity
white 40 (11.1) 1 Referent 4.21 3.09, 5.34 ~
African American 85 (23.6) 1.73 0.39, 3.08 5.95 5.17, 6.72 vs. white
Vietnamese 97 (26.9) -0.92 -2.39, 0.55 3.29 2.47, 4.12 vs. African American
Russian-speaking 63 (17.5) -1.22 -2.66, 0.22 2.99 2.09, 3.90 vs. African American
Latino 76 (21.1) 2.06 0.68, 3.44 6.27 5.44, 7.10 vs. white; vs. Vietnamese; vs. Russian
Adjusted Mean Difference
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, number of 
comorbid chronic diseases.
Adjusted Predicted Social Stressors
Cases (n=82; 8+ Stressors) Adjusted Pairwise Comparisons
N(%) OR  95% CI Low Stress 95% CI p<0.05
Race Ethnicity
white 7 (8.5) 1.0 Referent 0.24 0.14, 0.35 ~
African American 33 (40.2) 1.67 0.80, 3.48 0.17 0.10, 0.23 ~
Vietnamese 5 (6.1) 0.58 0.25, 1.31 0.35 0.25, 0.44 vs. African American
Russian-speaking 6 (7.3) 0.52 0.24, 1.11 0.37 0.26, 0.47 vs. African American
Latino 31 (37.8) 2.51 1.20, 5.28 0.12 0.07, 0.17 vs. white; vs. Vietnamese; vs. Russian
Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, BMI.
Adjusted Proportional Odds Adjusted Predicted Prevalence
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Figure 28. Adjusted Mean Difference and 95% CI in Social Stressors by Race/Ethnicity 
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Figure 29. Adjusted Predicted Social Stressors and Pairwise Comparisons by Race/Ethnicity 
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